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Zusammenfassung  
Diese Doktorarbeit beschreibt unsere Studien zu der Totalsynthese des ent-Trachyloban 
Diterpenoids Mitrephorone A. 
 
Mitrephorone A wurde  aus der Rinde von Mitrephora glabra, einem indonesischen 
Annonengewächs, isoliert. Der Naturstoff hat einen einzigartigen molekularen Aufbau mit einem 
hexazyklischen Ringsystem, acht Stereozentren, einem Diketon und einem Oxetanring. 
Mitrephorone A zeigt moderate zytotoxische Aktivität gegen Tumorzelllinien und ist somit ein 
potentielles Krebsmedikament. 
 
Der erste Teil dieser Doktorarbeit beschreibt unsere Versuche, eine enantioselektive und 
konvergente Syntheseroute der Kernstruktur von Mitrephorone A zu entwickeln. Die 
ausgearbeitete Route beginnt mit der Herstellung von Enon I durch eine enantioselektive Diels–
Alder Reaktion. Die Umwandlung zu Alkin II wurde in einer sechsschrittigen Sequenz realisiert, 
die eine intramolekulare Diels–Alder Reaktion beinhaltet und die Käfigstruktur des Naturstoffs 
aufbaut. Als nächstes wurden die Bausteine II und III in einer Sonogashira Kupplung miteinander 
verbunden. Eine asymmetrische dearomative Zyklisierung von V schließt den letzten 
Kohlenstoffring von Mitrephorone A und setzt an C10 die richtige Stereochemie. Des Weiteren 
werden Studien zu dem Versuch, die Vorstufe VI in den Naturstoff umzuwandeln, präsentiert. 
 
 
Abbildung A Konvergente und enantioselektive Syntheseroute für die Kernstruktur von Mitrephorone A. 
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In dem zweiten Teil dieser Doktorarbeit haben wir eine andere, robuste und enantioselektive 
Synthese des kompletten Kohlenstoffgerüsts von Mitrephorone A entwickelt. Die Synthesesequenz 
beginnt mit dem literaturbekannten Baustein VII. Eine Sharpless Dihydroxylierung und eine 
Robinson Annulierungssequenz ergeben Enon VII, das unter anderem durch eine α-Vinylierung 
und eine intramolekulare Diels–Alder Reaktion weiter zu IX umgesetzt wird. Die anspruchsvolle 
finale Entschützung von Carbonat IX ergibt Triol X. Zusammenfassend präsentieren wir eine 
vielseitige synthetische Strategie, mit der ein funktionalisiertes Gerüst der ent-Trachylobane unter 
vergleichbar milden Bedingungen herstellt werden konnte. 
 
Abbildung B Enantioselektive Synthese des kompletten Kohlenstoffgerüsts von Mitrephorone A. 
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Abstract 
This Ph.D. thesis describes progress toward the total syntheses of the ent-trachylobane diterpenoid 
mitrephorone A. 
Mitrephorone A was isolated from the bark of Mitrephora glabra, an Indonesian custard apple tree. 
The natural product possesses an interesting molecular scaffold, comprising a hexacyclic ring 
system with eight stereocenters, an adjacent ketone moiety and an oxetane ring. Mitrephorone A 
shows moderate cytotoxic activities against tumour cell lines, which makes it a potential 
chemotherapeutic agent. 
The first part of this thesis describes our efforts to develop an enantioselective and convergent 
synthetic route to the core structure of mitrephorone A. The elaborated route commences with the 
preparation of enone I via an enantioselective Diels–Alder reaction. Conversion to alkyne II is 
realized in a six-step sequence involving an intramolecular Diels–Alder reaction to build up the 
caged structure found in the natural product. Next, the two building blocks II and III are joined via 
a Sonogashira cross coupling. An asymmetric dearomative cyclization of V closes the last carbon 
ring of mitrephorone A and sets the right quaternary stereochemistry at C10. Moreover, studies to 
advance precursor VI to the natural product are presented. 
 
Scheme A Convergent and enantioselective synthesis of the core of mitrephorone A. 
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In the second part of this thesis, we present an alternative enantioselective synthesis of the complete 
mitrephorone A carbon skeleton. This robust synthetic sequence starts with literature-known 
building block VII. A Sharpless dihydroxylation and a Robinson annulation sequence gave enone 
VIII, which is further converted to IX by α-vinylation and a late stage intramolecular Diels–Alder 
reaction. The challenging final deprotection of carbonate IX afforded triol X. In summary, a 
versatile synthetic strategy which yields a decorated scaffold of the ent-trachylobanes under 
comparably mild conditions is presented. 
 
Scheme B Enantioselective synthesis of the complete carbon skeleton of mitrephorone A. 
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1 Introduction 
1.1 General Introduction 
Since the synthesis of urea by F. Wöhler in 1828,[1] total synthesis of natural products has evolved 
into an important branch of organic chemistry with many opportunities for discoveries and 
innovation. The reasons for performing natural product synthesis are diverse, ranging from the 
development of useful synthetic methods or reagents to improve chemical processes.[2] One 
important aspect is that small molecules isolated from natural sources often possess medically 
relevant biological activity. Over the last decades, pharmacologically active compounds from 
plants and microbes have played an important role for drug discovery. From the 1940s to 2014, 
49% of all approved anti-cancer agents worldwide were “either natural products or directly derived 
therefrom”.[3] 
1.2 Oxetane Natural Products 
Paclitaxel (2) is probably one of the best known examples of a natural product successfully applied 
in cancer chemotherapy. Its potent biological activity is reliant on the oxetane ring present in the 
structure (Figure 1). The oxetane, as small polar heterocycle, serves as hydrogen-bond acceptor[4] 
and conformationally locks the entire structure.[5] Since the track record of paclitaxel as a highly 
potent pharmaceutical, oxetanes have emerged as potentially attractive structural motif in drug 
discovery. 
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Figure 1 Examples of natural products containing an oxetane ring: mitrephorone A (1), taxol (2), 
dictyoxetane (3), laureatin (4), oxetanocin A (5), maoyecrystal I (6). 
Studies have shown that the incorporation of oxetanes beneficially influences the “druglike” 
properties of a molecule like solubility and metabolic stability. As a result, oxetane rings have 
gained interest in medicinal chemistry as gem-dimethyl and carbonyl group isosteres.[6] Natural 
products containing oxetane rings are rare, but often show interesting biological activity. For 
example, marine oxocene laureatin (4) exhibits insecticidal activity,[7] oxetanocin A (5) inhibits the 
in vivo replication of human immunodeficiency virus[8] and maoyecrystal I (6) is cytotoxic (Figure 
1).[9] A review of J. Bull et al. gives a detailed overview of recent advances in the synthesis, 
reactivity, and medicinal chemistry of oxetanes.[10] 
1.3 ent-Trachylobane Diterpenoids 
The first ent-trachylobane diterpenes were extracted from the resin of Trachylobium verrucosum 
(family Leguminosae) by Ourisson and coworkers in 1965.[11] The flowering plant Trachylobium 
verrucosum is a large tropical tree, originally native in East Africa now cultivated in many tropical 
regions of the world (Figure 2). 
 
Figure 2 Image of the plant Trachylobium verrucosum.* 
Three ent-trachylobanes shown in Figure 3 have been isolated: ent-trachyloban-18-ol (7), ent-
trachyloban-18-oic acid (8) and ent-3-hydroxy-trachyloban-18-oic acid (9). Until now, more than 
60 different ent-trachylobanes have been isolated from natural sources and new compounds are still 
discovered today.[12] ent-Trachylobanes all share the same carbon skeleton but vary in their 
                                                     
* Photograph and copyright by John Elliott. 
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oxidation pattern. Most remarkable about their complex hexacyclic scaffold is the caged tricyclo-
[3.2.1.02,7]oct-3-ene structure present in all ent-trachylobanes.  
 
Figure 3 Structures of the first three isolated ent-trachylobanes: ent-trachyloban-18-ol (7), ent-trachyloban-
18-oic acid (8) and 3α-hydroxy-trachyloban-18-oic acid (9).[11] 
As depicted in Figure 3, most of the ent-trachylobane natural products have no trivial names and 
are consistently named and numbered according to the IUPAC nomenclature.[13] This common 
numbering of the carbon skeleton is also used throughout this thesis and shown in Figure 4. 
 
Figure 4 Common numbering of the ent-trachylobane carbon skeleton.[13] 
 
1.3.1 Biosynthesis of the ent-Trachyloane Skeleton 
ent-Trachylobanes belong to the labdane-related diterpenoids and are biosynthetically derived from 
the general diterpenoid precursor (E,E,E)-geranylgeranyl diphosphate (11).[14] An initial double 
cyclization event leads to a copalyl diphosphate (CPP) intermediate which is mediated by a class 
II diterpene cyclases (Scheme 1). Three different cyclization modes are possible leading either to 
normal CPP (12), ent-CPP (13) or syn-CPP (14). From each CPP intermediate a variety of natural 
products can be formed. A few examples of ent-CPP derived natural products are shown in Scheme 
1.[15] 
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Scheme 1 Selected examples of labdane-related diterpenoids and the origin of their underlying 
stereochemistry.[15] 
Starting from intermediate ent-CPP (13) different biosynthetic pathway towards ent-trachylobane 
(10) have been proposed over the years. In 2007, Coates and co-workers suggested the mechanism 
depicted in Scheme 2.[16] They propose that the biosynthesis of ent-trachylobane and other tetra- 
and pentacyclic diterpenes includes a secondary carbocation 21 as a key branch point. Their 
assumption is based on isotopic labelling studies with ent-kaurene synthase,[17][18][19] experiments 
with mutant kaurene synthases[20] and on related biosyntheses published previously.[21]  
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Scheme 2 Mechanism of the biosynthesis of ent-trachylobane (10) proposed by Roy et al.[16] 
ent-CCP (13) undergoes an SN´ ring closure with loss of pyrophosphate to generate carbocation 20. 
A cation–alkene cyclization then results in a new carbocation 21. Deprotonation of the secondary 
carbocation 21 gives ent-trachylobane (10). 
A more recent study from 2010 by Hong and Tantillo suggests a modified biosynthesis of the ent-
trachylobane skeleton based on quantum chemical calculations.[22] Earlier computational studies 
have shown that biosynthetic pathways are often concerted processes and many formerly proposed 
secondary carbocations are actually transition state structures instead of reaction 
intermediates.[23][24] 
Their reformed biosynthesis starts just like the pathway postulated by Roy et al. with the formation 
of carbocation 20 (Scheme 3). Instead of a cation–alkene cyclization to generate a secondary cation, 
20 undergoes a cyclization and an alkyl shift in a concerted fashion. Hereby, tertiary 
carbocation 23a is formed, which is then more stable in conformation 23b. The authors’ 
calculations predict that ent-trachylobane (10) can then be directly formed by ring closure and 
deprotonation from 23b or from intermediate 24. Tertiary carbocation 24 is another possible 
transition state found in their calculations, which is formed in a three-step process (concerted alkyl 
shift, 1,3-H shift, alkyl shift) and also serves as precursor for other diterpenes.[22] 
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Scheme 3 Proposed changes to the mechanism of the biosynthesis of ent-trachylobane (10) by Hong and 
Tantillo.[22] 
A completely different biosynthetic hypothesis was postulated by Trauner and co-workers.[25] They 
speculated whether the biosynthesis of ent-trachylobanes could involve an intramolecular Diels‒
Alder reaction of an ent-pimarane-type precursor 25 (Scheme 4). Their studies on intramolecular 
[4+2] cycloadditions of unactivated 5-vinyl-1,3-cyclohexadienes leading to the same caged 
structures and the fact that other Diels‒Alder reactions are known in the biosyntheses of natural 
products,[26][27] nourishes this tantalizing notion. 
 
Scheme 4 Speculative biosynthetic pathway via a [4+2] cycloaddition suggested by Trauner et al.[25]  
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1.3.2 Syntheses of ent-Trachylobane Natural Products 
The remarkable molecular structures make the ent-trachylobane natural products attractive targets 
for synthetic chemists. However, only a few total syntheses have been reported since their first 
isolation in 1965. 
 
Scheme 5 Semisynthesis of methyl ent-(+)-trachyloban-18-oate (33) by Herz.[28] 
The first synthesis of the unusual caged ring system of the ent-trachylobane family was reported 
by Herz et al. in 1968 (Scheme 5).[28] Their semisynthetic approach starts with levopimaric acid, a 
commercially available natural product isolated from pine oleoresin. Methyl levopimarate (27) 
underwent a Diels–Alder reaction with n-butyl crotonate (28) and after hydrolysis of both esters, 
[2.2.2]bicyclooctene 29 was obtained. Oxidative lactonization and subsequent esterification 
yielded lactone 30. Ozonolysis of 30 followed by reduction and opening of the lactone to acid 31 
proceeded in quantitative yield. Oxidative decarboxylation of acid 31 introduced a double bond and 
subsequent reduction and mesylation of the ketone gave mesylate 32. Treating 32 with sodium 
borohydride without intermediate aqueous work-up gave methyl ent-(+)-trachyloban-18-oate (33) 
via a cationic cyclization terminated by hydride attack. In a detailed full paper published shortly 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
 
 
8 
 
after this communication, Herz and co-workers intensively discuss all their elaborated routes 
towards the successful semisynthesis shown in Scheme 5.[29] 
 
Scheme 6 Kelly’s ent-trachylobane synthesis.[30] 
Kelly et. al. started their synthesis from literature known enone 35 (Scheme 6).[31] Stereo- and 
regiospecific photo-addition of propadiene to enone 35 gave cyclobutane 36 in good yield. 
Subsequent oxidative Lemieux–Johnson cleavage[32] followed by reduction of the resulting ketone 
gave 37. Treatment with aqueous hydrochloric acid resulted in a retro-aldol reaction forming 
intermediate 38, which underwent a skeletal rearrangement to give keto alcohol 39 in excellent 
yield. Following protection, methylation, oxidation and dehydration steps afforded ketone 40. In 
further seven steps 40 is converted to tosylate 41. Finally, an intramolecular attack of the generated 
enolate of 41 onto the tosylate formed the tricyclic trachylobane scaffold. The ketone was removed 
via a Wolff–Kishner reduction[33] under very harsh conditions to afford ent-trachylobane (10). 
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Scheme 7 Semisynthesis of methyl ent-trachyloban-19-oate (ent-49) by Cory.[34] 
In 1980, Cory et al. developed a novel strategy, they called “bicycloannulation”, to access the caged 
trachylobane structure (Scheme 7).[34] Starting from readily available podocarpic acid (42), enone 
43 was synthesized in five steps by a procedure of Cambie et al.[35] Treatment of 43 with lithium 
diisopropylamide (LDA) gave enolate 44, which attacked the polarized double bond of 
vinylphosphonium salt 45 whereupon the Wittig ylide 46 underwent a 1,4-addition to the enone. 
The obtained enolate 47 underwent a SN2' reaction eliminating triphenylphosphine. Obtained 
ketone 48 was reduced under Wolff–Kishner conditions to yield methyl ent-trachyloban-
19-oate (ent-49). 
During their efforts to synthesize 63, Toyota et al. wanted to mimic the originally proposed 
biosynthesis by Wenkert which suggested non-classical cations.[36] To achieve such a 
transformation under mild conditions with satisfactory selectivity, Toyota and co-workers designed 
cyclopropylcarbinyl radical precursor 50 which should rearrange to 51 and 52, and furthermore, 
the introduction of hydrogen at C17, if possible, would afford 53 (Scheme 8a).[37] However, the 
more stable secondary radical 56 is formed as soon as the cyclopropane ring in 55 is closed. Both 
alternative structures share a more stable secondary homoallyl radical. The equilibrium reaction 
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favored the more stable products 51 and 52 therefore cyclopropane 53 could not be isolated 
(Scheme 8b). 
 
Scheme 8 a) Synthesis and b) mechanism of Toyota’s radical cyclization. 
Despite this setback Toyota et al. were able to synthesize a trachylobane natural product using a 
different cyclopropanation strategy (Scheme 9). Their total synthesis started with known enone 
57[38] which was transformed into the silyl enol ether 58. A palladium(II)–catalyzed cyclization 
afforded exo-methylene 59. Diels–Alder precursor 60 was obtained in nine further steps. The 
intramolecular Diels–Alder reaction built up the decalin system 61 and four further steps were 
required to afford intermediate 62. During the final Wolff–Kishner reduction towards kaurene 
natural product 63, methyl trachyloban-19-oate (rac-49) was formed as a side product, presumably 
via an acyl radical. 
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Scheme 9 Racemic methyl trachyloban-19-oate (rac-49) as a side product under Wollf–Kishner 
conditions.[38]  
In 2006, Abad et al. came up with a new approach to the tricyclooctane structure of trachylobanes 
and related natural product families (Scheme 10).[39] Starting from chiral hydrocarbon 64 diazo-
precursor 65 was prepared in six steps using a similar strategy as developed by Toyota.[37] 
α-Diazoketone 65 was activated by copper(II) complex 66 to form in situ a carbene, which reacted 
with the double bond of the enone. A stereoselective Simmons‒Smith cyclopropanation sequence 
introduced the C19 methyl group to give the complete trachylobane skeleton. Noteworthy this 
reaction took place stereoselectively from the less hindered upper side of the double bond. The 
characteristic diterpene C4 gem-dimethyl group was introduced by opening the cyclopropane under 
reductive conditions to afford 68. Unfortunately, intermediate 68 could not be successfully 
advanced to ent-trachylobane (10). 
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Scheme 10 Cyclopropanation of Abad et al.[39] 
Concurrent with our efforts, the Carreira group published the first total synthesis of mitrephorone A 
(1) in late 2018 (Scheme 11).[40]†  
                                                     
† The total synthesis by Carreira was published after we finished our own synthetic studies towards 
mitrephorone A. Hence, none of the synthetic work presented in this PhD thesis was inspired or affected by 
their results. 
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Scheme 11 Synthesis of the core of mitrephorone A (1) by Carreira.[40] 
Their synthesis commenced with a TADDOL-catalyzed Diels−Alder reaction[41] of Rawal’s diene 
(69) with methacrolein (70), followed by Wittig methenylation and acidic hydrolysis to afford 
cyclohexenone 71 (Scheme 12).[42] Alkylation using Mander’s reagent[43] and TBS protection gave 
triene 72. The caged tricyclooctane structure in ring C was obtained by an intramolecular 
Diels−Alder reaction and subsequent in situ reduction of 73 yielded hydroxyketone 74. Alcohol 74 
was further converted to nitrile 76 in two steps. Introduction of the 1,3-diene was realized by 
addition of penta-2,4-dien-2-yllithium (75) in the presence of lanthanum(III) chloride bis(lithium 
chloride) complex.[44] Extensive investigations were undertaken to improve the diastereoselectivity 
(d.r. = 1:1.2) in the ketone addition reaction. However, only 28% of the correct diastereomer 76 
could be isolated. Subsequent protection of the tertiary alcohol, reduction of the nitrile group and 
addition of lithiated ethynyl p-tosyl sulfone to the generated aldehyde gave secondary alcohol 77. 
The following key Diels‒Alder reaction of 77 proceeded spontaneously following DMP oxidation 
of the propargyl alcohol at room temperature. A challenging substitution of the sulfone with methyl 
cuprate furnished 78, the pentacyclic core of the mitrephorone skeleton. The completion of the total 
synthesis is depicted in Scheme 12. 
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Scheme 12 Completion of the total synthesis of mitrephorone A (1).[40] 
Diene 78 was chemoselectively reduced using Adams’ catalyst. Installation of the quaternary center 
that incorporates an ester was realized by hydrocyanation with Nagata’s reagent,[45] subsequent 
hydration with Ghaffar‒Parkins catalyst (79),[46] basic hydrolysis and esterification with 
trimethylsilyldiazomethane. Riley oxidation[47] with selenium dioxide installed the 1,2-diketone 
and afforded 80 in high yield. Final one-pot deprotection of the tertiary silyl ether with tris-
(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) and subsequent reaction of 81 with 
Koser’s reagent (PhI(OH)OTs) closed the oxetane ring and completed the total synthesis. 
  
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
 
 
15 
 
1.4 Asymmetric Dearomative Cyclizations of Phenols in Natural Product Synthesis 
The dearomatization of aromatic compounds has been widely recognized as a powerful 
transformation for the generation of high levels of molecular complexity from simple planar 
starting materials. The following section outlines current developments in asymmetric dearomative 
cyclization reactions forming complex ring structures by using transition-metal catalysts. 
 
Scheme 13 Palladium-catalyzed asymmetric dearomatization of naphthalene derivatives by Buchwald.[48] 
In 2009, Buchwald and co-workers found that a palladium(0)complex bearing the chiral P,N-ligand 
84 catalyzed asymmetric, intramolecular dearomatizations of naphthalene derivatives 83 to 
produce fused tetracyclic indolenines 85 which contains two contiguous nonaromatic rings 
proximal to a quaternary stereocenter (Scheme 13).[48] 
Since then, various asymmetric dearomative cyclizations have been investigated. Of particular 
interest is the dearomatization of phenols to cyclohexadienone derivatives. These are versatile 
intermediates for further functionalization towards more complex molecules or natural products. 
 
Scheme 14 Palladium-catalyzed intramolecular ipso‒Friedel‒Crafts allylic alkylation of phenols by 
Hamada.[49] 
One year later, the Hamada group published the first Pd-catalyzed intramolecular ipso-Friedel‒
Crafts allylic alkylation of phenols (Scheme 14). This novel method provided new access to 
spiro[4.5]cyclohexadienones. In one example, the authors demonstrated the application of their 
method to the catalytic enantioselective construction of an all-carbon quaternary spirocenter in 
cyclohexadienone 88. In the following years they further developed their methodology, but focused 
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on broadening the substrate scope rather than developing other enantioselective variants of this 
reaction.[50][51][52] 
 
Scheme 15 Iridium-catalyzed intramolecular asymmetric allylic dearomatization of phenols by You.[53] 
Similar substrates as Hamada et al. were also used in the methodology by You and co-workers.[53] 
Their iridium-catalyzed intramolecular asymmetric allylic dearomatization reaction of phenols 89 
is depicted in Scheme 15. The reaction provides facile access to enantioenriched, substituted 
spirocyclohexadienone derivatives 91 with up to 97% enantiomeric excess. 
.  
Scheme 16 Total synthesis of tatanan B (96) and C (97) by Zakarian.[54] 
Based on the methodologies by Hamada and You, Zakarian and co-workers realized their 
enantioselective total synthesis of tatanans A–C, potential antidiabetic agents.[54] Starting from 
cinnamic ester 92, enantiomeric pure phenol 93 was synthesized in nine steps (Scheme 16). For the 
key intramolecular allylic dearomatization several iridium and palladium catalyst / ligand systems 
were screened. Under optimized conditions, the desired cyclization could be achieved and afforded 
atropisomeric products 94 and 95 together with one undesired diastereomer. During this 
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challenging reaction, three of the six stereocenters of the target molecule, including the quaternary 
center at the core of the spirocyclic ring system, are set with a high degree of stereocontrol. 
Remarkably, only the formation of three out of sixteen possible stereoisomers has been observed. 
Methylation and chemoselective hydrogenation of the vinyl group finished the total synthesis of 
tatanan B (96) and C (97). 
 
Scheme 17 Asymmetric dearomatization of phenols 98 to spirocyclohexadienones 100.[55] 
In 2011, Buchwald and co-workers published their studies on the palladium-catalyzed arylative 
dearomatization of phenols to give spirocyclohexadienones bearing all-carbon quaternary centers 
in good to excellent yields. Initial studies with two substrates 98 using ligand 99, they demonstrated 
that the development of a highly enantioselective variant of this reaction is practical (Scheme 17). 
 
Scheme 18 Asymmetric dearomatization of aminophenols 101 to spiroamines 103 by You.[56] 
Three years later, You and co-workers reported a highly efficient intramolecular dearomative 
arylation method to convert 5-hydroxyl indolines to tetracyclic spiroamines.[56] In addition to a 
broad substrate scope resulting in racemic dearomatization products, the first asymmetric reactions 
were also performed. The successful asymmetric dearomative cyclization of phenol 101 to 
spiroamine 103 is depicted in Scheme 18. This methodology is a promising tool towards natural 
products containing an erythrinane skeleton.  
Comprehensive studies with exclusive focus on asymmetric dearomatization reactions were 
published by Tang and co-workers in 2015.[57] Aim of their work was the development of an 
efficient enantioselective method to synthesize natural products (Scheme 19). 
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Scheme 19 Dearomative cyclization for the synthesis of terpenes and steroids by Tang.[57] 
They developed a novel and efficient palladium-catalyzed dearomative cyclization, which enabled 
the synthesis of a series of chiral tricyclic phenanthrenone derivatives 106 bearing all-carbon 
quaternary centers in excellent enantioselectivities. Studies on diverse P-chiral ligands showed that 
dihydrobenzooxaphosphole ligand 105 gave the best results. Investigation of the substrate scope of 
the asymmetric cyclization revealed a reasonable tolerance for several functional groups. 
Furthermore substrates bearing alternate aromatic motifs, for example naphthalene, quinone or 
furan motifs were also found to be competent reaction partners. Moreover, the reaction is also 
suitable for vinyl triflates as well as of aromatic bromides 104.  
 
Scheme 20 Proposed mechanism of palladium-catalyzed asymmetric cyclization of phenol 104.[57] 
The proposed catalytic cycle is shown in Scheme 20 and it rationalizes all other mechanisms 
presented in this chapter. The authors assumed, that asymmetric dearomative cyclization reaction 
of bromine-substituted phenol 104 could either result in the desired spirocyclohexadienone 109 or 
the regioisomeric biaryl 111. Both pathways start with oxidative addition of 104 to form 
palladium(II)-complex 107. Base promoted nucleophilic substitution could lead to cyclization 
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products 109 and 111, respectively. Reductive elimination of 110 provides achiral ortho-product 
111 wheras chiral spirocyclohexadienone 109 could result from 108. Formation of the dearomative 
cyclization product 109 is assumed to be the kinetically favored pathway.  
 
Figure 5 Proposed stereochemical model for the reductive elimination step of the cyclization of 104 with 
Pd/105 as the catalyst.[57] 
The authors suggested a stereochemical model for the cyclization which could rationalize the high 
enantioselectivity of the reaction. As shown in Figure 5, the 2,5-diphenylpyrrole moiety of rigid 
ligand 105 blocks the backside of the complex, and its bulky tert-butyl group can well dictate the 
orientation of substrate coordination. It is assumed, that after oxidative addition and nucleophilic 
substitution, the substrate could adopt two major conformers, A and B, when coordinated to the 
Pd/105 complex. Conformer B appears to be more strained whereas the more favorable 
conformer A undergoes reductive elimination to provide the cyclization product 109 with the 
observed R-configuration. 
 
Scheme 21 Total synthesis of (‒)-totaradiol (116) by Tang.[57] 
Tang and co-workers applied their new dearomatization strategy to the synthesis of a kaurane 
intermediate and the synthesis of the boldenone skeleton.[57] Furthermore (‒)-totaradiol (116) was 
synthesized in ten steps (Scheme 21). Starting from known aldehyde 113[58] and Wittig salt 112, 
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key intermediate 114 was prepared in four steps. Asymmetric cyclization of 114 with Pd/105 as the 
catalyst provided the desired product 115 in 78% yield and 89% enantiomeric excess. The total 
synthesis of (‒)-totaradiol (116) was completed in five further steps. 
 
Scheme 22 Total synthesis of (+)-dalesconol A (123) by Tang.[59] 
Recently, W. Tang and co-workers published the first enantioselective synthesis of 
immunosuppressant (+)-dalesconol A (Scheme 22).[59] Starting from commercially available 
precursors 117, 118 and 119, key intermediate 120 was obtained in three steps. Asymmetric 
dearomative cyclization reaction of 120 resulted in product 122 in excellent enantioselectivity. The 
synthesis of (+)-dalesconol A (123) could be completed in five further steps.  
In conclusion, asymmetric dearomative cyclizations of phenols can be an efficient strategy to 
synthesize complex natural products bearing all carbon quaternary centers. 
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2 Project Outline 
2.1 Mitrephorone A – Isolation and Bioactivity 
 
 
 
 
 
 
Figure 6 Images of the custard apple tree Mitrephora glabra.‡ 
Mitrephorone A (1) is an ent-trachylobane-type diterpenoid that was isolated in 2005 from the bark 
of Mitrephora glabra (family Annonaceae), an Indonesian flowering plant (Figure 6).[60] One 
kilogram of dried bark was extracted and concentrated to a tannin-free organic extract, which was 
separated by flash silica gel column chromatography and purified with reversed phase HPLC to 
give mitrephorone A (1) in 0.00021% yield (21 mg). 
Together with mitrephorone A, mitrephorone B (124) and C (125) were isolated (Figure 7). They 
all share the ent-trachylobane skeleton, but only mitrephorone A features the intriguing oxetane 
ring. Mitrephorone A (1) has a complex hexacyclic scaffold that contains a caged tricyclooctane, 
the oxetane ring and an adjacent 1,2-diketone moiety. Furthermore it has eight stereogenic centers, 
four of which are quaternary. 
 
Figure 7 Three mitrephorones A, B and C isolated from Mitrephora glabra. 
None of the three mitrephorones is crystalline, so no crystal structure is available. Oberlies and 
coworkers established the relative stereochemistry of mitrephorone A based on ROESY data 
                                                     
‡ Photograph and copyright by Prof. Dr. Kamarudin Mat Salleh. 
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analysis (Figure 8). The absolute stereochemistry for all three compounds was presumed to belong 
to their enantio-series, as determined by crystallographic analysis and chemical transformations of 
other known ent-trachylobane-type diterpenoids.[60] 
 
Figure 8 Energy minimized model of 1 illustrating the major ROESY correlations used to define the relative 
stereochemistry.[60] 
With the limited material of mitrephorone A, Oberlies and co-workers conducted a first biological 
screen (Table 1). All three mitrephorones show moderate activity against bacteria (Micrococcus 
luteus and Mycobacterium smegmatis), a yeast (Saccharomyces cerevisiae), and a filamentous 
fungus (Aspergillus niger). Among them, mitrephorone C (125) exhibits the strongest antimicrobial 
activity and mitrephorone A (1) exhibits promising activity against human cancer cell lines. 
Table 1 Antimicrobial activity and cytotoxicity of mitrephorone A–C.[60] 
 
mitrephorone 
Antimicrobial Activity MIC, [µg/mL]a  Anticancer Activity IC50, [µg/mL]b 
M. 
luteus 
M. 
smegmatis 
S. 
cerevisiae 
A. 
niger 
 KB MCF-7 H460 SF-268 
A 125 63 63 63  8.0 15.7 23.3 30.9 
B 88 88 88 88  7.0 inactive inactive inactive 
C 63 31 31 63  inactive  inactive inactive inactive 
a Antimicrobial activity results were recorded as minimal inhibitory concentration (MIC, [µg/mL]), which corresponds 
to the lowest concentration of compound that prevents visible growth of a microorganism. b Anticancer activity against 
human cancer cell panels was described in half maximal inhibitory concentration (IC50, [µg/mL]), the concentration to 
inhibit growth by 50%. KB = oral epidermoid carcinoma, MCF-7 = mammary adenocarcinoma, H460 = large cell lung 
carcinoma, SF-268 = brain cancer. 
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The authors of the study conclude: „The oxetane ring in mitrephorone A was not present in any of 
the known members of this class, making it the first representative of this novel hexacyclic ring 
system. On the basis of a limited set of human tumor cell cytotoxicity data, this unique structure 
seems to impart a greater degree of anticancer activity than in the other trachylobanes.”[60] 
2.2 Aims of the Project 
Mitrephorone A (1) represents a unique and challenging target for total synthesis. The primary 
challenge lies in the successful construction of the sterically demanding carbon skeleton. 
Additionally, the installation of its four quaternary stereocenters was expected to cause difficulties. 
The rare 1,2-diketone moiety and the adjacent oxetane ring render this natural product a veritable 
challenge in synthetic chemistry and these functionalities are planned to be introduced after the 
assembly of the highly congested carbon skeleton. 
We planned to access mitrephorone A (1) by two different strategies (Figure 9). At first, we aimed 
to synthesize the core structure with a convergent dearomatization approach by disconnection of 
bond C9−C10 (Strategy A), relying on new methodologies for phenol dearomatization strategies. 
In addition, we set out to investigate the assembly of the carbon skeleton from literature known 
building block 129 by a Robinson annulation (Strategy B).  
 
 
Figure 9 Retrosynthetic bond disconnections for the tricyclic core structure of mitrephorone A (1). 
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3 Results and Discussion 
3.1 Strategy A: Dearomative Cyclization 
3.1.1 First-generation Approach: Dihydroxylation and Dearomatization 
The earlier synthetic approaches towards trachylobane natural products (see chapter 1.3.2) 
struggled with the construction of the caged tricyclooctene structure in ring C. Harsh reaction 
conditions were needed to install these unique carbon-carbon bonds at the end of the syntheses. 
Thus, only very few functional groups were tolerated and only unfunctionalized trachylobanes have 
been synthetized. Since mitrephorone A is a highly functionalized natural product, a completely 
new synthetic strategy was necessary. Due to the literature known challenges in synthesizing the 
caged tricyclooctene at later stages, we envisioned to start our synthesis with the caged ring 
structure. 
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Scheme 23 Initial retrosynthetic analysis for mitrephorone A (1). 
The retrosynthetic analysis for mitrephorone A (1) is depicted in Scheme 23. The oxetane ring 
should be introduced in a late stage of the synthesis via cyclization onto the activated double bond 
of 130. This activation could be realized by epoxidation or halocyclization. As the key step of the 
synthesis we envisioned an intramolecular dearomative cyclization to assemble the sterically 
demanding ring structure of mitrephorone A. Key intermediate 132 could be prepared by 
dihydroxylation after Z-selective Lindlar reduction of alkyne 133. To allow for a convergent 
assembly process, we disconnected the alkyne 133 by Sonogashira coupling, giving rise to aromatic 
building block 135 and tricycle 134. To construct the caged tricyclo-[3.2.1.0]oct-3-ene structure of 
134 we foresaw an intramolecular Diels-Alder reaction of precursor 137 which can be traced back 
to literature known enone 71.[61] 
Based on a literature known procedure, racemic enone rac-71 was synthesized in four steps 
(Scheme 24). Starting from 4-methoxy-3-buten-2-one (138), Danishefsky’s diene (139) was 
prepared followed by Diels‒Alder reaction with methacrolein to obtain aldehyde rac-140. Wittig 
olefination and subsequent acidic work-up gave enone rac-71. Deprotonation of rac-71 with LDA, 
followed by quenching the resulting enolate with 1H-benzothiazole-1-methanol (142) furnished the 
labile hydroxymethyl product rac-143 which was immediately protected with tert-butyl-
dimethylsilyl trifluoromethanesulfonate (TBSOTf) to afford compound rac-137. 
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Scheme 24 Racemic synthesis of Diels‒Alder precursor 137. 
In order to achieve better yields for a Diels‒Alder precursor and to diversify the possible substrates 
for the first key step, two alternative alkylations were tested (Scheme 25). With Mander’s reagent 
a methylester rac-72 was synthesized (Scheme 25a), but subsequent DielsAlder reaction did only 
afford a complex mixture of products. Additionally, the corresponding benzyl chloromethyl ether 
did not lead to the desired enone rac-144 (Scheme 25b). 
 
Scheme 25 Alternative substrates for the intramolecular Diels‒Alder reaction. 
However, by heating the TBS-protected Diels‒Alder precursor rac-137 the intramolecular 
cycloaddition smoothly afforded the caged cyclooctene rac-136 (Scheme 26). Following, the 
synthesis of alkyne rac-134 required some optimization. Deprotection of rac-136 gave primary 
alcohol rac-74, which was further oxidized to aldehyde rac-145 with DessMartin periodinane 
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(DMP). In comparison, impurities from an alternative Swern oxidation of rac-74 influenced the 
following Sonogashira coupling and dramatically decreased the yield. The oxidation attempt with 
tetrapropylammonium perruthenate and N-methylmorpholine N-oxide led to incomplete 
conversion. Finally, Ohira-Bestmann homologation of aldehyde rac-145 afforded alkyne rac-134 
in very good yield. 
 
Scheme 26 Racemic synthesis of alkyne rac-134. 
The coupling partner for alkyne rac-134 was synthesized in two steps starting from commercially 
available aniline 147 (Scheme 27). Sandmeyer reaction of the aryldiazonium salt 148 yielded 
phenol 149, which was subsequently TBS protected to give aryl iodide 135. 
 
Scheme 27 Synthesis of aryl iodide 135.  
With the two building blocks alkyne rac-134 and aryl iodide 135 in hand, it was possible to carry 
out the following Sonogashira coupling (Scheme 28). 
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Scheme 28 Sonogashira coupling of alkyne rac-134 and aryl iodide 135. 
The following hydrogenation had to be optimized. Screening different reaction conditions, Z-
selective Lindlar hydrogenation of alkyne 133 was optimized to obtain alkene 150 in excellent yield 
with only traces of the alkane 151 (Table 2). 
Table 2 Investigation of the hydrogenation of alkyne 133. 
  
Entrya Catalyst Solvent t [min]b Observation 
1 Rosenmundc THF 5 no conversion 
2 Lindlard THF 5 no conversion 
3 Rosenmund MeOH 2 150 : 151 (1:2) 
4 Lindlar MeOH 2 150 : 151 (1:1) 
5 Lindlar THF / MeOH 8 no conversion 
6 Lindlar MeOH 1 150 (94% yield) 
a all reactions were conducted on a 0.01 mmol scale. b purging the solution with H2 gas. 
c 5% Pd on BaSO4. 
d 5% Pd on 
CaCO3 with 3.5% Pb. 
Dihydroxylation of styrene 150 gave a diastereomeric mixture of diol 152 (d.r. = 3:7) that proved 
to be inseparable (Scheme 29). The moderate yield of this reaction was attributed to overoxidation 
of the alkene, leading to carboncarbon bond cleavage. Asymmetric Sharpless dihydroxylation was 
tested, but no conversion was observed, probably due to the steric encumbrance of alkene 150. 
Therefore, diol 152 was protected as an acetonide to yield 153. A first attempt to convert a small 
amount of ketone 153 into the vinyl triflate 132 gave a mixture of products. 
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Scheme 29 Synthesis of acetonide 153. 
As dihydroxylation was not productive, we decided to modify the synthetic sequence. An 
alternative route towards the dearomatization precursor was to synthesize diketone 154 (Scheme 
30). According to a publication of Zhao and co-workers a Wacker-type oxidation using molecular 
oxygen was applied.[62] Unfortunately only small amounts of diketone 154 could be isolated as most 
of the starting material decomposed. 
 
Scheme 30 Wacker-type oxidation of alkyne 133.  
Given this result, we decided to introduce the diketone oxidation stage after the key 
dearomatization. Therefore, before putting additional effort into synthesizing acetonide 153, we 
proceeded with the route to alkene 155 in order to investigate the key dearomative cyclization. 
Ketone 150 was converted to the corresponding vinyl triflate, which was subsequently treated with 
TBAF to obtain phenol 155 (Scheme 31).  
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Scheme 31 Synthesis of dearomatization precursor 155. 
Additionally, as the intramolecular cyclization methodology is only known for substrates without 
substitution or unsaturation at the C6-C7 bridge,[57] we also synthesized alkane 156 (Scheme 32) as 
a possible substrate for the dearomative cyclization. Ketone 151 was converted to the corresponding 
vinyl triflate, which was subsequently TBS-deprotected to obtain phenol 156. 
 
Scheme 32 Synthesis of dearomatization precursor 156. 
In parallel to the building block syntheses, the dihydrobenzooxaphosphole ligand AntPhos 121 for 
the dearomatization key step was synthesized according to a literature known procedure (Scheme 
33).[63] Commercially available dichloromethylphosphine (157) was alkylated with tert- 
butylmagnesium chloride and arylated with lithiated 1,3-dimethoxybenzene (158), followed by 
oxidation to give phosphine oxide 159 in good yield. Subsequent iodination gave iodide 160 in 
moderate yield, but unreacted starting material could be reisolated.  
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Scheme 33 Synthesis of racemic dihydrobenzooxaphosphole ligand AntPhos rac-121. 
Dihydroxybenzene 161 was prepared using a modified procedure which involved an aqueous work 
up. Subsequently, it was cyclized to phenol rac-162 in 57% yield over two steps. Starting from this 
intermediate rac-162, the enantiomerically pure ligands could be synthesized by chiral resolution 
of the corresponding menthyl carbonate. For the moment we proceeded to prepare the racemic 
ligand. Therefore, phenol rac-162 was converted to triflate rac-163 and subsequent Suzuki 
coupling with antracene boronic acid gave dihydrobenzooxaphosphole oxide rac-164 in very good 
yield. Final reduction of rac-164 using polymethylhydrosiloxane (PMHS) proved challenging. In 
solution dihydrobenzo-oxaphosphole rac-121 is extremely sensitive to reoxidation. A quickly 
performed aqueous work-up with thoroughly degassed solvents was not sufficient to prevent 
reoxidation. However, addition of degassed water to the reaction mixture in a Schlenk tube under 
argon atmosphere and repeated decanting of the organic phase enabled reduction of rac-164 to 
ligand rac-121. The concentrated and dried dihydrobenzooxaphosphole rac-121 was stable under 
air. 
The stage was set to investigate the dearomative cyclization with vinyl triflate rac-155 (Table 3). 
The literature known conditions did not lead to the desired product 165 (Entry 1). 
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Table 3 Investigation of dearomative cyclization of alkene 155. 
 
Entrya Ligand Solvent T [°C] Observation 
1 rac-AntPhos (rac-121) toluene 90 traces of side product 168 
2 rac-AntPhos (rac-121) dioxane 90 no conversion 
3 rac-AntPhos (rac-121) dioxane 120 decomposition 
4 166 toluene 90 no conversion 
a all reactions were conducted on a 0.03 mmol scale. 
Instead we isolated small amounts of 168 which result from a Tsuji‒Trost allylic alkylation of 
deprotonated phenol and the cinnamyl ligand. More polar solvent as dioxane (Entry 2) or higher 
temperatures were also ineffective (Entry 3). We also tested ligand 166, which was used by 
Buchwald and co-workers for similar palladium-catalyzed arylative dearomatization,[55] but it also 
led to no conversion of the starting material (Entry 4). 
 
Figure 10 Isolated side product of the dearomatization attempts of alkene 155. 
Moreover, the cyclization was investigated for alkane 156 (Table 4). Instead of the desired 
dearomatization to dienone 169, the reaction occurred at the free ortho position and gave 
rearomatized phenol 170 in 47% yield (d.r. = 1:1). Buchwald’s ligand 166 led to no conversion, 
hence the dihydrobenzooxaphosphole ligand 121 seems crucial for the proceeding of the reaction. 
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Table 4 Investigation of dearomative cyclization of alkane 156. 
 
Entrya Ligand Solvent T [°C] Observation 
1 rac-AntPhos (rac-121) toluene 90 170 (47% yield) 
2 rac-AntPhos (rac-121) dioxane 90 traces 170 
3 166 toluene 90 decomposition 
4 166 dioxane 90 no conversion 
a all reactions were conducted on a 0.03 mmol scale. 
Although rearomatized compound 170 was useless for our purpose, these results showed, that 
palladium inserts into the triflate and a cyclization of system 156 is possible. As proposed by Tang, 
maybe steric effects inhibit the attack at the methyl substituted para position.[57]  
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3.1.2 Second-generation Approach: Enantioselective Synthesis 
As the dearomative cyclization of precursor 156 led to the ortho functionalization followed by 
rearomatization, we redesigned our retrosynthetic plan. Since methyl groups are needed in ortho 
and para position, we foresaw to introduce them both into the aromatic ring (Scheme 34). 
Intramolecular cyclization of 127 should then either give dienone 126 (para attack) or enone 171 
(ortho attack). A rearomatization is not possible in either systems and both products could be further 
used in our total synthesis. 
 
Scheme 34 Foreseen synthesis of an alternative key intermediate 127. 
In a four-step sequence, iodine 174 was prepared starting from 2-iodo-m-xylene (172) in good yield 
(Scheme 35). 
 
Scheme 35 Synthesis of aromatic building block 174. 
According to the already established route, building blocks 174 and rac-134 were coupled by 
Sonogashira cross coupling to rac-175. Subsequent hydrogenation, triflation and deprotection gave 
phenol rac-127 (Scheme 36). 
 
Scheme 36 Synthetic route towards vinyl triflate rac-127. 
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With vinyl triflate rac-127 in hand, we investigated the palladium catalyzed cyclization (Scheme 
37). We were pleased to find that under the reported conditions[57] only para product rac-126 was 
obtained as an inseparable mixture of diastereomers (d.r. = 1:1) at C10. The next steps of the 
synthesis were continued with the diastereomeric mixture of rac-126. Hydrogenation of the least 
hindered double bond gave enone rac-176 in full conversion. However, high catalyst loading (0.5 
eq) and 15 bar pressure were necessary for this hydrogenation. The diastereomers of enone rac-176 
were still not separable. 
 
Scheme 37 Successful dearomatization of rac-127 and subsequent hydrogenation to rac-176. 
With these promising results we decided to tackle the enantioselective route. The first attempt 
towards enantiopure enone ent-71 was performed according to Rawal via an auxiliary mediated 
asymmetric Diels‒Alder reaction (Scheme 38).[64][65]  
 
Scheme 38 Initially envisioned asymmetric Diels‒Alder reaction towards enone ent-71. 
The chiral amino siloxy diene 180 should react with methacrolein and thereby set the stereocenter 
at C16. This option was discarded as the synthesis proved to be not amenable due to the low 
solubility of 1,2-dibenzoylethane (177). 
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Therefore we turned to hydrogen bonding catalysis mediated DielsAlder reaction (Scheme 5).[42] 
Hydrogen bonding of the dienophile to TADDOL (183) enables an asymmetric Diels-Alder 
reaction between Rawal’s diene 69 and methacrolein (70). “The dienophile is expected to complex 
with TADDOL through a two-point interaction. First, the free hydroxyl group on TADDOL is 
expected to form a strong intermolecular hydrogen bond to the carbonyl group of the dienophile, 
which provides the necessary lowering of the lowest unoccupied molecular orbital energy through 
a Lewis acid-like mechanism. Second, the complexed, electrondeficient carbonyl double bond is 
expected to be stabilized through a π–π donor-acceptor interaction with the electron-rich system 
of the proximal equatorial 1-napthyl ring, which would selectively shield one face of the 
dienophile.” [66] 
 
 
Scheme 39 TADDOL controlled asymmetric Diels‒Alder reaction of Rawal’s diene (69). 
In a two-step procedure twenty gram of Rawal’s diene (69) were prepared (Scheme 39). Subsequent 
Diels‒Alder reaction with methacrolein gave unstable aldehyde 184 which was in situ reduced to 
alcohol 185. Crude intermediate 185 was then converted to enone 186. The enantiomeric excess of 
alcohol 186 (90.4% ee) was determined by 1H NMR analysis of the two diastereomeric Mosher’s 
ester derivatives.[67] This synthetic sequence confirmed the reproducibility of the reaction and the 
reported enantiomeric excess. 
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For our synthesis, we require a robust and scalable procedure of enone ent-71, which turned out to 
be more challenging to synthesize. Different procedures were tested as shown in Scheme 40. The 
main challenges were instability of the intermediates, evaporation of toluene from volatile products 
and separation of TADDOL after the Diels‒Alder step. First, we tried to react intermediate 
aldehyde 184 with hydrofluoric acid and isolate enone 187, which could then be subjected to further 
Wittig reaction. But aldehyde 187 is quite unstable and was always obtained in maximum 50‒57% 
yield. Different olefination attempts never yielded more than 16% of enone ent-71.  
 
Scheme 40 Synthetic approaches towards enone ent-71. 
Therefore, we next tried to isolate and purify aldehyde 184, but as suspected aldehyde 184 was 
even more unstable than aldehyde 187 and different purifications always led to low yield or 
complete decomposition. In addition, both routes suffered from severe yield dropping during scale 
up. 
 
Given these results, we decided to try a one-pot procedure to avoid isolating the unstable 
intermediates 184 and 187 (Scheme 42). We assumed that TADDOL would not interfere the 
following Wittig reaction and the subsequent deprotection-elimination sequence. We were pleased 
to find, that adding the Diels‒Alder reaction mixture to the deprotonated Wittig salt, and stirring 
overnight, followed by addition of aqueous hydrofluoric acid gave enone ent-71 in 96% yield over 
three steps. The remaining toluene was removed from highly volatile ent-71 by column 
chromatography and crude ent-71 could then be purified by column chromatography using a 
mixture of diethyl ether and pentane. 
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Scheme 41 Gram-scale synthesis of TADDOL 183. 
Since TADDOL 183 is commercially available but rather expensive, it was synthesized on 
160 mmol scale (Scheme 41). Although purification was challenging, we were able to obtain twelve 
gram of clean TADDOL. With sufficient amount of TADDOL and the optimized one-pot procedure 
in hand the stage was set to scale the route up. Multigram quantities of enone ent-71 were prepared 
in one-pot in excellent yield starting from Rawal’s diene 69 (Scheme 42). 
 
Scheme 42 Enantioselective scale up and molecular structure of alkyne ent-134. 
Following the established racemic route (see Scheme 24 and Scheme 26), alkyne ent-134 was 
synthesized in 29% yield over six steps. The structure of alkyne ent-134 was further verified by 
single crystal X-ray analysis (Scheme 42).  
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Scheme 43 Synthesis of enantiopure vinyl triflate ent-127.   
With alkyne ent-134 in hand, cyclization precursor ent-127 was prepared in further four steps 
(Scheme 43). 
 
For the subsequent dearomative cyclization of enantiopure vinyl triflate ent-127, we prepared chiral 
AntPhos ligand ent-121 in order to achieve the highest possible diastereoselectivity. Following the 
procedure by Tang and coworkers, chiral ent-121 was prepared in five steps from intermediate 
rac-162 (Scheme 44).[63]  
 
Scheme 44 Completed synthesis of dihydrobenzooxaphosphole ligand (S)-AntPhos ent-121. 
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Resolution of rac-162 was successfully accomplished by conversion to menthyl carbonate rac-192. 
After crystallization of the diastereomerically pure isomer ent-192 was isolated in 34% yield. Basic 
hydrolysis of carbonate ent-192 afforded enantiomerically pure compound ent-162. The following 
transformation to (S)-AntPhos ent-121 was accomplished according to the synthesis of the racemic 
ligand shown in Scheme 44.§ 
Hence, the stage was set for the key cyclization. The first attempt to cyclize vinyl triflate ent-127 
gave tricycle ent-126 in 63% yield as an 8:1 mixture of diastereomers. The relative configuration 
of the newly installed stereogenic center at C10 position was verified by NOESY experiments to 
be corresponding to the one of the natural product. Hydrogenation of the least hindered double 
bond gave enone ent-176 in excellent yield. 
 
Scheme 45 Successful dearomative cyclization of vinyl triflate ent-127. 
  
                                                     
§ Meanwhile an improved synthesis of intermediate ent-162 was published[107] and (S)-AntPhos ligand 121 
(CAS: 1807740-34-6) is now commercially available from Strem chemicals. 
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3.1.3 Functionalization Attempts of the Core Structure 
Starting from dienone 126 or enone 176 (see Scheme 45) various options to reach mitrephorone A 
can be pursued. For example, γ-hydroxylation of decalin enone 176, elimination and 
dihydroxylation was planned to introduce the oxygens at C6 and C7 needed for the diketone moiety 
in mitrephorone A (1) (Scheme 46). 
 
Scheme 46 Envisioned functionalization of enone 176. 
Oxidation under conditions reported by Baran and coworkers in their synthesis of thapsigargin[68] 
were tested (Table 5), but no alcohol 193 could be isolated. Entry 2 looked promising based on 
1H NMR analysis, however repeating the conditions with more material to isolate the main products 
revealed that the starting material decomposed (Entry 3). 
Table 5 Investigation of γ-hydroxylation of enone 176. 
 
Entry Oxygen source Scale [mg] Observation 
1 air 0.5 no conversion 
2 O2 balloon 0.5 unidentified products 
3 O2 balloon 5 decomposition 
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We then tested Ang Li’s two-step protocol used in a synthesis of epoxyeujindole.[69] Unfortunately, 
the desired ketal 196 could not be obtained, and the subsequent oxidation step was therefore not 
attempted (Scheme 47).   
 
Scheme 47 Oxidation attempt towards allylic alcohol 193. 
Next, oxidation under conditions reported in Ang Li’s synthesis of longeracinphyllin A[70] were 
tested (Table 6), but no diketone 197 could be isolated. 
Table 6 Investigation of oxidation of enone 176. 
 
Entry Oxygen source T [°C] t [h] Observation 
1 air 24 3 no conversion 
2 air 40 5 no conversion 
3 O2 balloon 40 22 no conversion 
 
Since the abovementioned oxidation methods failed on our system 176, we investigated the 
classical selenium dioxide-mediated allylic oxidation. Therefore, enone 176 was reduced to allylic 
alcohol 198 and TBS protected to obtain precursor 199 (Scheme 48). No conversion was observed 
in dioxane at 24 °C. Heating the reaction mixture to 80 °C gave a mixture of different products. 
Although, the 1H NMR of the main isolated compound looked promising, alcohol 193 could not be 
prepared on reasonable scale and the reaction proved unreproducible, resulting in intractable 
product mixtures. The desired TBS-protected allylic alcohol 200 was never observed. 
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Scheme 48 Allylic oxidation attempts towards alcohol 200. 
Moreover, the introduction of a C6C7 double bond was investigated starting from enone 176. 
With the desired product 202 in hand dihydroxylation could directly introduce the two oxygen 
atoms required for the diketone moiety in mitrephorone A.  
Table 7 Investigation of DDQ oxidation of enone 176. 
 
Entry Solvent T [°C] Additive Observation 
1 benzene 24 - no conversion 
2 benzene 75 - no conversion 
3 benzene 75 p-TsOH 
complex mixture, containing 
203 and 204 
4 1,4-dioxane 24 - no conversion 
5 1,4-dioxane 75 - no conversion 
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6 1,4-dioxane 75 p-TsOH 
complex mixture, containing 
176 and 126 
 
As shown in Table 7, oxidation of 176 with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) 
was unselective and led to product mixtures. It was not possible to obtain one main product cleanly, 
in line with literature reports that often proceed in only moderate yield. Similarly, DDQ oxidation 
of dienone 126 afforded traces of rearranged aromatized phenol 204 (Scheme 49). 
 
Scheme 49 DDQ oxidation attempt of dienone 126. 
Another idea for functionalizing decalin 176 towards the synthesis of 1, is depicted in Scheme 50. 
Selective reduction and directed iridium-catalyzed oxidative functionalization, established by 
Simmons and Hartwig,[71] could introduce the C-19 oxidation. 
 
Scheme 50 Foreseen synthesis of alcohol 206 towards mitrephorone A (1). 
Methylation of similar decalin enones have been reported and are most commonly carried out using 
potassium tert-butoxide as base.[72][73][74] Table 8 shows different conditions that were investigated 
for this transformation. Unfortunately, all conditions tested only led to decomposition of starting 
enone 176 or resulted in its recovery. 
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Table 8 Investigation of methylation of enone 176. 
 
Entrya Solvent T [°C] Base [equiv.] Observation 
1 benzene 60‒70 KOt-Bu [1.0] no conversion 
2 t-BuOH 60‒70 KOt-Bu [1.2] no conversion 
3 t-BuOH 60‒70 KOt-Bu [excess] decomposition 
4 1,4-dioxane 85 NaH [1.1] decomposition 
5 THF, HMPA 0‒25 LDA [1.1] no conversion 
a all reactions were conducted on a 0.01 mmol scale with an excess of MeI. 
Since alkylation of enone 176 with methyl iodide proved unsuccessful we examined whether the 
deprotonation at C6 occurs at all. Thus, a solution of 176 in benzene was treated with potassium 
tert-butoxide (1.5 equiv) at 60 °C for one hour before an excess of deuterium oxide was added. 
NMR studies revealed that no deuterium incorporation took place (Scheme 51). 
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H-6 H-6 
 
Scheme 51 Deuterium incorporation experiment with KOt-Bu as a base. 
Considering that with potassium tert-butoxide only a small fraction of the starting material is 
deprotonated, we repeated the experiment with lithium diisopropylamide at 0 °C for 30 minutes 
(Scheme 52). Again, no deuterium incorporation was observed. We reasoned that the 
tetrasubstituted carbon center and the caged C ring create a sterically demanding periphery that 
complicates further functionalization of enone 176. 
  
crude reaction mixture 
starting material 
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H-6 H-6 
 
  
Scheme 52 Deuterium incorporation experiment with LDA as a base. 
Furthermore a different approach to functionalize enone 176 was tested. Allylic alcohol 198 was 
eliminated to diene 208 (Scheme 53). A Diels–Alder reaction of diene 208 with singlet oxygen 
would give intermediate endoperoxide 209.  
 
 
Scheme 53 Synthesis of diene 208. 
We hypothesized that the stereochemistry would be controlled by the methyl group at C10 and 
shielding the a-side of the molecule. Subsequent Kornblum‒DeLaMare rearrangement[75] should 
crude reaction mixture 
starting material 
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then introduce the tertiary alcohol at C5 and establish a new α,β-unsaturated ketone 210 that could 
undergo a 1,4-addition of methyl cuprate to complete the carbon skeleton. However, different 
reaction conditions led to no conversion and prolonged reaction times, led to decomposition of the 
starting material (Table 9). 
Table 9 [4+2] attempts with diene 208 and singlet oxygen. 
 
Entry T [°C] Photosentizer Solvent Observation 
1 ‒78 to 0 rose bengal CH2Cl2 no conversion 
2 ‒78 to 15 rose bengal CH2Cl2 no conversion 
3 ‒78 rose bengal CH2Cl2 / MeOH no conversion 
4 ‒78 TPP CH2Cl2  decomposition 
5 ‒40 rose bengal CH2Cl2 / MeOH decomposition 
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3.1.4 Third-generation Approach: B-Alkyl Suzuki‒Miyaura cross coupling 
In parallel to the route presented in chapter 3.1.3, a modified alternative approach towards 
mitrephorone A (1) was investigated. A cyclization product such as 212, which already contains 
the desired methyl ester at C19, might simplify the following functionalization towards the natural 
product significantly (Scheme 54). In only one methylation step the complete carbon skeleton of 1 
would be generated with full control of the stereochemistry, since methylation would be controlled 
by the sterical hindrance imparted by the C20 methyl group. For this route, an aromatic building 
block such as 211 was required. 
 
Scheme 54 Envisioned alternative synthesis towards mitrephorone carbon skeleton 213.  
Scheme 55 summarizes our efforts towards building blocks of type 211. The first attempt failed, 
because methyl salicylic acid 214 could not be selectively TIPS protected or deprotected (Scheme 
55a). 
The next approach started from methyl salicylic aldehyde 216, which was protected as 
triisopropylsilyl (TIPS) ether to obtain 217 (Scheme 55b). Subsequent Pinnick oxidation cleaved 
the TIPS group regardless of the reaction or workup conditions, revealing an unexpected instability 
of the phenolic silyl group. 
Therefore, the more stable methoxymethyl acetal (MOM) group was employed and mono-protected 
acid 218 could be prepared (Scheme 55c). Unfortunately, the direct iodination to give 220 was not 
successful, and led to decomposition. 
Another approach was based on a methodology by Merck to convert haloarenes to phenols by a 
SNAr reaction / Lossen rearrangement sequence (Scheme 55d).[76] Intermediate 223 could be 
synthesized in three steps in 45% overall yield. However, several attempts to convert aryl fluoride 
223 to phenol 226 via the depicted sequence were unsuccessful.  
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Scheme 55 Failed attempts to synthesize a methyl ester building block 211. 
Due to these results, a new approach towards aryl bromide 211 was investigated. Based on studies 
published by G. Shan et al., a one-step synthesis starting from the commercially available methyl 
2-bromo-3-methylbenzoate (227) was envisioned.[77] Mechanistically chelation of palladium(II) to 
the carbonyl leads to a palladium-catalyzed C–H functionalization and oxidation with 
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1-fluoropyridinium tetrafluoroborate (228) forms a trifluoroacetated product which is converted 
into the desired phenol 226 under aqueous work up. The reaction gives the building block 226 in 
excellent yield (Scheme 56). 
 
Scheme 56 Palladium-catalyzed C–H oxygenation of benzoate 227. 
With the new aromatic building block 226 in hand, different alkynes 175 and 229ac have been 
prepared (according to Scheme 28). An alternative possibility to introduce the missing diketone 
moiety is the direct Wacker-type oxidation of alkynes (Table 10). This methodology was already 
investigated for the racemic system (see Scheme 30).[62] However, with four different substrates 
this methodology led to no conversion and prolonged reaction times led to decomposition. Only 
with alkyne 229b traces of diketone 230b could be isolated.  
Table 10 Wacker oxidation attempts of alkynes. 
 
Entry Substrate R PG Observation 
1 175 Me TBS no conversion, starts to decompose 
2 229a Me Bn no conversion, starts to decompose 
3 229b CO2Me TBS complex mixture, traces 230b 
4 229c CO2Me Bn complex mixture 
 
With the same alkyne substrates 229ad, we also investigated the formation of a cobalt complex 
to mask the alkyne for later functionalization.[78] Upon addition of dicobalt octacarbonyl, the 
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hexacarbonyldicobalt moiety of the bridged alkyne complexes reduces the bond order from triple 
to approximately that of a double bond, with corresponding change in bond angles. Hence, the 
substituents are in much more favorable locations for cyclization reactions. However, no reaction 
was observed and only starting material was isolated (Table 11). With a tetrasubstituted carbon as 
one substituent, and an ortho,ortho-disubstituted aromatic ring on the other, the internal the triple 
bond is probably not accessible enough for the cobalt complex. 
Table 11 Attempts to protect alkynes with dicobalt octacarbonyl. 
 
Entry Substrate R PG Observation 
1 175 Me TBS no conversion, starts to decompose 
2 229a Me Bn no conversion 
3 229b CO2Me TBS no conversion, starts to decompose 
4 229c CO2Me Bn no conversion 
 
In order to find an opportunity to improve the synthesis of the cage and look for alternative 
C2 spacers to connect the aromatic ring, we were working on the modification and improvement of 
the synthesis for the cage building block. Major challenges where the instability of β-hydroxy 
ketone 143 and aldehyde 145, the volatility of alkyne 134 and aldehyde 145 as well as 
unreproducible yields in the Sonogashira coupling to alkyne 175 (Scheme 57). Furthermore the 
alkylation step to alcohol 143 and the DMP oxidation of alcohol 74 gave lower yields for large 
scale reactions. 
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Scheme 57 Summary of the drawbacks of the synthetic route presented in chapter 3.1.2. 
We planned to skip the preparation of an alkyne and prepare a C2 alkyl chain instead in order to 
perform a sp3-sp2 coupling as an alternative to the current Sonogashira coupling. The first 
improvement would be a more efficient and reliable alkylation of enone ent-71. Table 12 
summarizes alkylation attempts of enone ent-71. We were pleased to find that upon addition of 
three equivalents of hexamethylphosphoramide (HMPA), the stable methyl ester ent-232 could be 
prepared in high yields.  
Table 12 Investigation of alternative alkylations of enone 71. 
 
Entry R-Hal Additive Observation 
1  - no conversion 
2  HMPA (3 equiv.) no conversion 
3  - 233 (20% yield) 
4  HMPA (3 equiv.) 233 (84% yield) 
5  HMPA (2 equiv.) 233 (71% yield) 
6  HMPA (1 equiv.) 233 (43% yield) 
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Scheme 58 Synthesis of methyl ester 237. 
Ketone 235 was transformed into diene 236 and subsequent intramolecular Diels-Alder smoothly 
furnished 237 (Scheme 58). However, subsequent reduction of the methyl ester 237 was not 
successful (Table 13). TBS enol ether 237 is probably too unstable under reductive conditions.  
Table 13 Investigation of reduction conditions towards primary alcohol 238. 
 
Entry Reagent T [°C] Observation 
1 LiAlH4 0 complex mixture, containing 240, 241 
2 DIBAL-H ‒78 complex mixture, containing 239, 240 
3 DIBAL-H 0 complex mixture, containing 239, 240, 241 
4 DIBAL-H 24 complex mixture, containing 240, 241 
 
Next we investigated alternative enol ethers (triflate, TIPS and TBDPS). Vinyl triflate 243 and 
TIPS enol ether 242 were prepared (Table 14). The TBDPS protecting group was too bulky and no 
conversion took place. While with TIPS enol ether 242 the intramolecular Diels-Alder was 
performed successfully, for vinyl triflate 243 no conversion was observed. 
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Table 14 Investigation of alternative Diels-Alder precursors. 
 
 Entry R Conditions Observation 
a) 1 Tf KHMDS, PhNTf2 243 (20% yield) 
 2 TIPS lutidine, TIPSOTf, 24 °C 242 (84% yield) 
 3 TBDPS lutidine, TIPSOTf, 50 °C no conversion 
 4 TBDPS imidazole, TIPSOTf, 50 °C no conversion 
b) 5 Tf 130 to 180°C no conversion 
 6 TIPS 170 °C 244 (quant. yield) 
 
Reduction of TIPS enol ether 244 gave a primary alcohol which was sensitive to silica gel and was 
therefore used without further purification for the subsequent iodation under Appel’s conditions. 
The desired iodide 246 was formed in good yield over two steps and proved amendable to storage 
over prolonged periods of time (Scheme 59).**  
 
Scheme 59 Conversion of ester 244 to iodine 246. 
Suzuki‒Miyaura cross coupling between the boronate derived from iodide 246 and aryl bromide 
247 using Buchwald’s SPhos ligand and SPhos second generation precatalyst gave 248 in very 
good yield (Scheme 60).[79] TIPS deprotection, triflation and benzyl deprotection gave vinyl 
triflate 249. 
                                                     
** Optimization of the synthetic steps shown in Scheme 59 and Scheme 60 was carried out by Aylin 
Hirschvogel. 
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Scheme 60 Suzuki‒Miyaura cross coupling between iodide 246 and aryl bromide 247. 
With cyclization precursor 249 in hand, studies on the asymmetric dearomatization were performed 
(Table 15).†† Unfortunately, reaction of 249 under our standard conditions (see Scheme 45) mainly 
resulted in decomposition. Only an undesired Tsuji–Trost allylation between 249 and the cinnamyl 
ligand was observed (Entry 1). To avoid competing Tsuji‒Trost reaction of key intermediate 249, 
other palladium sources were investigated. However, Pd(OAc)2, Pd2(dba)3 or [Pd2(dppf)Cl]2 
resulted in either no reaction or the recovery of starting material 249 (Entries 2–4).  Using 
potassium acetate or silver carbonate while maintaining the original palladium-source 
([Pd(cinnamyl)Cl]2) also did not led to product 212 (Entry 5 and 6). 
Cesium carbonate as base resulted in decomposition, but traces of the desired cyclization product 
212 could be isolated (Entry 7). However, repeating the experiment on a larger scale (0.08 mmol) 
impaired the reaction and even less product was isolated than on small scale (0.02 mmol). Lowering 
the reaction temperature led to no conversion (Entry 8). Screening other palladium source with 
cesium carbonate also did not afford conversion to 212 either (Entries 9‒11). 
                                                     
†† Experiments of entry 1-7 in Table 15 were carried out by Aylin Hirschvogel. 
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Table 15 Attempts of the dearomative cyclization of vinyl triflate 249. 
 
Entrya Catalyst Base Observation 
1 Pd(cinnamyl)Cl]2 K2CO3 250 (traces) 
2 Pd(OAc)2 K2CO3 no conversion, starts to decompose 
3 Pd2(dba)3 K2CO3 no conversion, starts to decompose 
4 [Pd2(dppf)Cl]2 K2CO3 no conversion, starts to decompose 
5 Pd[(cinnamyl)Cl]2 KOAc 250 (traces) 
6 Pd[(cinnamyl)Cl]2 Ag2CO3 decomposition 
7 Pd[(cinnamyl)Cl]2 Cs2CO3 212 (traces), decomposition 
8b Pd[(cinnamyl)Cl]2 Cs2CO3 no conversion 
9 Pd(OAc)2 Cs2CO3 no conversion, starts to decompose 
10 Pd2(dba)3 Cs2CO3 212 (traces), decomposition 
11 [Pd2(dppf)Cl]2 Cs2CO3 no conversion, starts to decompose 
a all reactions were conducted on a 0.02 to 0.03 mmol scale, with a 0.05 M concentration, reaction temperature of 90 °C 
and a reaction time of 15‒18 h. b reaction temperature: 70 °C. 
Therefore, we decided to reduce ester 249 to benzyl alcohol 252 (Scheme 61). The unprotected 
alcohol was subjected to the dearomative cyclization conditions. A new product was isolated, but 
NMR analysis revealed the formation of benzaldehyde 254, probably formed via the suggested 
mechanism. 
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Scheme 61 Cyclization attempt of unprotected benzyl alcohol 252. 
Protection of benzyl alcohol 252 with TBSCl smoothly gave monoprotected 255. The standard 
dearomatization conditions gave a mixture of products (Scheme 62). Out of this mixture, dienone 
256 could be isolated in 21% yield as an inseparable mixture of diastereomers at C10 (d.r. = 2:3).  
 
Scheme 62 Cyclization attempt of TBS-protected 255. 
The low yield and diastereoselectivity in the dearomatization reaction forced us to revise our 
approach and a new route was pursued as shown in chapter 3.2.  
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
 
 
59 
 
3.2 Strategy B: Robinson Annulation and late-stage Diels‒Alder Reaction 
Since further functionalization of decalin enone 176 proved difficult, a different alternative route 
was investigated in parallel to the synthetic studies presented in chapter 3.1. The general idea was 
to combine already established decalin chemistry for building the substitution pattern of ring A and 
B with our intramolecular Diels‒Alder reaction to form the C-ring cage. The new retrosynthetic 
analysis is depicted in Scheme 63. 
 
Scheme 63 Second-generation retrosynthetic analysis of mitrephorone A (1). 
For the second-generation strategy, we envisioned to trace mitrephorone A (1) back to literature 
known intermediate 129,[80] which already contains two of the three rings and the quaternary center 
at C4. As in our first strategy, the oxetane ring should be closed at last after the Riley oxidation to 
introduce the 1,2-diketone moiety. Disconnecting the caged ring by an intramolecular Diels-Alder 
reaction would lead to intermediate 258, which could be traced back to enone 259 after methylation 
and vinylation in alpha position. A Robinson annulation would build up enone 259 and the diol 
motif should be introduced by a Sharpless asymmetric dihydroxylation of 129, which can be build 
up from acrolein (260) and diketone 261 via an eight-step sequence.[80] 
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3.2.1 Synthesis of the Carbon Skeleton of Mitrephorone A 
The literature known synthesis[80] of building block 129 is depicted in Scheme 64.‡‡ The sequence 
commenced with a Michael addition of 2-methyl-1,3-cyclohexadione (261) to acrolein[81] followed 
by Wittig reaction to access ester 262. Subsequent enantioselective reductive aldol cyclization of 
262 under copper(I)-catalysis, builds up ring A and B ring and sets the stereocenter at C10. The 
enantiomeric excess of intermediate 264 (85% ee) was determined by chiral gas chromatography. 
 
Scheme 64 Synthesis of literature known builig block 129. 
Treatment of silyl ether 264 with trifluoroacetic acid and subsequent esterification with methyl 
iodide gave methyl ester 265 in good yield over four steps. Subsequent elimination of the tertiary 
alcohol followed by carbonyl protection, α-methylation of the ester and deprotection afforded 
multigram amount of 5,6-dehydro decalin 129 (d.r. = 4:1). The diastereomers were separated by 
flash column chromatography. With methyl ester 129 in hand two stereocenters at C4 and C10 of 
mitrephorone A are already set. 
The following dihydroxylation of sterically demanding alkene 129 proved to be challenging. This 
was solved by adding hydroquinidine-1,4-phthalazinediyl diether ligand [(DHDQ)2PHAL] to the 
classical oxidation reagents osmium tetroxide and N-methylmorpholine N-oxide and heating the 
reaction mixture for three days to 80 °C in a sealed tube. Single crystal X-ray analysis of diol 266 
verified the putative carbon skeleton and confirmed that the dihydroxylation occurred from the 
                                                     
‡‡ Optimization of the synthetic steps shown in Scheme 64 and Scheme 65 was carried out by Lukas Wein. 
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upper side of the molecule (Scheme 65). Diol 266 was subjected to a three-step Robinson 
annulation sequence[82][83] and enone 267 was obtained in good yield. 
 
 
Scheme 65 Synthesis of the mitrephorone carbon skeleton 257. 
The next task was the installation of the triene motive needed for the intramolecular Diels‒Alder 
reaction. Therefore diol 267 was protected as acetonide and the enone was methylated in alpha 
position. Following direct vinylation was not possible, therefore an aldol condensation of 
acetaldehyde was conducted to yield alcohol 268. Elimination of the secondary alcohol using 
Martin sulfurane, Luche reduction of the enone and following dehydration of the resulting allylic 
alcohol gave the corresponding triene 258. 
With the corresponding [4+2]-cycloaddition-precursor 258 in hand the intramolecular Diels–Alder 
reaction was carried out in toluene to yield tricyclooctane 257 in quantitative yield. At this stage 
the full carbon skeleton of mitrephorone A was installed. The relative configuration of the carbon 
skeleton was verified by NOESY experiments. 
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For the envisioned endgame of the total synthesis, acetonide 257 needed to be deprotected. 
Unfortunately, an extensive screening of reaction conditions for the acetonide cleavage was 
unsuccessful and either no conversion or decomposition of the starting material was observed 
(Table 16). 
Table 16 Deprotection attempts of acetonide 257. 
 
Entry Reagent Solvent T [°C] Observation 
1 4 M aq. HCl dioxane 24 to 110 decomposition 
2 H2SO4 dioxane 80 no conversion 
3 AcOH (80%) AcOH 110 no conversion, starts to decompose 
4 BF3·OEt2 MeOH ‒78 to 24 no conversion 
5 BF3·OEt2, HS(CH2)3SH MeOH 0 to 24 no conversion 
6 diluted HClO4 THF ‒20 to 24 no conversion 
7 HClO4 (70%) THF ‒20 to 24 no conversion, starts to decompose 
 
We investigated several standard conditions such as Brønsted-acid catalyzed deacetalizations 
(hydrochloric acid,[84] sulfuric acid[85], acetic acid[86] and perchloric acid[87]) as well as boron 
trifluride as strong Lewis-acid.[88] However, the acetonide proved to be surprisingly stable even 
under harsh reaction conditions.  
Since attempts to deprotect acetonide 257 were unsuccessful, deprotection was investigated with 
acetonide 258. The conformation of 258 before the Diels–Alder step is quite different to 257. The 
formation of the caged ring structure changes the steric demand of the molecule and the acetonide 
should be more accessible in structure 258.  
In addition to the conditions already tested with acetonide 257, we investigated further possible 
deprotection conditions for acetonide 258 (Table 17). Several Bronsted acids were screened 
including: Amberlyst,[89] para-toluene sulfonic acid[90] and trifluroacetic acid.[91] With iodine[92] and 
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magnesium bromide[93] even more uncommon conditions were used, but no product formation was 
observed. 
 
Table 17 Attempts to deprotect acetonide 258. 
 
Entry Reagent Solvent T [°C] Observation 
1 4 M aq. HCl MeOH 80 no conversion 
2 H2SO4 dioxane 80 no conversion 
3 TsOH MeOH 80 no conversion 
4 TFA CH2Cl2 60 no conversion 
5 TFA THF/H2O 80 no conversion 
6 Amberlyst CHCl3 60 no conversion 
7 I2 MeOH 24 no conversion, starts to decompose 
8 MgBr2 benzene 80 no conversion 
9 BCl3 CH2Cl2 24 decomposition 
10 BF3·OEt2 MeOH ‒78 to 0 no conversion 
11 BF3·OAc MeOH ‒78 to 0 no conversion 
12 BF3·OEt2 MeOH 0 to 24 no conversion, starts to decompose 
13 BF3·AcOH MeOH 0 to 24 no conversion, starts to decompose 
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3.2.2 Protecting Group Studies 
Since neither acetonide 257 nor 258 could be deprotected, we decided to put a different protecting 
group on diol 267. Eight different diol protecting groups were investigated (Table 18). Successful 
protection of diol 267 could be realized with Bn or PMP acetal or a carbonate. Methyl orthoformate 
(entry 3) and di-silylether (entry 7) only protected the secondary alcohol and the tertiary alcohol 
remained unprotected. These results additionally confirmed that the diol functionality is sterically 
extremely hindered already in less hindered structure of enone 267 and even before the bulky cage 
in ring C is introduced. 
Table 18 Protection attempts of diol 267. 
 
Entry Protecting group Reagents Observation 
1  
 
p-TsOH, benzaldehyde product formation 
2 
 
 
p-TsOH, anisaldehyde product formation 
3 
 
 
p-TsOH, HC(OMe)3 undesired side product 
4 
 
 
pyridine, Me2SiCl2 
product formation, but 
extremely unstable 
5 
 
 
lutidine, i-Pr2Si(OTf)2 complex mixture 
6 
 
 
lutidine, (t-Bu)2Si(OTf)2 no conversion 
7 
 
 
imidazol, Cl-Si(i-Pr)2OSi(i-Pr)2-Cl undesired side product 
8 
 
 
pyridine, triphosgene product formation 
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With the three protected diols in hand, we investigated different deprotection conditions starting 
with standard condition as shown in Table 19. Hydrogenation of the acetals did not lead to product 
formation, instead new compounds were detected. With 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ), the PMP acetal decomposed and the carbonate deprotection led to new spots 
monitored by thin layer chromatography. Formation of diol 267 was not observed. Although no 
diol 267 formation was observed, these results did not indicate, that the protecting groups cannot 
be cleaved later on in the synthesis. However, it seemed not trivial to find a feasible diol protecting 
group for this molecule. 
Table 19 Attempts to directly cleave the diol protecting group. 
 
Entry Protecting group Reagents Observation 
1 
 
 
H2, Pd(OH)2 
complex mixture, no product 
formation 
2 
 
 
H2, Pd(OH)2 
complex mixture, no product 
formation 
3 
 
 
DDQ decomposition 
4 
 
 
KOH, MeOH / H2O 
complex mixture, no product 
formation 
 
Since diol protecting groups proved to be challenging, we changed the strategy to a mono protected 
system. Since we assumed that the unprotected sterically extremely hindered tertiary alcohol will 
not interfere with the next steps. 
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Scheme 66 TBS protection and direct deprotection attempts of diol 267. 
The secondary alcohol of diol 267 could be mono protected with TBSOTf and subsequent 
deprotection was realized with both hydrofluoric acid in pyridine or tetrabutylammonium fluoride 
(TBAF) (Scheme 66). 
 
Scheme 67 Methylation of TBS protected alcohol 271. 
When performing the reaction on larger scale we found that also the silyl enol ether is formed under 
these conditions (Scheme 67). But since the enol ether is unstable on silica gel, after a second 
column chromatography, enone 271i was afforded in good yield. Subsequent methylation of enone 
271i gave 272 in moderate yield. 
The following alkylation with acetaldehyde to alcohol 273 was first performed with the optimized 
reaction conditions from the acetonide route (see Scheme 65): LDA and N,N,N′,N′-
tetramethylethylendiamin (TMEDA) as additive. Under these conditions no conversion was 
observed and 70% of the starting material could be reisolated (Table 20). Also N,N′-
dimethylpropyleneurea (DMPU) or without the addition of an additive no conversion of the starting 
material was observed. With HMPA a complex mixture of products and remaining starting material 
was obtained. Also the intermediate protection of the free tertiary alcohol with trimethylsilyl 
chloride and methyl lithium could not enable the reaction (entry 5). The intermediate TMS species 
was not isolated and analyzed, so maybe the tertiary alcohol was not protected but instead the enone 
was converted to the TMS enol ether. 
  
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
 
 
67 
 
Table 20 Attempts to alkylate enone 272 with acetaldehyde. 
 
Entry Additive Observation 
1 - no conversion 
2 DMPU no conversion 
3 TMEDA no conversion 
4 HMPA decomposition 
5 
MeLi, TMSCl, 
then LDA, TMEDA, acetaldehyde 
no conversion 
 
Therefore we investigated the synthetic sequence with the PMP acetal protecting group (Scheme 
68). Protection of diol 267 gave only moderate yield of PMP acetal 271b, but subsequent 
methylation worked smoothly under the addition of HMPA. Without the addition of HMPA, no 
conversion could be observed. The following alkylation of enone 271b with acetaldehyde gave, 
similar to the TBS-protected version 272, no product. The same conditions as for TBS protected 
alcohol 272 were tested (no additive, TMEDA, HMPA, DMPU). The aldol reaction with 
acetaldehyde seems to be the challenging “bottle neck” reaction of the sequence for which the 
protecting group is required. 
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Scheme 68 Investigation of the alkylation steps with PMP acetal protection. 
In parallel to the PMP acetal, carbonate protection was investigated (Scheme 69). Carbonate 271h 
was obtained in excellent yield and subsequent methylation of 271h gave enone 276 in acceptable 
yield. As with PMP acetal 274 no conversion for the methylation was observed without the addition 
of HMPA. The aldol reaction of enone 276 with acetaldehyde without additive led to no conversion 
and decomposition was observed when HMPA was added. 
 
Scheme 69 Investigation of the alkylation steps with carbonate protected diol 271h. 
The addition of TMEDA gave alcohol 277 in good yield (Scheme 70). The subsequent elimination 
- reduction - elimination sequence gave diene 278 in moderate yield. We tried to improve the 
elimination reaction of alcohol 277 to vinyl 278 by using less expensive Burgess reagent (benzene, 
25 to 80 °C) instead of Martin sulfurane, but no conversion to 278 was observed. 
Intramolecular Diels−Alder reaction of 278 gave 279 in quantitative yield and built up the complete 
carbon skeleton of the natural product. 
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Scheme 70 Synthesis of the complete mitrephorone carbon skeleton. 
With carbonate 279 in hand, we tested various deprotection methods. The efforts to deprotect 
carbonate 279 are summarized in Table 21. Basic, aqueous, as well as inert and water free 
conditions were tested.[94][95] Furthermore reducing reagents were investigated.[96] However, like 
the acetonides 258 and 257, carbonate 279 proved to be surprisingly stable even under harsh 
reaction conditions. 
Table 21 Attempts to deprotect carbonate 279. 
 
Entry Reagent Solvent T [°C] Observation 
1 K2CO3 MeOH 65 no conversion 
2 NaOMe MeOH 65 no conversion 
3 K2CO3 MeOH / ethylene glycol 65 no conversion 
4 NaOMe MeOH / ethylene glycol 65 no conversion 
5 Ba(OH)2 H2O 70 no conversion 
6 Ba(OH)2 H2O / DMF 100 no conversion 
7 LAH THF 65 no conversion 
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8 LAH toluene 100 no conversion 
9 NaH toluene 120 decomposition 
10 KOH ethylene glycol 150 no conversion 
11 LiOH, H2O2 THF 60 no conversion 
 
Treating carbonate 279 with lithium triethylborohydride (Super-Hydride®) finally resulted in 
conversion of the starting material. The product turned out to be an inseparable mixture of two 
products: alcohol 280 still being carbonate protected and completely reduced triol 281.  
 
Scheme 71 First successful deprotection of carbonate 279. 
Repeating the same reaction conditions as shown in Scheme 71, this time under prolonged reaction 
time (60 h instead of 30 h) to get full conversion to triol 281, unfortunately did not resulted in 
formation of the desired triol 281. An unidentified new product was isolated, again as an 
inseparable mixture of two products. High resolution mass spectrometry revealed that a boron was 
incorporated into the molecule. Two hypothetical structures 282 and 283 that would fit to the found 
mass are depicted in Figure 11. 
 
Figure 11 Hypothetical undesired reaction products after prolonged reaction time of carbonate 279 with 
Super-Hydride®. 
In order to hydrolyze the putative boron species, the isolated material was subjected to aqueous 
acidic conditions. Unfortunately, only decomposition took place. Also with aqueous sodium 
hydroxide and hydrogen peroxide triol 281 could not be isolated. 
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The reduction of carbonate 279 to triol 281 was therefore tested with sodium bis(2-
methoxyethoxy)aluminium hydrid (Red-Al), another strong reducing agent, without containing any 
boron. Indeed, reacting carbonate 279 with Red-Al at low temperatures first reduced the ester to 
alcohol 280 and in a second reduction step triol 281 could be obtained in very good yield.  
Scheme 72 Reduction and deprotection of carbonate 279 to triol 281. 
Although triol 281 is not ideal the methyl ester has to be rebuild, we were finally able to deprotect 
the diol, which represents a huge progress towards the total synthesis of mitrephorone A (1). 
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4 Summary and Outlook 
Progress toward the total synthesis of the diterpenoid mitrephorone A (1) was discussed in this 
thesis. 
At first, the challenging carbon core structure was constructed by employing a dearomatization 
strategy (Scheme 73). The elaborated route commences with the preparation of enone 71 via an 
enantioselective Diels–Alder reaction. Conversion towards alkyne 134 was realized in a six-step 
sequence involving an intramolecular Diels–Alder reaction to build up the caged structure found in 
the natural product. Next, the two building blocks 134 and 174 were coupled via a Sonogashira 
cross coupling reaction. Asymmetric dearomative cyclization of 127 closed the last carbon ring of 
mitrephorone A and set the right quaternary stereocenter at C10. 
 
Scheme 73 Convergent asymmetric synthesis of the core structure of mitrephorone A (1). 
With the established route toward the core structure of the natural product in hand, we extensively 
investigated various synthetic strategies toward the natural product. The convergent synthesis 
enabled the preparation of different coupling partners and thus diverse cyclization precursors. 
However, with this synthetic approach the further functionalization of the sterically demanding 
scaffold was found to be challenging. 
An alternative approach commenced with literature known building block 129 which was prepared 
in eight steps (Scheme 74). A Sharpless dihydroxylation and Robinson annulation sequence led to 
enone 259. In six further steps enone 259 was converted to triene 278. An intramolecular Diels‒
Alder reaction of 278 built up the complete carbon skeleton of the natural product. Subsequent 
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deprotection of carbonate 279 proved to be challenging and was realized using the strong reducing 
agent bis(2-methoxyethoxy)aluminium and resulted in the formation of triol 281. 
 
Scheme 74 Asymmetric synthesis of the mitrephorone carbon skeleton 281. 
In future, the substrate should be further transformed to ketone 284 via oxidation and esterification. 
With tertiary alcohol 284 in hand, the stage is set for the last key step of our synthesis.  
 
Scheme 75 Envisioned synthesis of oxetane 285 and completion of the total synthesis of mitrephorone A. 
We envision to activate the double bond of 284 with iodine to enable a 4-exo-trig cyclisation which 
should form oxetane 285. Other reagents are conceivable for this transformation like 
N-bromosuccinimide, which was used for the oxetane cyclisation in cisclerodane diterpenes 
syntheses[97] or bis(sym-collidine)iodine perchlorate [I(coll)2ClO4] another reagent already 
successfully applied in oxetane formations.[98] Also for the following dehalogenation of 285 various 
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reducing protocols are possible: hydrogen gas and palladium,[99] a radical version with 
azobisisobutyronitrile (AIBN) and tributyltin hydride,[100] or a mild version using samarium iodide 
as applied in the total synthesis of (–)-huperzine Q.[101] A Riley oxidation with selenium dioxide 
should complete our total synthesis of mitrephorone A (1). 
 
Overall, the pursued strategies presented in this thesis constitute significant progress toward the 
total synthesis of mitrephorone A (1). The developed robust and asymmetric route of the complete 
carbon skeleton of mitrephorone A provides a basis for further efforts toward this structurally 
unique natural product. Further studies on the completion of the total synthesis of mitrephorone A 
are currently under investigation in the Magauer laboratories. 
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5 Experimental Part 
5.1 General Experimental Details 
5.1.1 General Working Methods 
All reactions were performed in glassware fitted with rubber septa under a positive pressure of 
argon, unless otherwise noted. All glassware was dried in an oven at 130 °C prior to use. Air‐ and 
moisture‐sensitive liquids were transferred via syringe or stainless-steel cannula through rubber 
septa. Solids were added under inert gas or were dissolved in appropriate solvents. High pressure 
reactions were conducted in a miniclave steel apparatus from BÜCHI AG. Low temperature‐
reactions were carried out in a Dewar vessel filled with a cooling agent: acetone/dry ice (−78 °C), 
H2O/ice (0 °C). Reaction temperatures above 24 °C were conducted in a heated oil bath. The 
reactions were magnetically stirred and monitored by NMR spectroscopy or analytical thin‐layer 
chromatography (TLC), using glass plates precoated with silica gel (0.25 mm, 60 Å pore size, 
Merck) impregnated with a fluorescent indicator (254 nm). TLC plates were visualized by exposure 
to ultraviolet light (UV), were stained by submersion in aqueous basic potassium permanganate 
solution (KMnO4), aqueous acidic ceric ammonium molybdate solution (CAM), or an aqueous 
acidic p-anisaldehyde solution and were developed by heating with a heat gun. Flash‐column 
chromatography on silica gel was performed as described by Still et al.,[102] employing silica gel 
(60 Å, 40–63 μm, Merck KGaA). Flash column chromatography on silica gel using triethylamine 
pretreated silica gel was performed by preparing the silica gel slurry with triethylamine (7.5% v/v 
in corresponding eluent mixture) and flushing the column with the eluent prior to loading the 
compound on the column. The yields refer to chromatographically and spectroscopically (1H and 
13C NMR) pure material. 
5.1.2 Solvents and Reagents 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from sodium/benzophenone prior to 
use. Dichloromethane (CH2Cl2), triethylamine (Et3N), diisopropylamine (DIPA) and N,N-
diisopropylethylamine (DIPEA) were distilled under nitrogen atmosphere from calcium hydride 
prior to use. Benzene, toluene, 1,4-dioxane, dimethylformamide (DMF), dimethyl sulfoxide 
(DMSO), acetonitrile (MeCN), ethanol (EtOH) and methanol (MeOH) were purchased from Acros 
Organics as 'extra dry' reagents and used as received. All other reagents and solvents were 
purchased from chemical suppliers (Sigma‐Aldrich, Acros Organics, Alfa Aesar, Strem Chemicals, 
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TCI Europe, carbolution, ABCR) and were used as received. Solvents for extraction, crystallization 
and flash column chromatography on silica gel were purchased in technical grade and distilled 
under reduced pressure prior to use. Lithium chloride and lithium bromide were dried at 100 °C 
under vacuum (0.1 mmHg) for 12 h and stored in a drying oven at 130 °C (760 mmHg); the hot, 
dried solid was flame dried under vacuum (0.1 mmHg) for 4–5 min immediately prior to use. 4 Å 
molecular sieves were washed (methanol, acetone, dichloromethane) and then dried at 100 °C 
under vacuum (0.1 mmHg) for 12 h and stored in a drying oven at 130 °C (760 mmHg); the 
molecular sieves were flame dried under vacuum (0.1 mmHg) for 4–5 min immediately prior to 
use. The molarity of n‐butyllithium solutions was determined by titration against diphenylacetic 
acid as an indicator (average of three determinations).[103] 
5.1.3 NMR Spectroscopy 
NMR spectra were measured on a Bruker Avance III HD 800 MHz spectrometer equipped with a 
CryoProbeTM, Bruker Avance III HD 400 MHz spectrometer equipped with a CryoProbeTM, 
Bruker AXR300, Varian VXR400 S, Bruker AMX600, Bruker Avance Neo 400 MHz, an Agilent 
500 DD2 or a Bruker Avance II 600 MHz spectrometer. Proton chemical shifts are expressed in 
parts per million (ppm, δ scale) and are referenced to residual protium in the NMR solvent (CHCl3: 
δ 7.26, C6HD5: 7.16). Carbon chemical shifts are expressed in parts per million (δ scale, assigned 
carbon atom) and are referenced to the carbon resonance of the NMR solvent (CDCl3: δ 77.16, 
C6D6: 128.06). 1H NMR spectroscopic data are reported as follows: Chemical shift in ppm 
(multiplicity, coupling constants J (Hz), integration intensity, assigned proton) (e.g. “5.21 (t, J = 
7.3 Hz, 1H, H-9)”). The multiplicities are abbreviated with s (singlet), br s (broad singlet), d 
(doublet), t (triplet), q (quartet), p (pentet), se (sextet), h (heptet) and m (multiplet). In case of 
combined multiplicities, the multiplicity with the larger coupling constant is stated first. Except for 
multiplets, the chemical shift of all signals, as well for centrosymmetric multiplets, is reported as 
the center of the resonance range. Protons of diastereotopic methylene groups are reported as H-Xa 
and H-Xb, where H-Xa is the more downfield shifted proton. The nomenclature is arbitrarily and 
does not correspond to the spin system. Furthermore, the numbering of the proton and carbon atoms 
does not correspond to the IUPAC nomenclature. 13C NMR spectroscopic data are reported as 
follows: Chemical shift in ppm (assigned carbon) (e.g. “159.22 (C‐21)”). In cases were resonances 
overlap or cannot be unambiguously assigned to a single proton or carbon atom, multiple 
assignments are listed (e.g. the 13C NMR assignment “18.29 (C‐16, C‐17), 17.84 (C‐16, C‐17)” 
indicates that the resonance at 18.29 is either C‐16 or C‐17). In addition to 1H and 13C NMR 
measurements, 2D NMR techniques such as homonuclear correlation spectroscopy (COSY), 
heteronuclear single quantum coherence (HSQC) and heteronuclear multiple bond coherence 
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(HMBC) were used to assist signal assignment. For further elucidation of 3D structures of the 
products, nuclear Overhauser enhancement spectroscopy (NOESY) was conducted. All raw FID 
files were processed and the spectra analyzed using the program MestReNova 9.0.1 from Mestrelab 
Research S. L. 
5.1.4 Mass Spectrometry 
Mass spectra were recorded on a MAT 95 (EI) and MAT 90 (ESI) from Thermo Finnigan GmbH 
at the Department of Chemistry, Ludwig-Maximilians-University Munich or a Thermo Scientific™ 
LTQ Orbitrap XL™ Hybrid Ion Trap-Orbitrap Mass Spectrometer at the Institute of Organic 
Chemistry and Center for Molecular Biosciences, University of Innsbruck. Mass spectra were 
recorded in high‐resolution. The method used is reported at the relevant section of the experimental 
section. 
5.1.5 IR Spectroscopy 
IR spectra were recorded on a PerkinElmer Spectrum BX II FT‐IR system or on a Bruker™ 
ALPHA FT-IR Spectrometer from Bruker. Data are represented in frequency of absorption (cm−1). 
Samples were prepared as a neat film or a film by evaporation of a solution. 
5.1.6 Optical Rotation 
Optical rotation values were recorded on a PerkinElmer 241 or Anton Paar MCP 200 or a 
Schmidt+Haensch UniPol L1000 Peltier polarimeter. The specific rotation is calculated as follows: 
[𝛼]λ
𝜑
= 
𝛼
𝛽 ∙ 𝑑
 
α: recorded optical rotation 
β: concentration of the analyte in 10 mg/mL 
d: length of the cuvette in dm 
φ: measuring temperature in °C 
λ: wave length in nm  
The respective concentration and the solvent are denoted in the analytical part of the experimental 
description. 
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5.1.7 Optical Rotation 
The data collections were performed either on an Oxford Diffraction Xcalibur diffractometer, on a 
Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoKα‐
radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro software (version 
1.171.33.41) was applied for the integration, scaling and multi‐scan absorption correction of the 
data. The structures were solved by direct methods with SIR97 and refined by least‐squares 
methods against F2 with SHELXL‐97. All non‐hydrogen atoms were refined anisotropically. The 
hydrogen atoms were placed in ideal geometry riding on their parent atoms. Further details are 
summarized in the tables at the different sections. 
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5.2 Experimental Procedures 
4-Methyl-4-vinylcyclohex-2-enone (rac-71) 
 
In a pressure flask, a solution of the Danishefsky’s diene[104] 139 (24.3 g, 141 mmol, 1 equiv) in 
toluene (260 mL) was sparged with argon for 5 min. Methacrolein (23.3 mL, 282 mmol, 2.00 equiv) 
was added. The reaction mixture was heated to 110 °C for 20 h. The mixture was allowed to cool 
to 24 °C and concentrated. The residue was used without further purification for the next step. 
A suspension of methyltriphenylphosphonium bromide (60.4 g, 169 mmol, 1.20 equiv) in 
tetrahydrofuran (360 mL) was treated with n-butyl lithium (2.50 M in n-hexane, 67.7 mL, 
1.20 equiv) at ‒20 °C and the orange suspension was warmed to 24 °C. After 30 min, the suspension 
was cooled to –40 °C. A solution of crude aldehyde rac-140 in tetrahydrofuran (200 mL) was added 
via cannula over a period of 10 min. After 20 min, the orange cloudy mixture was allowed to warm 
to 24 °C and stirred for 1 h. The dark red mixture was cooled to 0 °C.  Saturated aqueous ammonium 
chloride solution (400 mL), water (200 mL) and aqueous hydrochloric acid (1 M, 100 mL) were 
added. The layers were separated and the aqueous layer was extracted with diethyl ether (2 × 
200 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (200 mL) and the washed solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated (Caution, the compound is volatile! Vacuum >300 mbar, 
30 °C water bath). The residue was purified by flash column chromatography on silica gel (2030% 
diethyl ether in pentane) to yield rac-71 (15.4 g, 80% over two steps) as a yellow oil. The analytical 
data matched those previously described in the literature.[61] 
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(4S-trans)-2,2-Dimethyl-α,α,α′,α′-tetra(1-naphthyl)-1,3-dioxolane-4,5-dimethanol (183) 
 
To preheated magnesium turnings (4.1 g, 168 mmol, 8.40 equiv), a grain of iodine and 
tetrahydrofuran (50 mL) was added. A solution of 1-bromonaphthalene (188) (22.3 mL, 160 mmol, 
8.00 equiv) in tetrahydrofuran (100 mL) was added dropwise via a dropping funnel. After 10 min, 
20 mL of the 1-bromonaphthalene solution were added and gentle refluxing of the tetrahydrofuran 
started. The remaining solution was added dropwise over 1 h. The reaction mixture was stirred at 
24 °C for 1 h. A gray solid precipitated. More tetrahydrofuran (60 mL) was added and the mixture 
was warmed to 40 °C for 30 min. The resulting suspension was cooled to 24 °C. A solution of 
(+)-dimethyl 2,3-O-isopropylidene-D-tartrate (190) (4.4 g, 20 mmol, 1 equiv) in tetrahydrofuran 
(100 mL) was dropwise added via the dropping funnel over 1.5 h. The reaction mixture was heated 
to 70 °C and stirred for 3 h. The reaction mixture was cooled to 24 °C. Saturated aqueous 
ammonium chloride solution (200 mL) was added carefully. The layers were separated and the 
aqueous layer was extracted with diethyl ether (4 × 200 mL). The combined organic extracts were 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel (15% ethyl acetate in 
hexanes) to yield 183 (12.3 g, 92%) as light yellow solid. The analytical data matched those 
previously described in the literature.[105] 
 
(S)-4-Methyl-4-vinylcyclohex-2-enone (ent-71) 
 
The first reaction step was carried out in parallel in two separate flasks. The following procedure 
describes the synthesis for one batch of 13.8 mmol: (4S-trans)-2,2-Dimethyl-α,α,α′,α′-tetra(1-
naphthyl)-1,3-dioxolane-4,5-dimethanol (183) (1.86 g, 2.76 mmol, 0.18 equiv) was added to a 
Schlenk tube. The tube was pumped and back-filled with argon three times. Toluene (15.5 mL) and 
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methacrolein (1.15 mL, 13.8 mmol, 1 equiv) were added dropwise. The orange solution was cooled 
to –80 °C using a cryostat and trans-3-(tert-butyldimethylsilyloxy)-N,N-dimethyl-1,3-butadien-1-
amine 69[106] (3.98 mL, 15.4 mmol, 1.10 equiv) was added dropwise. During the addition, the 
solution turned green and immediately afterwards the color changed to brown. The reaction mixture 
was stirred at ‒80 °C for five days. 
A phosphonium ylide suspension was prepared: Methyltriphenylphosphonium bromide (35.2 g, 
96.6 mmol, 3.50 equiv) was added in a 3-necked round bottom flask. The flask was pumped and 
back-filled with argon for three times. Tetrahydrofuran (230 mL) was added and the suspension 
was cooled to –78 °C. A solution of n-butyl lithium (2.44 M in n-hexane, 39 mL, 3.45 equiv) was 
added dropwise and the orange suspension was warmed to 0 °C. After 30 min, the suspension was 
cooled to –78 °C. Both bathes of the crude Diels–Alder product ent-184 were added dropwise to 
the prepared phosphonium ylide suspension. During the addition, a green foam occurred, which 
dissolved after 20 min and an orange suspension remained. The reaction mixture was allowed to 
warm to 24 °C.  
After stirring for 15 h, the suspension was cooled to –15 °C and hydrofluoric acid (51% in water, 
18.8 mL, 552 mmol, 20.0 equiv) was added dropwise into the open flask. The reaction mixture was 
allowed to warm to 24 °C. After 8 h, saturated aqueous sodium bicarbonate solution (600 mL) and 
solid sodium bicarbonate was added slowly over 12 h until the gas evolution stopped. Diethyl ether 
(300 mL) was added and the layers were separated. The aqueous layer was extracted with diethyl 
ether (5 × 150 mL) and the combined organic layers were washed with water (2 × 200 mL) and 
saturated aqueous sodium chloride solution (300 mL). The washed solution was dried over sodium 
sulfate. The dried solution was filtered, and the filtrate was concentrated (Caution, the compound 
is volatile! Vacuum >300 mbar, 30 °C water bath). The residue was purified by flash column 
chromatography on silica gel (20% diethyl ether in pentanes) to remove high boiling toluene. A 
second flash column chromatography on silica gel (2‒10% diethyl ether in pentane) provided 
ent-71 (3.6 g, 96%, 90% ee as determined by Mosher[67] analysis using 1H spectroscopy) as a yellow 
oil. 
TLC (20 % diethyl ether in pentane): Rf = 0.37 (UV, CAM). 
[𝛂]𝑫
𝟐𝟎
 = +110 (c = 1.20, CH2Cl2). 
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Triene ent-137 
 
n-Butyllithium (2.40 M, 33.2 mL, 79.8 mmol, 3.00 equiv) was added dropwise at −78 °C to a 
solution of diisopropylamine (11.3 mL, 79.8 mmol, 3.00 equiv) in tetrahydrofuran (200 mL) and 
was stirred for 5 min at the same temperature. The reaction mixture was allowed to warm to 24 °C 
and stirred for 15 min. The reaction mixture was cooled to −78 °C. A solution of ent-71 (4.00 g, 
26.6 mmol, 1 equiv) in tetrahydrofuran (20 mL) was added dropwise to the lithium 
diisopropylamide solution and was stirred for 30 min at the same temperature. 1H-Benzotriazole-
1-methanol (8.10 g, 53.2 mmol, 2.00 equiv) was added and the reaction mixture was stirred for at 
−78 °C. After 3 h, water (100 mL) was added and the mixture was allowed to warm to 24 °C. The 
layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 100 mL). The 
combined organic layers were washed with aqueous sodium chloride solution (100 mL). The 
washed solution was dried over sodium sulfate. The dried solution was filtrated and the filtrate was 
concentrated. The residue was purified by fast flash column chromatography on silica gel (40% 
ethyl acetate in hexanes) with deactivated silica (10% triethylamine) to yield the hydroxyl ketone 
ent-143. 
 
2,6-Lutidine (6.41 mL, 53.9 mmol, 4.00 equiv) and tert-butyldimethylsilyl trifluoromethane-
sulfonate (6.2 mL, 27.0 mmol, 2.00 equiv) were added at 0 °C to a solution of crude hydroxyl 
ketone ent-143 (3.09 g, 18.6 mmol, 1 equiv) in dichloromethane (160 mL). The reaction mixture 
was stirred for 16 h at 24 °C. Saturated aqueous ammonium chloride solution (100 mL) was added 
to the reaction mixture. The layers were separated. The aqueous layer was extracted with 
dichloromethane (3 × 100 mL). The combined organic layers were washed with aqueous sodium 
chloride solution (100 mL). The washed solution was dried over sodium sulfate. The dried solution 
filtrated and concentrated. The residue was purified by flash column chromatography on silica gel 
(1% ethyl acetate in hexanes) to yield ent-137 (4.71 g, 45% over two steps) as a yellow oil. 
TLC (20 % ethyl acetate in hexanes): Rf = 0.81 (UV, CAM). 
IR (Diamond-ATR, neat) ?̃?max: 2956, 2929, 2886, 2857, 1660, 1472, 1463, 1394, 1361, 1253, 1192, 
1090, 1049 cm−1. 
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1H NMR (400 MHz, C6D6) δ = 5.85 (dd, J = 17.4, 10.6 Hz, 1H), 5.78 (d, J = 9.8 Hz, 1H), 5.47 (d, 
J = 9.8 Hz, 1H), 5.14 (dd, J = 17.4, 1.4 Hz, 1H), 4.96 (dd, J = 10.6, 1.4 Hz, 1H), 4.38 (s, 2H), 2.55 
(d, J = 16.4 Hz, 1H), 2.39 (d, J = 16.4 Hz, 1H), 1.11 (s, 3H), 1.02 (s, 9H), 1.01 (s, 9H), 0.14 (s, 6H), 
0.13 (s, 6H). 
13C NMR (100 MHz, C6D6) δ = 145.1, 142.4, 135.8, 125.6, 114.2, 111.2, 60.1, 38.1, 37.2, 26.2, 
26.0, 25.9, 18.6, 18.3, −4.0, −4.1, −5.1.  
HRMS (ESI): calcd for (C22H43O2Si2)+ [M+H]+: 395.2796 , found: 395.2800. 
[𝛂]𝑫
𝟐𝟎
 = +64.7 (c = 0.69, CH2Cl2). 
 
Triene rac-72 
 
A solution of diisopropylamine (0.13 mL, 0.92 mmol, 1.25 equiv) in tetrahydrofuran (7 mL) was 
treated with n-butyllithium solution (2.23 M in n-hexane, 0.40 mL, 0.88 mmol, 1.20 equiv) 
at 78 °C. After 5 min, the cooling bath was removed for 20 min, and then the mixture was cooled 
to ‒78 °C. A solution of the rac-71 (100 mg, 0.73 mmol, 1 equiv) in THF (1 mL) was added and 
the solution was stirred for 30 min at ‒78 °C. Methyl cyanoformate (0.99 mL, 1.25 mmol, 
1.70 equiv) was added. After 1 h, the reaction mixture was warmed to 0 °C and the color changed 
from yellow to dark red. After 1 h, ethyl acetate (10 mL) and saturated aqueous sodium bicarbonate 
solution (20 mL) was added. The layers were separated. The aqueous layer was extracted with ethyl 
acetate (3 × 15 mL). The combined organic extracts were washed with water (2 × 15 mL) and 
saturated sodium chloride solution (2 × 15 mL), dried over sodium sulfate. The dried solution 
filtrated and concentrated. The residue was purified by flash column chromatography on silica gel 
(15% ethyl acetate in hexanes) to afford rac-S1 (95 mg, 67%) as inconsequential mixture of 
diastereomers. 
To a solution of rac-S1 (95 mg, 0.49 mmol, 1 equiv) in dichloromethane (2.5 mL) was added 2,6-
lutidine (0.17 mL, 1.47 mmol, 3.00 equiv) at 0 °C. tert-Butyldimethylsilyl trifluoromethane-
sulfonate (0.17 mL, 0.73 mmol, 1.50 equiv) was added. After 18 h, saturated aqueous ammonium 
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chloride solution (20 mL) was added. The layers were separated and the aqueous layer was 
extracted with dichloromethane (3 × 20 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (15 mL) and the washed solution was dried over sodium 
sulfate. The dried solution was filtered, and the filtrate was concentrated. The crude product was 
purified by flash column chromatography on silica gel (hexanes) to afford rac-72 (139 mg, 92%) 
as a colorless oil. The analytical data matched those previously described in the literature.[40] 
 
Tricyclo[3.2.1.02,7]octene ent-136 
 
A solution of ent-137 (4.71 g, 11.9 mmol) in toluene (100 mL) was sealed in a pressure tube and 
the solution was heated to 170 °C. After 13 h, the solution was cooled to 24 °C and concentrated 
to yield ent-136 (4.71 g, 100%) as a yellow oil. 
TLC (2% ethyl acetate in hexanes): Rf = 0.57 (UV, CAM).  
IR (Diamond-ATR, neat) 𝜐 max: 3852, 3745, 3675, 3649, 3031, 2953, 2928, 2857, 1733, 1717, 1699, 
1684, 1637, 1558, 1540, 1506, 1472, 1463 1388, 1363, 1343, 1307, 1244, 1209, 1177, 1162, 1076, 
1005 cm−1. 
1H NMR (600 MHz, C6D6) δ = 5.09 (d, J = 6.4 Hz, 1H), 4.05 (d, J = 2.8 Hz, 2H), 2.20 (dd, J = 10.9, 
2.4 Hz, 1H), 1.89 (d, J = 10.7 Hz, 1H), 1.31 (t, J = 6.6 Hz, 1H), 1.23 (s, 3H), 1.09 (dd, J = 7.1, 
2.4 Hz, 1H), 1.01 (s, 9H), 0.98 (s, 9H), 0.96 (d, J = 3.7 Hz, 1H), 0.94 (d, J = 3.6 Hz, 1H), 0.14 (s, 
3H), 0.13 (s, 3H), 0.12 (s, 6H). 
13C NMR (150 MHz, C6D6) δ = 154.4, 96.4, 62.8, 48.4, 37.3, 31.6, 26.3, 26.0, 23.1, 22.7, 21.9, 
18.8, 18.8, 18.4, −4.4, −4.5, −5.2. 
HRMS (ESI): calcd for (C22H43O2Si2)+ [M+H]+: 395.2796, found: 395.2796. 
[𝛂]𝑫
𝟐𝟎
 = –21.2 (c = 1.78, CH2Cl2). 
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Alcohol ent-74 
 
To a solution of ent-136 (4.71 g, 11.9 mmol, 1 equiv) in tetrahydrofuran (50 mL) at 0 °C was slowly 
added a solution of tetrabutylammonium fluoride (1 M in tetrahydrofuran, 25.0 mL, 25.0 mmol, 
2.10 equiv). The reaction mixture was stirred for 5 min at 0 °C and was then allowed to warm to 
24 °C. The reaction mixture was stirred for 3 h. Saturated aqueous sodium hydrogen carbonate 
solution (150 mL) was added. The layers were separated. The aqueous layer was extracted with 
diethyl ether (3 × 100 mL). The combined organic layers were dried over sodium sulfate. The dried 
solution was filtrated and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (50–80% diethyl ether in pentane) to yield alcohol ent-74 (1.7 g, 86%) 
as a yellow oil.  
TLC (70% ethyl acetate in hexanes): Rf = 0.34 (UV, CAM).  
IR (Diamond-ATR, neat) 𝜐 max: 3412, 3028, 2924, 2864, 2360, 1703, 1447, 1401, 1382, 1350, 1306, 
1242, 1187, 1160, 1110, 1080, 1036 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 3.61 (d, J = 6.6 Hz, 2H), 2.60 (qd, J = 20.9, 2.4 Hz, 2H), 2.49 (t, 
J = 6.9 Hz, 1H), 1.93 (dd, J = 12.8, 3.3 Hz, 1H), 1.84 (s, 1H), 1.80 (s, 1H), 1.72 (d, J = 12.7 Hz, 1H), 
1.28 (s, 3H), 1.24 (dd, J = 7.6, 3.2 Hz, 1H), 0.93 (ddd, J = 7.6, 2.7, 1.3 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ = 214.8, 65.2, 56.8, 37.3, 34.1, 32.2, 22.8, 22.0, 19.4, 17.7. 
HRMS (ESI): calcd for (C10H15O2)+ [M+H]+: 167.1067, found: 167.1068. 
[𝛂]𝑫
𝟐𝟎
 = –2.9 (c = 0.90, CH2Cl2). 
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Aldehyde ent-145 
 
Dess‒Martin Periodinane (5.21 g, 12.3 mmol, 1.2 equiv) was added at 0 °C to a solution of alcohol 
ent-74 (1.7 g, 10.2 mmol, 1 equiv) in dichlormethane (80 mL) and was stirred for 10 min. The 
reaction mixture was stirred for 2 h at 24 °C. Saturated aqueous sodium hydrogen carbonate 
solution (100 mL) was added and the layers were separated. The aqueous layer was extracted with 
diethyl ether (3 × 120 mL). The combined organic layers were dried over sodium sulfate. The dried 
solution was filtrated and concentrated (Caution, the compound is volatile! Vacuum >300 mbar, 
30 °C water bath). The residue was purified by flash column chromatography on silica gel (30% 
diethyl ether in pentane) with deactivated silica gel (10% triethylamine) to yield aldehyde 
ent-145(1.57 g, 94%) as a light yellow oil.  
TLC (50%ethyl acetate in hexanes): Rf = 0.53 (CAM).  
IR (Diamond-ATR, neat) 𝜐 max: 3413, 3032, 2928, 2867, 2742, 1713, 1469, 1448, 1401, 1336, 1306, 
1269, 1159, 1129, 1081, 1004 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 10.01 (s, 1H), 2.68 (qd, J = 20.8, 20.5, 2.7 Hz, 2H), 2.26 (dd, 
J = 12.8, 3.5 Hz, 1H), 2.10–1.91 (m, 3H), 1.32 (d, J = 4.3 Hz, 1H), 1.31 (s, 3H), 0.98 (ddt, J = 7.2, 
2.6, 1.4 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ = 209.0, 200.6, 64.1, 35.4, 34.1, 30.6, 22.4, 21.4, 19.1, 17.1. 
HRMS (EI): calcd for (C10H12O2)+ [M+H]+: 164.0832, found: 164.0833. 
[𝛂]𝑫
𝟐𝟎
 = –8.4 (c = 0.80, CH2Cl2). 
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Alkyne ent-134 
 
Potassium carbonate (1.9 g, 13.7 mmol, 1.50 equiv) was added to a solution of aldehyde ent-145 
(1.5 g, 9.13 mmol, 1 equiv) in methanol (8 mL) at 24 °C. To this suspension was added dimethyl 
(1-diazo-2-oxopropyl)phosphonate (2.63 g, 13.7 mmol, 1.50 equiv) in methanol (5 mL). The 
reaction mixture was stirred for 2 h at 24 °C. The mixture was diluted with saturated aqueous 
sodium hydrogen carbonate solution (20 mL) and diethyl ether (5 mL). The layers were separated. 
The aqueous layer was extracted with diethyl ether (3 × 20 mL). The combined organic layers were 
dried over sodium sulfate. The dried solution was filtrated and the filtrate was concentrated 
(Caution, the compound is volatile! Vacuum >300 mbar, 30 °C water bath). The residue was 
purified by flash column chromatography on silica gel (10% diethyl ether in pentane) to yield 
ent-134 (1.05 g, 72%) as a white solid. 
TLC (20% ethyl acetate in hexanes): Rf = 0.35 (Anis, CAM).  
IR (Diamond-ATR, neat) 𝜐 max: 3275, 3031, 2927, 2866, 2119, 1728, 1446, 1424, 1403, 1336, 1306, 
1289, 1261, 1249, 1156, 1095, 1081, 1068, 1036 cm−1. 
1H NMR (600 MHz, CDCl3) δ = 2.72–2.60 (m, 2H), 2.39 (m, 1H), 2.37 (ddt, J = 12.9, 3.4, 1.0 Hz, 
1H), 2.20 – 2.07 (m, 3H), 1.29 (s, 3H), 1.26 (dd, J = 7.6, 3.4 Hz, 1H), 0.93 (dtt, J = 7.8, 2.7, 1.2 Hz, 
1H). 
13C NMR (150 MHz, CDCl3) δ = 205.6, 81.5, 73.6, 51.0, 41.7, 36.8, 33.3, 22.7, 21.8, 19.0, 17.3. 
HRMS (EI): calcd for (C11H12O)+: 160.0883, found: 160.0885. 
[𝛂]𝑫
𝟐𝟎
 = –6.0 (c = 0.91, CH2Cl2). 
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Phenol 149 
 
A suspension of aniline 147 (4.00 g, 17.2 mmol, 1 equiv) in water (25 mL) and aqueous sulfuric 
acid (0.5 M, 25 mL) was heated to 80 °C until the solid dissolved. The yellowish solution was 
cooled to 0 °C and a finely dispersed suspension was formed. Sodium nitrite (1.78 g, 25.8 mmol, 
1.50 equiv) was added. The reaction mixture was stirred at 0 °C for 2 h. Urea (0.52 g, 8.6 mmol, 
0.50 equiv) was added. The reaction mixture was allowed to warm to 24 °C. More aqueous sulfuric 
acid (0.5 M, 25 mL) was added and the reaction mixture was heated to 110 °C and refluxed for 
30 min. After cooling down to 24 °C, ethyl acetate (150 mL) was added. The layers were separated 
and the aqueous phase was extracted with ethyl acetate (3 × 150 mL). The combined organic 
extracts were dried over sodium sulfate, filtrated and concentrated to yield a dark red oil. The 
residue was purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) 
to yield phenol 149 (3.36 g, 84%) as a yellow solid. 
TLC (10% ethyl acetate in hexanes): Rf = 0.22 (UV, CAM).  
IR (Diamond-ATR, neat) 𝜐 max: 3345, 2918, 1704, 1600, 1580, 1486, 1451, 1414, 1379, 1277, 1228, 
1024 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 7.35 (d, J = 2.6 Hz, 1H), 7.10 (dd, J = 8.3, 0.7 Hz, 1H), 6.77 (dd, 
J = 8.3, 2.6 Hz, 1H), 4.61 (s, 1H), 2.38 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ = 153.6, 133.6, 129.9, 125.5, 115.3, 100.6, 26.8. 
HRMS (EI): calcd for (C7H7O1127I)+: 233.9536, found: 233.9538. 
 
Silyl ether 135 
 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
 
 
90 
 
To a orange solution of phenol 149 (3.30 g, 14.1 mmol, 1 equiv) in dichloromethane (7 mL) was 
added trimethylamine (2.35 mL, 16.9 mmol, 1.2 equiv).  tert-Butyldimethylchlorosilane (2.55 g, 
16.9 mmol, 1.2 equiv) was added and after a few minutes the solution turned into a yellow 
suspension which was stirred at 24 °C for five hours. Water (50 mL) and dichloromethane (50 mL) 
was added and the layers were separated. The aqueous layer was extracted with dichloromethane 
(3 × 50 mL). The combined organic layers were washed with water (80 mL), dried over sodium 
sulfate, filtrated and concentrated. The residue was purified by flash column chromatography on 
silica gel (10% ethyl acetate in hexanes) to yield 135 (4.80 g, 98%) as a yellow oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.66 (UV, CAM).  
IR (Diamond-ATR, neat) 𝜐 max: 2954, 2928, 2885, 2857, 1592, 1552, 1481, 1444, 1389, 1361, 1279, 
1245, 1197, 1023, 1006 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 7.32 (d, J = 2.5 Hz, 1H), 7.06 (d, J = 8.2 Hz, 1H), 6.73 (dd, J = 
8.2, 2.5 Hz, 1H), 2.35 (s, 3H), 0.97 (s, 9H), 0.18 (s, 6H). 
13C NMR (101 MHz, CDCl3) δ = 153.8, 134.0, 130.3, 129.6, 119.8, 100.5, 27.0, 25.7, 18.19, ‒4.5. 
HRMS (EI): calcd for (C13H21O1127I128Si1)+: 348.0406, found: 348.0405. 
 
Alkyne 133 
 
To a stirring suspension of bis(triphenylphosphine)palladium(II) dichloride (7.0 mg, 0.01 mmol, 
0.01 equiv) and copper(I) iodide (0.9 mg, 0.005 mmol, 0.005 equiv) in triethylamine (8 mL) was 
added a mixture of alkyne rac-134 (160 mg, 1.00 mmol, 1 equiv) and iodide 135 (383 mg, 
1.10 mmol, 1.1 equiv). The reaction mixture was stirred for 16 h at 24 °C. The mixture was diluted 
with water (100 mL) and ethyl acetate (10 mL). The layers were separated. The aqueous layer was 
extracted with ethyl acetate (3 × 80 mL). The combined organic layers were dried over sodium 
sulfate. The dried solution was filtrated and the filtrate was concentrated. The residue was purified 
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by flash column chromatography on silica gel (2% ethyl acetate in hexanes) to yield alkyne 133 
(0.32 g, 84%) as a light yellow oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.50 (Anis, CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 3028, 2953, 2929, 2896, 2859, 1730, 1603, 1568, 1488, 1472, 1447, 
1407, 1390, 1361, 1342, 1314, 1290, 1273, 1258, 1210, 1179, 1143, 1119, 1078, 1066, 1035 cm−1. 
1H NMR (600 MHz, CDCl3) δ = 7.00 (d, J = 8.2 Hz, 1H), 6.87 (d, J = 2.6 Hz, 1H), 6.67 (dd, J = 8.3, 
2.7 Hz, 1H), 2.78 – 2.61 (m, 2H), 2.45 (ddt, J = 12.9, 3.5, 1.1 Hz, 1H), 2.34 (s, 3H), 2.28 – 2.14 (m, 
3H), 1.31 (s, 3H), 1.28 (dd, J = 7.7, 3.3 Hz, 1H), 0.96 (s, 9H), 0.96 – 0.94 (m, 1H), 0.16 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ = 205.7, 153.2, 133.4, 130.2, 123.8, 123.2, 120.4, 90.6, 84.5, 51.9, 
42.1, 37.2, 33.5, 25.8, 22.8, 22.0, 19.9, 19.1, 18.3, 17.4, −4.3. 
HRMS (EI): calcd for (C24H32O2Si)+: 380.2166, found: 380.2163.  
 
Alkene 150 
 
To a solution of 133 (200 mg, 0.53 mmol, 1 equiv) in methanol (20 mL) was added palladium on 
calcium carbonate (224 mg, 0.11 mmol, 0.2 equiv). The reaction mixture was stirred under a 
positive pressure of hydrogen and the gas was passed through the mixture. The reaction was 
monitored by TLC. After a hydrogen gas flow of altogether 3 min, the reduction was finished. The 
mixture was filtrated through celite. The filtrate was washed with dichloromethane. The washed 
solution was concentrated to yield alkene 150 (251 mg, 94%) as a light yellow oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.42 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 2929, 2858, 1719, 1605, 1572, 1491, 1464, 1416, 1288, 1256, 1199, 
1166, 1074 cm−1. 
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1H NMR (800 MHz, CDCl3) δ = 6.96 (d, J = 8.0 Hz, 1H), 6.64 (d, J = 9.2 Hz, 1H), 6.58 (s, 1H), 
6.51 (d, J = 11.9 Hz, 1H), 5.70 (d, J = 13.0 Hz, 1H), 2.61 (d, J = 20.3 Hz, 1H), 2.55 (d, J = 20.5 Hz, 
1H), 2.13 (s, 3H), 1.86 (d, J = 13.0 Hz, 1H), 1.77–1.70 (m, 2H), 1.66 (d, J = 12.9 Hz, 1H), 1.15 (s, 
3H), 1.05 (d, J = 7.4 Hz, 1H), 0.96 (s, 9H), 0.81 (d, J = 5.7 Hz, 1H), 0.16 (s, 6H). 
13C NMR (200 MHz, CDCl3) δ = 210.7, 153.2, 138.9, 131.0, 130.2, 129.8, 128.7, 120.3, 119.0, 
57.8, 40.4, 35.2, 34.1, 25.9, 22.3, 21.9, 19.4, 19.3, 18.4, 17.6, −4.2. 
HRMS (EI): calcd for (C24H34O2Si)+ [M‒CH3]+: 382.2323, found: 382.2325. 
 
Diol 152 
 
To a solution of 150 (46 mg, 0.12 mmol, 1 equiv) in acetone (0.5 mL) was added 
4-methylmorpholine N-Oxide (50% in water, 19.0 μL, 0.18 mmol, 1.50 equiv) and osmium 
tetroxide (73.0 μL, 0.01 mmol, 0.10 equiv). The reaction mixture was stirred at 24 °C for 14 h. 
Saturated aqueous sodium thiosulfate solution (10 mL) was added and the mixture was stirred for 
15 min. Water (10 mL) and ethyl acetate (10 mL) was added. The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (10 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (5‒20% ethyl acetate in 
hexanes) to yield 152 as mixture of diastereomers (26 mg, 52%) as a yellow oil. 
TLC (40% ethyl acetate in hexanes): Rf = 0.23 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 3448, 2929, 2859, 1698, 1608, 1495, 1472, 1287, 1254, 1160, 1004 
cm−1. 
Peaks of the minor diastereomers are also visible in the NMR spectra, but only chemical shifts of 
the major diastereomer are reported: 
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1H NMR (400 MHz, CDCl3) δ = 7.03 – 6.90 (m, 2H), 6.66 (d, 1H), 5.00 – 4.88 (m, 1H), 3.94 – 
3.82 (m, 1H), 2.64 (dd, 2H), 2.28 (s, 3H), 2.18 – 1.97 (m, 2H), 2.04 (s, 1H), 1.64 (m, 1H), 1.43 (dd, 
, 1H), 1.27 (s, 3H), 0.98 (s, 9H), 0.88 (m, 1H), 0.18 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ = 215.9, 154.1, 141.2, 131.3, 128.4, 119.2, 117.7, 75.1, 72.2, 60.2, 
36.9, 35.0, 31.8, 25.7, 22.9, 21.9, 19.1, 18.8, 18.2, 17.1, 4.3. 
HRMS (EI): calcd for (C24H36O4Si)+: 416.2377, found: 416.2374.   
 
Acetonide 153 
 
To a solution of 152 (15 mg, 0.04 mmol, 1 equiv) in dimethylformamide (0.8 mL) was added 
camphorsulfonic acid (0.4 mg, 1.80 μmol, 0.05 equiv) and 2-methoxypropene (7.0 μL, 0.07 mmol, 
2.00 equiv). The reaction mixture was stirred at 24 °C for 2 h. Saturated aqueous  sodium 
bicarbonate solution (2 mL) and ethyl acetate (5 mL) was added. The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (10 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (5% ethyl acetate in hexanes) 
to yield 153 as mixture of diastereomers (11 mg, 65%) as a yellow oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.29 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 2961, 2929, 2858, 2360, 1678, 1609, 1496, 1412, 1258, 1018 cm−1. 
Peaks of the minor diastereomers are also visible in the NMR spectra, but only chemical shifts of 
the major diastereomer are reported: 
1H NMR (600 MHz, CDCl3) δ = 7.02 – 6.98 (m, 1H), 6.81 (d, J = 2.7 Hz, 1H), 6.66 (dd, J = 8.2, 
2.7 Hz, 1H), 5.20 (d, J = 4.5 Hz, 1H), 5.05 (d, J = 6.0 Hz, 1H), 2.30 (s, 3H), 1.81 – 1.75 (m, 2H), 
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1.40 (t, J = 6.6 Hz, 1H), 1.31 (s, 3H), 1.26 (s, 6H), 1.12 (dd, J = 7.0, 2.3 Hz, 1H), 1.07 (d, J = 10.7 
Hz, 1H), 0.96 (s, 9H), 0.90 – 0.83 (m, 3H), 0.15 (d, J = 3.5 Hz, 6H). 
13C NMR (150 MHz, CDCl3) δ = 211.8, 175.0, 160.0, 151.8, 131.4, 119.2, 116.8, 114.0, 87.7, 85.7, 
80.5, 45.1, 41.2, 34.5, 33.6, 29.7, 25.7, 21.7, 20.4, 18.5, 18.4, 18.2, 4.4. 
HRMS (ESI): calcd for (C27H41O4Si)+ [M+H]+: 457.2769, found: 457.2781.   
 
Diketone 154 
 
To a solution of 133 (25 mg, 65.7 μmol, 1 equiv) in dioxane (1.5 mL) and water (0.3 mL) was 
added palladium(II) chloride (2.3 mg, 13.1 μmol, 0.20 equiv), cupric bromide (6.0 mg, 26.3 μmol, 
0.40 equiv) and lithium bromide (2.3 mg, 26.3 μmol, 0.4 equiv). The dark orange mixture was 
sparged with oxygen gas for 2 min, and stirring was then continued under an oxygen atmosphere 
(1 atm, balloon) at 50 °C for 2.5 h. The reaction mixture was cooled to 24 °C, diluted with water 
(5 mL) and diethyl ether (10 mL). The layers were separated and the aqueous layer was extracted 
with ether (2 × 10 mL). The combined organic layers were dried over sodium sulfate and the dried 
solution was filtered. The filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (7% ethyl acetate in hexanes) to yield 154 (0.8 mg, 3%) as a yellow 
oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.39 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 2953, 2929, 2848, 1716, 1676, 1603, 1565, 1496, 1469, 1298, 1255 
cm−1. 
1H NMR (800 MHz, CDCl3) δ =  7.14 (d, J = 2.7 Hz, 1H), 7.10 (dd, J = 8.2, 0.9 Hz, 1H), 6.92 (dd, 
J = 8.2, 2.6 Hz, 1H), 2.75 – 2.65 (m, 2H), 2.59 – 2.55 (m, 1H), 2.42 (s, 3H), 2.39 – 2.27 (m, 4H), 
1.35 (m, 1H), 1.34 (s, 3H), 0.96 (s, 9H), 0.18 (s, 6H). 
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13C NMR (200 MHz, CDCl3) δ = 208.6, 201.7, 194.0, 153.2, 133.4, 133.0, 132.4, 125.0, 123.8, 
65.2, 38.6, 34.2, 33.7, 25.9, 22.5, 21.5, 20.7, 19.0, 18.4, 17.3, 4.3. 
HRMS (EI): calcd for (C24H32O4Si)+: 412.2064, found: 412.2065.   
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Vinyl-triflate S2 
 
To a solution of 150 (101 mg, 263 μmol, 1 equiv) in tetrahydrofuran (2 mL) at −78 °C was added 
dropwise a solution of potassium bis(trimethylsilyl)amide (1  M in tetrahydrofuran, 368 mL, 
368 μmol, 1.4 equiv). The reaction mixture was stirred for 50 min at −78 °C. N-phenyl 
bis(trifluoromethanesulfonimide) (132 mg, 368 μmol, 1.4 equiv) was added. The mixture was 
stirred for 60 min at −78 °C. The reaction mixture was allowed to warm to 24 °C. The mixture was 
diluted with water (100 mL) and ethyl acetate (20 mL). The layers were separated. The aqueous 
layer was diluted with aqueous sodium chloride solution (20 mL) and was extracted with ethyl 
acetate (3 × 50 mL). The combined organic layers were washed with aqueous sodium chloride 
solution (50 mL). The washed solution was dried over sodium sulfate. The dried solution was 
filtrated and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to yield S2 (128 mg, 95%) as a light 
yellow oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.63 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 2930, 2860, 1605, 1572, 1492, 1473, 1420, 1288, 1248, 1208, 1142, 
1119, 1098, 1058 cm−1. 
1H NMR (600 MHz, CDCl3) δ = 6.97 (d, J = 8.1 Hz, 1H), 6.71 (d, J = 2.3 Hz, 1H), 6.65 (dd, J = 8.3, 
2.6 Hz, 1H), 6.61 (d, J = 12.1 Hz, 1H), 5.93 (d, J = 6.9 Hz, 1H), 5.84 (d, J = 12.1 Hz, 1H), 2.16 (s, 
3H), 1.59 (dd, J = 11.8, 1.4 Hz, 1H), 1.46–1.40 (m, 1H), 1.28 (dd, J = 11.8, 1.2 Hz, 1H), 1.23 (dd, 
J = 6.8, 2.0 Hz, 1H), 1.19 (s, 3H), 1.05 (d, J = 11.8 Hz, 1H), 1.01 (d, J = 11.8 Hz, 1H), 0.96 (s, 9H), 
0.13 (s, 3H), 0.13 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ = 153.4, 146.9, 138.6, 132.6, 130.3, 128.6, 128.3, 120.0, 119.3, 
118.8 (q, J = 360.6 Hz), 113.4, 47.8, 41.3, 35.8, 25.8, 24.8, 23.6, 21.9, 19.3, 18.3, 17.8, −4.5. 
HRMS (EI): calcd for (C25H33F3O4SSi)+: 514.1815, found: 514.1809. 
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Phenol 155 
 
A solution of tetrabutylammonium fluoride (1  M in tetrahydrofuran, 0.30 mL, 0.30 mmol, 
1.2 equiv) was added dropwise to a solution of S2 (128 mg, 0.25 mmol, 1 equiv) in tetrahydrofuran 
(2 mL) at 0 °C. The mixture was allowed to warm to 24 °C. The reaction mixture was diluted with 
aqueous ammonium chloride (20 mL) and dichloromethane (20 mL). The layers were separated. 
The aqueous layer was extracted with dichloromethane (3 × 30 mL). The combined organic layers 
were washed with water (20 mL). The washed solution was dried over sodium sulfate. The dried 
solution was filtrated and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to yield 155 (83 mg, 83%) as a 
colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.55 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 3034, 2929, 2867, 2741, 1710, 1469, 1449, 1401, 1336, 1306, 1288, 
1269, 1159, 1129, 1080, 1004 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 7.00 (d, J = 9.0 Hz 1H), 6.66 (m, 2H), 6.60 (d, J = 12.2 Hz, 1H), 
5.95 (d, J = 6.9 Hz, 1H), 5.86 (d, J = 12.1 Hz, 1H), 4.53 (s, 1H), 2.16 (s, 3H), 1.58 (d, J = 1.6 Hz, 
1H), 1.44 (t, J = 6.9 Hz, 1H), 1.29 (d, J = 11.6 Hz 1H), 1.25–1.21 (m, 1H), 1.19 (s, 3H), 1.04 (d, 
J = 11.7 Hz, 1H), 0.99 (d, J = 11.8 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ = 153.2, 147.0, 138.8, 132.0, 130.6, 128.5, 128.2, 120.4, 115.5, 
114.2, 113.2, 47.9, 41.4, 35.8, 24.7, 23.6, 21.8, 19.2, 17.8. 
HRMS (EI): calcd for (C19H19F3O4S)+: 400.0951, found: 400.0947. 
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Cinnamyl ether 168 
 
In a Schlenk-tube a solution of 155 (10.0 mg, 25 μmol, 1 equiv) in degassed toluene (1 mL) was 
added to a mixture of potassium carbonate (5.18 mg, 37.5 μmol, 1.5 equiv), ligand rac-AntPhos 
(0.215 mg, 0.5 μmol, 0.02 equiv) and palladium(π-cinnamyl) chloride dimer (0.13 mg, 0.25 μmol, 
0.01 equiv). The reaction vessel was heated in a preheated oil bath to 90 °C for 4.5 h. The reaction 
mixture was allowed to cool to 24 °C. Ethyl acetate (5 mL) was added. The reaction mixture was 
filtrated through celite. The residue was purified by flash column chromatography on silica gel 
(10% ethyl acetate in hexanes) to yield 168 (1 mg, 8%). 
TLC (10% ethyl acetate in hexanes): Rf = 0.31 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 2926, 1604, 1573, 1495, 1449, 1417, 1300, 1246, 1207, 1140, 1118, 
1097, 1056, 1021 cm−1. 
1H NMR (800 MHz, CDCl3) δ = 7.38 (d, J = 7.2 Hz, 2H), 7.31 (t, J = 7.7 Hz, 2H), 7.24 (tt, J = 7.3, 
1.1 Hz, 1H), 7.04 (d, J = 8.3 Hz, 1H), 6.82 (d, J = 2.7 Hz, 1H), 6.79 (dd, J = 8.3, 2.8 Hz, 1H), 6.67 
(d, J = 16.0 Hz, 1H), 6.64 (d, J = 12.1 Hz, 1H), 6.38 (dt, J = 15.9, 5.6 Hz, 1H), 5.85 (d, J = 12.1 Hz, 
1H), 5.82 (d, J = 6.9 Hz, 1H), 4.65 (dd, J = 5.6, 1.6 Hz, 2H), 2.17 (s, 3H), 1.57–1.55 (m, 1H), 1.35 
(t, J = 6.9 Hz, 1H), 1.28 (d, J = 11.8 Hz 1H), 1.18 (m, 1H), 1.16 (s, 3H), 1.02 (d, J = 11.8 Hz, 1H), 
0.97 (d, J = 11.8 Hz, 1H). 
13C NMR (200 MHz, CDCl3) δ = 156.3, 146.9, 138.6, 136.7, 132.7, 132.5, 130.4, 128.7, 128.5, 
128.2, 127.9, 126.7, 124.8, 118.8 (d, J = 321.3 Hz), 114.9, 114.2, 113.3, 68.5, 47.9, 41.5, 35.8, 24.7, 
23.6, 21.9, 19.2, 17.8. 
HRMS (EI): calcd for (C28H27F3O4S)+: 516.1577, found: 516.1568. 
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Alkane 151 
 
To a solution of 133 (100 mg, 0.263 mmol, 1 equiv) in methanol (15 mL) was added palladium on 
carbon (29.5 mg, 27.7 μmol, 0.1 equiv) was added. Hydrogen was passed through the reaction 
mixture for 15 min. The mixture was filtrated through celite. The filtrate was washed with diethyl 
ether. The washed solution was concentrated to yield alkane 151 (88.3 mg, 87%) as a light yellow 
oil. 
TLC (100% toluene): Rf = 0.41 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 3026, 2953, 2928, 2858, 1717, 1607, 1576, 1498, 1271, 1463, 1406, 
1361, 1289, 1260, 1207, 1161, 1116, 1099, 1077, 1054, 1000 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 6.95 (d, J = 8.1 Hz, 1H), 6.64 (d, J = 2.6 Hz, 1H), 6.56 (dd, J = 8.1, 
2.6 Hz, 1H), 2.69–2.52 (m, 2H), 2.53–2.43 (m, 2H), 2.25 (s, 3H), 1.99 (dd, J = 12.7, 3.4 Hz, 1H), 
1.83 (d, J = 3.4 Hz, 1H), 1.83–1.76 (m, 2H), 1.70–1.60 (m, 2H), 1.29 (s, 3H), 1.21 (dd, J = 7.6, 
3.3 Hz, 1H), 0.97 (s, 9H), 0.93 (dd, J = 7.5, 2.6 Hz, 1H), 0.17 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ = 212.5, 153.8, 142.4, 130.9, 128.7, 120.6, 117.3, 55.1, 40.0, 34.9, 
34.4, 33.8, 29.8, 25.9, 23.0, 22.4, 19.6, 18.5, 18.4, 18.1, −4.2. 
HRMS (EI): calcd for (C24H36O2Si): 384.2479, found: 384.2477. 
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Vinyl triflate S3 
 
To a solution of 151 (88.3 mg, 0.23 mmol, 1 equiv) in tetrahydrofuran (3 mL) was added dropwise 
a solution of potassium bis(trimethylsilyl)amide (1 mol/L in tetrahydrofuran, 320 μL, 0.32 mmol, 
1.4 equiv) at −78 °C. The reaction mixture was stirred at for 40 min at −78 °C. N-phenyl 
bis(trifluoromethanesulfonimide) (115 mg, 0.32 mmol, 1.4 equiv) was added. The mixture was 
stirred for 35 min at the same temperature. The reaction mixture was allowed to warm to 0 °C and 
was stirred for 45 min. The reaction mixture was allowed to warm to 24 °C and was stirred for 16 h. 
The mixture was diluted with water (10 mL) and ethyl acetate (10 mL). The layers were separated. 
The aqueous layer was diluted with aqueous sodium chloride solution (5 mL) and was extracted 
with ethyl acetate (3 × 10 mL). The combined organic layers were dried over sodium sulfate. The 
dried solution was filtrated and the filtrate was concentrated. The residue was purified by flash 
column chromatography on silica gel (10% ethyl acetate in hexanes) to yield S3 (91 mg, 77%) as 
light yellow oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.55 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 3056, 2958, 2926, 2854, 1737, 1610, 1499, 1465, 1417, 1378, 1330, 
1265, 1214, 1162, 1142, 1105, 1059 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 6.97 (d, J = 8.1 Hz, 1H), 6.68 (d, J = 2.5 Hz, 1H), 6.59 (dd, J = 8.2, 
2.6 Hz, 1H), 6.00 (d, J = 6.8 Hz, 1H), 2.63 (dd, J = 10.5, 6.9 Hz, 2H), 2.23 (s, 3H), 1.91–1.81 (m, 
2H), 1.77 (dd, J = 11.5, 2.2 Hz, 1H), 1.53 (t, J = 6.8 Hz, 1H), 1.47 (d, J = 11.5 Hz, 1H), 1.38 (d, 
J = 6.6 Hz, 1H), 1.33 (s, 3H), 1.15 (d, J = 6.4 Hz, 1H), 1.12 (d, J = 6.5 Hz, 1H), 0.98 (s, 9H), 0.18 
(s, 6H). 
13C NMR (100 MHz, CDCl3) δ = 154.0, 148.8, 141.5, 131.0, 128.3, 120.5, 118.7 (d, J = 320.5 Hz), 
117.7, 113.0, 46.1, 41.0, 35.5, 33.4, 29.8, 25.9, 25.3, 23.9, 22.2, 18.5, 18.4, 18.0, −4.4. 
HRMS (EI): calcd for (C25H35F3O4SSi): 516.1972, found: 516.1969.  
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Phenol 156 
 
To a solution of S3 (85.0 mg, 165 μmol, 1 equiv) in tetrahydrofuran (1.5 mL) was added dropwise 
tetrabutylammonium fluoride (1  M in tetrahydrofuran, 0.247 mL, 247 μmol, 1.5 equiv) at 0 °C. The 
reaction mixture was allowed to warm to 24 °C. The mixture was diluted with aqueous ammonium 
chloride (20 mL) and dichloromethane (20 mL). The layers were separated. The aqueous layer was 
extracted with dichloromethane (3 × 40 mL). The combined organic layers were washed with water 
(30 mL). The washed solution was dried over sodium sulfate. The dried solution was filtrated and 
the filtrate was concentrated. The residue was purified by flash column chromatography on silica 
gel (10% ethyl acetate in hexanes) to yield phenol 156 (61 mg, 92%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.43 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 3374, 3039, 2929, 2867, 1646, 1610, 1589, 1502, 1462, 1414, 
1360, 1293, 1245, 1205, 1139, 1121, 1101, 1059, 1008 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 6.99 (d, J = 8.1 Hz, 1H), 6.68 (d, J = 2.7 Hz, 1H), 6.60 (dd, J = 8.1, 
2.8 Hz, 1H), 6.00 (d, J = 6.8 Hz, 1H), 4.58 (s, 1H), 2.65 (dd, J = 10.7, 6.7 Hz, 2H), 2.23 (s, 3H), 
1.92–1.83 (m, 2H), 1.77 (dd, J = 11.5, 1.3 Hz, 1H), 1.54 (t, J = 6.8 Hz, 1H), 1.46 (dd, J = 11.5, 
1.2 Hz, 1H), 1.39 (dd, J = 7.1, 2.1 Hz, 1H), 1.33 (s, 3H), 1.16 (d, J = 6.3 Hz, 1H), 1.13 (d, J = 6.4 Hz, 
1H). 
13C NMR (101 MHz, CDCl3) δ = 153.9, 148.9, 141.9, 131.3, 127.8, 118.8 (q, J = 320.6 Hz), 115.76, 
113.1, 112.9, 46.2, 41.1, 35.6, 33.6, 29.8, 25.3, 23.9, 22.2, 18.4, 18.0. 
HRMS (EI): calcd for (C19H21F3O4S)+: 402.1107, found: 402.1111. 
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Phenol 170 
 
In a Schlenk-tube potassium carbonate (5.18 mg, 37.5 μmol, 1.5 equiv) was added to a solution of 
phenol 156 (10.1 mg, 25 μmol, 1 equiv) in degassed toluene (1 mL). To the mixture was added 
stock solution of ligand rac-AntPhos (rac-121) (0.185 mg, 0.5 μmol, 0.02 equiv) and palladium(π-
cinnamyl) chloride dimer (0.13 mg, 0.25 μmol, 0.01 equiv) in degassed toluene (0.1 mL). The 
reaction vessel was heated in a preheated oil bath to 90 °C for 16 h. The reaction mixture was cooled 
to 24 °C. Ethyl acetate (5 mL) was added. The mixture was filtrated through celite. The residue was 
purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to yield 
ortho-cyclised product 170 (3.0 mg, 47%). 
TLC (20% ethyl acetate in hexanes): Rf = 0.45 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 3518, 3030, 2920, 2857, 1710, 1603, 1585, 1476, 1460, 1436, 
1418, 1380, 1320, 1260, 1244, 1207, 1172, 1140, 1095, 1018 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 6.84 (d, J = 8.2 Hz, 1H, H-3), 6.67 (d, J = 8.1 Hz, 1H, H-2), 6.60 
(d, J = 5.9 Hz, 1H, H-11), 5.59 (s, 1H, OH), 2.59 (t, J = 5.8 Hz, 2H, H-6), 2.19 (s, 3H, H-18), 1.69 
(t, J = 5.9 Hz, 2H, H-7), 1.66–1.61 (m, 2H, H-12, H-14a), 1.37 (s, 1H, H-13), 1.34 (s, 3H, H-17), 
1.34 (m, 1H, H-15a), 1.06 (s, 1H, H-14b), 1.04 (s, 1H, H-15b). 
13C NMR (100 MHz, CDCl3) δ = 151.8 (C-1), 138.9 (C-5), 137.3 (C-9), 128.1 (C-3), 126.7 (C-4), 
120.5 (C-10), 119.5 (C-11), 113.3 (C-2), 44.0 (C-8), 41.1 (C-15), 35.3 (C-14), 32.4 (C-7), 25.6 (C-
6), 25.4 (C12), 24.7 (C-16), 23.8 (C-13), 19.4 (C-18), 18.7 (C-17). 
HRMS (EI): calcd for (C18H20O)+: 252.1509, found: 252.1505. 
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Silyl ether 174 
 
Fuming nitric acid (100%, 1.1 mL, 25.9 mmol, 2.40 equiv) was added dropwise to acetic anhydride 
(24 mL) at 0 °C. 2-Iodo-1,3-dimethylbenzene (172) (1.55 mL, 10.8 mmol, 1 equiv) was added 
dropwise and the reaction mixture was stirred 30 min at 0 °C. The reaction mixture was heated to 
50 °C and stirred for 2 h. The reaction mixture was cooled to 24 °C and then added to ice water 
(100 mL) and stirred for 1 h. Dichloromethane (100 mL) was added. The layers were separated and 
the aqueous layer was extracted with dichloromethane (3 × 100 mL). The combined organic layers 
were washed with aqueous sodium hydroxide solution (2 M, 2 × 100 mL) and water (100 mL), the 
washed solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated to afford S4 as a red oil which was used without further purification for the next step. 
To a solution of crude S4 in dioxane (150 mL) and water (150 mL) was added sodium sulfide 
(4.21 g, 32.4 mmol, 3.00 equiv) and the mixture was heated to 60 °C. After16 h, dichloromethane 
(200 mL) was added. The layers were separated and the aqueous layer was extracted with 
dichloromethane (3 × 150 mL). The combined organic layers were washed with water (200 mL) 
saturated aqueous sodium chloride solution (200 mL), the washed solution was dried over sodium 
sulfate and the dried solution was filtered. The filtrate was concentrated to afford 173 as a yellow 
oil which was used without further purification for the next step. 
To a solution of crude 173 in sulfuric acid (0.25 M, 60 mL) was added sodium nitrite (0.45 g, 
6.56 mmol, 1.50 equiv) at 0 °C. After 2 h, urea (0.13 g, 2.19 mmol, 0.50 equiv) was added and the 
reaction mixture was allowed to warm to 24 °C. After 1.5 h, more sulfuric acid (0.5 M, 60 mL) was 
added and the mixture was heated to 110 °C. After 1 h, ethyl acetate (200 mL) was added. The 
layers were separated and the aqueous layer was extracted with ethyl acetate (3 × 200 mL). The 
combined organic layers were washed with water (200 mL) saturated aqueous sodium chloride 
solution (200 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated the dark red solution was filtered through a plug of silica. 
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The filtrate was concentrated to yield S5 as a red solid that was directly used in the following step 
without further purification. 
To a solution of crude S5 (assumed: 0.65 g, 2.62 mmol, 1 equiv) in dichloromethane (5 mL) was 
added triethylamine (0.44 mL, 3.14 mmol, 1.20 equiv) and tert-butyldimethylsilyl chloride 
(474 mg, 3.14 mmol, 1.20 equiv). The reaction mixture was stirred for 6.5 h at 24 °C. Water 
(20 mL) and dichloromethane (20 mL) was added and the layers were separated. The aqueous layer 
was extracted with dichloromethane (3 × 20 mL). The combined organic layers were washed with 
water (20 mL) saturated aqueous sodium chloride solution (20 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered and the filtrate was concentrated. The residue 
was purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to yield 
174 (949 mg, 10% over 4 steps) as a yellow amorphous solid. 
TLC (10% ethyl acetate in hexanes): Rf = 0.66 (CAM, UV). 
IR (Diamond-ATR, neat) 𝜐 max: 2955, 2929, 2857, 1585, 1562, 1464, 1393, 1272, 1253, 1174, 1137 
cm−1. 
1H NMR (600 MHz, CDCl3) δ = 6.96 (d, J = 8.2 Hz, 1H), 6.67 (d, J = 8.2 Hz, 1H), 2.40 (s, 3H), 
2.40 (s, 3H) 1.01 (s, 9H), 0.20 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ = 150.6, 134.5, 132.8, 126.7, 118.0, 109.5, 29.2, 25.8, 23.3, 18.2, 
4.2. 
HRMS (EI): calcd for (C14H23O127I28Si)+: 362.0557, found: 362.0559. 
 
Alkyne ent-175 
 
To a suspension of tetrakis(triphenylphosphine)palladium (16 mg, 23.1 μmol, 0.01 equiv) and 
cuprous iodide (2.0 mg, 11.5 μmol, 0.005 equiv) in triethylamine (degassed, 16 mL) in a Schlenk 
tube was added a solution of 174 (1.0 g, 2.77 mmol, 1.20 equiv) and alkyne ent-134 (370 mg, 
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2.31 mmol, 1 equiv) in triethylamine (degassed, 4 mL). The reaction mixture was stirred at 24 °C 
for 23 h. Ethyl acetate (30 mL) and water (20 mL) were added. The layers were separated, and the 
aqueous layer was extracted with ethyl acetate (3 × 40 mL). The combined organic extracts were 
washed with water (30 mL) and saturated aqueous sodium chloride solution (30 mL) and dried over 
sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (5‒10% ethyl acetate in hexanes) to yield 
ent-175 (544 mg, 60%) as a yellow oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.37 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2929, 2858, 1731, 1474, 1278, 1254, 1170, 1114, 1072 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 6.85 (d, J = 8.2 Hz, 1H), 6.63 (d, J = 8.2 Hz, 1H), 2.78 – 2.59 (m, 
2H), 2.46 (dd, J = 12.9, 3.4 Hz, 1H), 2.35 (s, 3H), 2.31 (s, 3H), 2.26 – 2.15 (m, 3H), 1.32 (s, 3H), 
1.29 (dd, J = 7.7, 3.4 Hz, 1H), 1.00 (s, 9H), 0.98 – 0.94 (m, 1H), 0.16 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ = 205.7, 151.5, 133.2, 131.2, 126.8, 124.3, 118.1, 95.0, 83.5, 52.2, 
42.3, 37.4, 33.5, 26.0, 22.8, 22.1, 20.7, 19.2, 18.4, 17.5, 15.2, 4.1. 
HRMS (EI): calcd for (C25H34O2Si)+: 394.2323; found: 394.2322.  
[𝛂]𝑫
𝟐𝟎
 = –4.3 (c = 0.23, CH2Cl2). 
 
Alkane ent-S6 
 
To a solution of ent-175 (544 mg, 1.38 mmol, 1 equiv) in methanol (12 mL) was added palladium 
on carbon (587 mg, 0.28 mmol, 0.2 equiv). Hydrogen was passed through the reaction mixture for 
15 min. The mixture was filtrated through celite. The filtrate was washed with diethyl ether. The 
washed solution was concentrated to yield ent-S6 (524 mg, 95%) as a colorless oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.34 (CAM, UV). 
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IR (Diamond-ATR, neat) ṽmax: 2955, 2928, 2857, 1718, 1594, 1474, 1268, 1253, 1076 cm−1. 
1H NMR (600 MHz, CDCl3) δ = 6.82 (d, J = 8.1 Hz, 1H), 6.54 (d, J = 8.1 Hz, 1H), 2.67 – 2.54 (m, 
4H), 2.28 (s, 3H), 2.23 (s, 3H), 2.01 (dd, J = 12.7, 3.4 Hz, 1H), 1.87 – 1.76 (m, 3H), 1.58 – 1.51 
(m, 2H), 1.30 (s, 3H), 1.22 (dd, J = 7.5, 3.3 Hz, 1H), 1.01 (s, 9H), 0.95 – 0.91 (m, 1H), 0.19 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ = 212.4, 151.9, 140.6, 128.5, 127.4, 127.0, 115.8, 55.0, 39.8, 34.7, 
34.2, 32.1, 26.4, 25.8, 22.8, 22.2, 19.4, 19.3, 18.3, 17.9, 12.4, 4.2. 
HRMS (EI): calcd for (C25H38O2Si)+: 398.2636; found: 398.2633. 
[𝛂]𝑫
𝟐𝟎
 = +8.5 (c = 1.08, CH2Cl2). 
 
Vinyl triflate ent-S7 
 
To a solution of ent-S6 (440 mg, 1.10 mmol, 1 equiv) in tetrahydrofuran (12 mL) was added 
dropwise a solution of potassium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 1.43 mL, 1.43 
mmol, 1.30 equiv) at ‒78 °C. After 1 h, N-phenylbis(trifluoromethanesulfonimide) (443 mg, 1.21 
mmol, 1.10 equiv) was added. After 2 h, the reaction mixture was warmed to 0°C and stirred for 
1.5 h. Water (100 mL) and diethyl ether (40 mL) and saturated aqueous sodium chloride solution 
(40 mL) was added and the layers were separated. The aqueous layer was extracted with diethyl 
ether (3 × 80 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (100 mL), the washed solution was dried over sodium sulfate and the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to yield ent-S7 (550 mg, 94%) as a 
colorless oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.42 (CAM, UV). 
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IR (Diamond-ATR, neat) ṽmax: 2927, 2859, 1629, 1594, 1475, 1418, 1273, 1248, 1208, 1141, 1083 
cm−1. 
1H NMR (600 MHz, CDCl3) δ = 6.84 (d, J = 8.2 Hz, 1H), 6.57 (d, J = 8.2 Hz, 1H), 6.01 (d, J = 6.8 
Hz, 1H), 2.75 – 2.66 (m, 2H), 2.26 (s, 3H), 2.19 (s, 3H), 1.86 (dd, J = 11.5, 2.2 Hz, 1H), 1.82 – 
1.70 (m, 2H), 1.52 – 1.55 (m, 2H), 1.39 (dd, J = 6.9, 2.0 Hz, 1H), 1.34 (s, 3H), 1.12 (m, 2H), 1.01 
(s, 9H), 0.20 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ = 152.1, 149.2, 143.5, 140.2, 128.5, 127.8, 127.1, 116.3, 112.2, 
46.3, 40.5, 35.0, 31.0, 26.5, 26.0, 25.2, 23.9, 22.1, 19.6, 18.4, 18.0, 12.6, 4.1 (signals for CF3 group 
not visible). 
19F NMR (565 MHz, CDCl3) δ = 72.9. 
HRMS (ESI): calcd for (C26H38O4SSi)+ [M+H]+: 531.221; found: 531.221. 
[𝛂]𝑫
𝟐𝟎
 = +3.6 (c = 0.60, CH2Cl2). 
 
Phenol ent-127 
 
To a solution of ent-S7 (550 mg, 1.04 mmol, 1 equiv) in tetrahydrofuran (10 mL) was added 
dropwise tetrabutylammonium fluoride solution (1 M in tetrahydrofuran, 1.55 mL, 1.55 mmol, 1.50 
equiv) at 24 °C and the reaction mixture was stirred for 19 h. Saturated aqueous sodium bicarbonate 
solution (20 mL) and diethyl ether (20 mL) was added and the layers were separated. The aqueous 
layer was extracted with diethyl ether (3 × 50 mL). The combined organic layers were washed with 
water (30 mL) and saturated aqueous sodium chloride solution (100 mL), the washed solution was 
dried over sodium sulfate and the dried solution was filtered and the filtrate was concentrated. The 
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residue was purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) 
to yield ent-127 (380 mg, 88%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.43 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax cm‒1: 3552, 3282, 2928, 1596, 1498, 1414, 1201, 1137, 1057 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 6.87 (d, J = 8.1 Hz, 1H), 6.57 (d, J = 8.1 Hz, 1H), 6.02 (d, J = 6.8 
Hz, 1H), 4.48 (s, 1H), 2.73 (dd, J = 10.5, 7.0 Hz, 2H), 2.26 (s, 3H), 2.22 (s, 3H), 1.86 (dd, J = 11.3, 
2.2 Hz, 1H), 1.77 (dt, J = 9.3, 6.7 Hz, 2H), 1.54 (m, 2H), 1.39 (dd, J = 7.2, 2.0 Hz, 1H), 1.34 (s, 
3H), 1.13 (m, 2H). 
13C NMR (100 MHz, CDCl3) δ = 152.1, 149.1, 140.2, 128.3, 128.2, 122.2, 112.6, 112.3, 46.2, 40.5, 
35.1, 31.2, 26.3, 25.2, 23.9, 22.0, 19.6, 18.0, 11.6 (signals for CF3 group not visible). 
19F NMR (377 MHz, CDCl3) δ = 73.2. 
HRMS (EI): calcd for (C20H23O4F3SNa)+ [M+Na]+: 439.116; found: 439,116. 
[𝛂]𝑫
𝟐𝟎
 = +10.7 (c = 0.70, CH2Cl2). 
 
Dienone ent-126 
 
Potassium carbonate (119 mg, 0.86 mmol, 1.50 equiv), palladium(π-cinnamyl) chloride dimer 
(75 mg, 0.14 mmol, 0.25 equiv) and (S)-AntPhos (26 mg, 0.07 mmol, 0.12 equiv) were added to a 
dry Schlenk flask and the flask was evacuated and back-filled with argon three times. A solution 
of ent-127 (240 mg, 0.58 mmol, 1 equiv) in degassed toluene (15 mL) was added. The orange 
suspension was heated to 90 °C. After 18 h, heating was ceased and the green suspension was 
allowed to cool to 24 °C. Dichloromethane (5 mL) was added and the mixture was filtered through 
a short pad of celite. The filter cake was rinsed with dichloromethane (30 mL) and the filtrate was 
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concentrated. The crude product was purified by flash column chromatography on silica gel (0‒5% 
ethyl acetate in hexanes) to yield ent-126 (97 mg, 63%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.50 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax 2954, 2918, 2850, 1738, 1658, 1614, 1459, 1377, 1260, 1182, 1088 
cm‒1. 
1H NMR (400 MHz, CDCl3) δ = 7.19 (d, J = 10.0 Hz, 1H, H-1), 6.22 (d, J = 10.0 Hz, 1H, H-2), 
5.86 (d, J = 5.9 Hz, 1H, H-11), 2.73 – 2.56 (m, 1H, H-6), 2.40 (m, 1H, H-7a), 1.83 (s, 3H, H-18), 
1.74 – 1.65 (m, 2H, H-7b, H-14a), 1.46 – 1.38 (m, 4H, H-12, H-20), 1.31 – 1.17 (m, 4H, H-17, 
H-13), 1.10 (d, J = 11.0 Hz, 1H, H-15a), 0.85 (d, J = 11.1 Hz, 1H, H-14b), 0.74 (d, J = 11.0 Hz, 
1H, H-15a). 
13C NMR (100 MHz, CDCl3) δ = 185.2 (C-3), 159.0 (C-5), 153.9 (C-1), 142.4 (C-9), 130.1 (C-4), 
125.5 (C-2), 117.2 (C-11), 43.8 (C-10), 42.5 (C-8), 41.6 (C-15), 36.8 (C-14), 29.8 (C-7), 29.7 (C-
20), 27.1 (C-6), 24.5 (C-16), 24.1 (C-12), 22.9 (C-13), 18.4 (C-17), 10.7 (C-18). 
HRMS (EI): calcd for (C19H22O)+: 266.1665; found: 266.1666.  
[𝛂]𝑫
𝟐𝟎
 = +228.9 (c = 0.43, CH2Cl2). 
 
Enone ent-176 
 
To a solution of ent-126 (70 mg, 0.26 mmol, 1 equiv) in toluene (20 mL) was added 
tris(triphenylphosphine)rhodium(I) chloride (49 mg, 0.05 mmol, 0.20 equiv). The open flask was 
placed in a miniclave under argon atmosphere. The miniclave was closed and flushed with 
hydrogen three times. Hydrogen pressure (15 bar) was applied. The reaction mixture was stirred 
under hydrogen atmosphere at 24 °C. After 14 h, the hydrogen pressure was released, the miniclave 
was opened and the flask was removed. The solution was concentrated. The crude product was 
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purified by flash column chromatography on silica gel (5‒10% ethyl acetate in hexanes) to yield 
ent-176 (68 mg, 96%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.43 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax 2923, 2851, 1717, 1664, 1458, 1180 cm‒1. 
1H NMR (600 MHz, CDCl3) δ = 5.78 (d, J = 6.0 Hz, 1H, H-11), 2.62 (m, 2H, H-6a, H-2a), 2.47 
(ddd, J = 17.7, 4.9, 2.5 Hz, 1H, H-2b), 2.41 – 2.33 (m, 1H, H-6b), 2.21 (td, J = 13.6, 4.6 Hz, 1H, 
H-7a), 2.10 (ddd, J = 12.9, 5.2, 2.5 Hz, 1H, H-1a), 1.98 (dddd, J = 14.8, 13.0, 4.9, 0.9 Hz, 1H, H-
1b), 1.70 (t, J = 1.3 Hz, 3H, H-18), 1.66 – 1.61 (m, 2H, H-7b, H-14a), 1.49 – 1.44 (m, 1H, H-12), 
1.35 (s, 3H, H-20), 1.27 (s, 3H, H-17), 1.19 (dd, J = 7.0, 2.2 Hz, 1H, H-13), 1.12 (dd, J = 10.9, 0.9 
Hz, 1H, H-15a), 0.89 (d, J = 10.8 Hz, 1H, H-15b), 0.78 (d, J = 11.1 Hz, 1H, H-14b). 
13C NMR (150 MHz, CDCl3) δ = 198.2 (C-3), 162.8 (C-5), 146.9 (C-9), 129.2 (C-4), 115.4 (C-11), 
42.6 (C-16), 41.7 (C-15), 40.0 (C-10), 36.9 (C-14), 35.0 (C-1), 33.8 (C-2), 29.2 (C-7), 28.6 (C-20), 
28.1 (C-6), 24.2 (C-12), 24.1 (C-8), 22.8 (C-13), 18.7 (C-17), 10.9 (C-18). 
HRMS (EI): calcd for (C19H24O)+: 268.1822; found: 268.1817.  
[𝛂]𝑫
𝟐𝟎
 = +22.1 (c = 0.41, CH2Cl2). 
 
Allyl alcohol ent-176 
 
To a solution of ent-176 (15 mg, 0.06 mmol, 1 equiv) in methanol (1 mL) was added cerium(III) 
chloride (28 mg, 0.11 mmol, 2.00 equiv). The mixture was cooled to ‒50 °C and sodium 
borohydride (4.3 mg, 0.11 mmol, 2.00 equiv) was added. After 15 min, water (10 mL) and ethyl 
acetate (10 mL) was added and the layers were separated. The aqueous layer was extracted with 
ethyl acetate (3 × 10 mL). The combined organic layers were washed with water (10 mL) and 
saturated aqueous sodium chloride solution (10 mL), the washed solution was dried over sodium 
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sulfate and the dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane) to yield 198 
(10 mg, 66%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.19 (CAM). 
IR (Diamond-ATR, neat) ṽmax 3395, 2923, 2853, 2361, 1631, 1452, 1414, 1357, 1110 cm‒1. 
1H NMR (300 MHz, CDCl3) δ = 5.63 (d, J = 5.9 Hz, 1H), 3.99 (br s, 1H), 2.40 – 2.25 (m, 1H), 2.20 
(d, J = 10.3 Hz, 1H), 2.07 (m, 1H), 1.81 – 1.46 (m, 5H), 1.62 (s, 3H) 1.41 (m, 2H), 1.25 (s, 6H), 
1.12 (m, 1H), 1.05 (d, J = 10.9 Hz, 1H), 0.83 (d, J = 10.9 Hz, 1H), 0.75 (d, J = 11.0 Hz, 1H). 
13C NMR (75 MHz, CDCl3) δ = 149.7, 137.6, 127.7, 113.3, 71.4, 42.8, 41.7, 38.2, 37.0, 34.3, 31.1, 
29.9, 29.6, 25.8, 24.0, 24.0, 22.7, 18.8, 14.7. 
HRMS (ESI): not found  
[𝛂]𝑫
𝟐𝟎
 = +16.7 (c = 0.41, CH2Cl2). 
 
Silyl ether 199 
 
To a solution of 198 (10 mg, 0.04 mmol, 1 equiv) in dichloromethane (0.5 mL) was added imidazole 
(3.1 mg, 0.04 mmol, 1.20 equiv) and tert-butyldimethylsilyl trifluoromethanesulfonate (11 μL, 
0.04 mmol, 1.20 equiv). After 5 h, water (10 mL) and dichloromethane (10 mL) was added and the 
layers were separated. The aqueous layer was extracted with dichloromethane (3 × 10 mL). The 
combined organic layers were washed with water (10 mL) and saturated aqueous sodium chloride 
solution (10 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography 
on silica gel (5% ethyl acetate in cyclohexane) to yield 199 (11 mg, 77%) as a colorless oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.61 (CAM). 
IR (Diamond-ATR, neat) ṽmax 2925, 2856, 1462, 1410, 1361, 1295, 1257, 1073, 1048, 1009 cm‒1. 
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1H NMR (400 MHz, CDCl3) δ = 5.62 (d, J = 5.9 Hz, 1H), 4.04 (t, J = 8.0 Hz, 1H), 2.35 (m, 1H), 
2.25 – 2.15 (m, 2H), 2.00 – 1.88 (m, 1H), 1.82 – 1.67 (m, 2H), 1.62 – 1.56 (m, 2H), 1.54 (s, 3H), 
1.52 – 1.46 (m, 1H), 1.40 (t, J = 6.5 Hz, 1H), 1.25 (s, 6H), 1.12 (dd, J = 7.1, 2.2 Hz, 1H), 1.05 (d, 
J = 10.8 Hz, 1H), 0.91 (s, 9H), 0.83 (d, J = 10.9 Hz, 1H), 0.74 (d, J = 11.1 Hz, 1H), 0.08 (s, 3H), 
0.09 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ = 150.3, 136.2, 128.8, 113.0, 72.2, 42.8, 41.7, 38.1, 37.0, 34.6, 
31.1, 30.0, 26.2, 26.0, 24.0, 23.9, 22.7, 18.8, 18.4, 15.0, 3.9, 4.5. 
HRMS (EI): calcd for (C25H40OSi)+: 384.2843; found: 384.2840.  
[𝛂]𝑫
𝟐𝟎
 = +7.5 (c = 0.08, CH2Cl2). 
 
Diene 208 
 
To a solution of 198 (3.0 mg, 0.01 mmol, 1 equiv) in diethyl ether (0.5 mL) was added 
(methoxycarbonylsulfamoyl)triethylammonium hydroxide (6.8 mg, 0.03 mmol, 2.50 equiv). After 
3 h, the solvent was removed and the crude product was purified by flash column chromatography 
on silica gel (1% ethyl acetate in cyclohexane) to yield 208 (2.5 mg, 89%) as a colorless oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.66 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax 2921, 2851, 1733, 1671, 1458, 13761179, 1080 cm‒1. 
1H NMR (400 MHz, Chloroform-d) δ 5.78 (dd, J = 7.6, 2.1 Hz, 1H), 5.72 (d, J = 5.9 Hz, 1H), 5.59 
(d, J = 6.0 Hz, 1H), 2.60 (d, J = 16.6 Hz, 1H), 2.27 – 2.11 (m, 3H), 1.95 – 1.87 (m, 1H), 1.78 (s, 
3H), 1.69 – 1.63 (m, 2H), 1.41 (t, J = 6.5 Hz, 1H), 1.25 (s, 6H), 1.13 – 1.07 (m, 1H), 0.90 – 0.85 
(m, 3H). 
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13C NMR (100 MHz, CDCl3) δ 150.6, 141.3, 131.2, 125.0, 119.9, 112.3, 43.6, 43.4, 37.4, 36.7, 
33.4, 32.8, 25.3, 23.8, 23.7, 22.5, 22.4, 20.1, 18.7, 1.2. 
HRMS (EI): calcd for (C20H29O)+ [M+MeOH+H]+: 285.221; found: 285.129. 
[𝛂]𝑫
𝟐𝟎
 = +95.5 (c = 0.12, CH2Cl2). 
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Phenol 226 
 
A suspension of 227 (2.01 g, 8.77 mmol, 1 equiv), 1-fluoropyridinium tetrafluoroborate (228) 
(3.34 g, 17.5 mmol, 2.00 equiv) and palladium(II) acetate (296 mg, 1.32 mmol, 0.150 equiv) in a 
mixture of trifluoroacetic acid and trifluoroacetic anhydride (9:1, 90 mL) was heated to 100 °C in 
a pressure flask. After 16 h, the reaction mixture was diluted in dichloromethane (300 mL) and 
saturated aqueous sodium bicarbonate solution was added slowly over 7 h (1.5 L). The layers were 
separated, and the aqueous layer was extracted with dichloromethane (3 × 200 mL). The combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (5% ethyl 
acetate in cyclohexane) to give 226 (1.95 g, 91%) as a yellow solid.  
TLC (20% ethyl acetate in hexanes): Rf = 0.29 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 3397, 2953, 1666, 1583, 1459, 1438, 1281, 1213, 1018 cm‒1. 
1H NMR (600 MHz, CDCl3) δ = 10.09 (s, 1H), 7.25 (d, J = 8.4 Hz, 1H), 6.87 (d, J = 8.5 Hz, 1H), 
3.98 (s, 3H), 2.36 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ = 170.1, 159.9, 135.7, 131.2, 123.9, 116.8, 115.4, 52.5, 24.0.  
HRMS (ESI): calcd for (C9H9BrO3K)+ [M+K]+: 282.9367; found: 281.2753. 
 
Silyl ether S8 
 
To a solution of 226 (133 mg, 0.543 mmol, 1 equiv) in dichloromethane (3 mL) was added 
triethylamine (0.226 mL, 1.63 mmol, 3.00 equiv) and tert-butyldimethylchlorosilane (100 mg, 
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0.651 mmol, 1.20 equiv) at 24 °C. After 15 h, the reaction mixture was diluted with 
dichloromethane (5 mL) and water (10 mL). The layers were separated, and the aqueous layer was 
extracted with dichloromethane (3 × 15 mL). The combined organic extracts were washed with 
saturated aqueous sodium chloride solution (30 mL) and dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10% ethyl acetate in cyclohexane) to give S8 (187 mg, 96%) as a 
yellow oil.  
TLC (5% ethyl acetate in hexanes): Rf = 0.35 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax cm‒1: 2952, 2859, 1739, 1598, 1469, 1280, 1224, 936, 781, 691. 
1H NMR (600 MHz, CDCl3) δ = 7.11 (d, J = 8.4 Hz, 1H), 6.70 (d, J = 8.4 Hz, 1H), 3.90 (s, 3H), 
2.33 (s, 3H), 0.95 (s, 9H), 0.21 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ = 167.3, 151.1, 131.4, 130.9, 129.3, 121.5, 117.9, 52.6, 25.6, 22.3, 
18.1, 4.3.  
HRMS (ESI): calcd for (C15H23BrO3SiNa)+ [M+Na]+: 381.0492; found: 381.0450. 
 
Alkyne 229b 
 
Tetrakis(triphenylphosphine)palladium (13.5 mg, 0.012, 0.050 equiv) was added to a Schlenk tube. 
A solution of 226 (100 mg, 0.278 mmol, 1.20 equiv) in degassed diisopropylamine (0.5 mL) was 
transferred to the Schlenk tube. The reaction mixture was heated to 50 °C. After 30 min, a solution 
of rac-134 (37.2 mg, 0.232 mmol, 1 equiv) in diisopropylamine (0.5 mL) was added slowly and 
the reaction mixture was heated to 80 °C. After 20 h, the solution was allowed to cool to 24 °C and 
ethyl acetate (10 mL) and water (20 mL) were added. The layers were separated, and the aqueous 
layer was extracted with ethyl acetate (3 × 15 mL). The combined organic extracts were washed 
with water (25 mL) and saturated aqueous sodium chloride solution (25 mL) and dried over sodium 
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sulfate. The dried solution was filtered, and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane) to give 229b 
(70.2 mg, 69%) as a yellow oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.15 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2929, 2859, 1731, 1575, 1473, 1286, 1249, 1204, 1102, 839, cm‒1.  
1H NMR (600 MHz, CDCl3) δ = 7.04 (d, J = 8.4 Hz, 1H), 6.68 (d, J = 8.4 Hz, 1H), 3.89 (s, 3H), 
2.66 (qd, J = 2.7, 20.4 Hz, 2H), 2.44 (dd, J = 3.5, 12.9 Hz, 1H), 2.35 (s, 3H), 2.16 (m, 3H), 1.29 (s, 
3H), 1.27 (dd, J = 3.5, 7.6 Hz, 1H), 0.95 (s, 10H), 0.17 (s, 6H).  
13C NMR (150 MHz, CDCl3) δ = 204.9, 168.0, 150.0, 133.4, 131.0, 129.3, 121.5, 119.5, 94.6, 81.6, 
52.3, 51.9, 42.0, 37.0, 33.4, 25.7, 22.8, 21.9, 20.0, 19.1, 18.2, 17.3, 4.3.  
HRMS (ESI): calcd for (C26H34O4SiNa)+ [M+Na]+: 461.2118; found: 461.2069. 
 
Diketone 230b 
 
To a solution of 229b (10.0 mg, 0.02 mmol, 1 equiv) in dioxane (0.75 mL) and water (0.1 mL) was 
added palladium(II) bromide (0.6 mg, 2.28 μmol, 0.10 equiv) and cupric bromide (1.0 mg, 
4.56 μmol, 0.20 equiv). The dark orange mixture was sparged with oxygen gas for 2 min, and 
stirring was then continued under oxygen atmosphere (1 atm, balloon) at 24 °C. After 22 h, the 
reaction mixture diluted with water (5 mL) and diethyl ether (10 mL). The layers were separated 
and the aqueous layer was extracted with ether (2 × 10 mL). The combined organic layers were 
dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel (5% ethyl acetate in 
hexanes) to yield 230b (1.5 mg, 14%) as a yellow oil. 
TLC (10% ethyl acetate in cyclohexan): Rf = 0.41 (CAM). 
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IR (Diamond-ATR, neat) ṽmax: 2926, 2858, 1837, 1736, 1504, 1464, 1246, 1200, 1026 cm‒1. 
1H NMR (600 MHz, CDCl3) δ = 7.22 (d, J = 8.4 Hz, 1H), 6.83 (d, J = 8.4 Hz, 1H), 3.78 (s, 3H), 
2.83 – 2.70 (m, 2H), 2.52 (dd, J = 13.3, 3.4 Hz, 1H), 2.43 (m, 2H), 2.30 (d, J = 13.2 Hz, 1H), 2.21 
(s, 3H), 1.34 (s, 3H), 1.04 (m, 1H), 0.99 (s, 9H), 0.96 (m, 1H), 0.20 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ = 208.2, 196.0, 191.0, 168.5, 153.0, 140.0, 135.8, 129.5, 122.5, 
121.2, 64.8, 52.5, 36.7, 34.2, 31.7, 25.7, 22.0, 21.2, 19.3, 18.7, 18.4, 17.6, 4.2. 
HRMS (ESI): calcd for (C26H34O6SiNa)+ [M+Na]+: 493.202; found: 493.201. 
 
Benzyl phenyl ether 247 
 
To a solution of phenol 226 (287 mg, 1.17 mmol, 1 equiv) in acetone (12 mL) was added potassium 
carbonate (194 mg, 1.41 mmol, 1.20 equiv) and benzyl bromide (0.172 mL, 1.41 mmol, 
1.20 equiv). The reaction mixture was stirred at 56 °C for 1.5 h, and then concentrated under 
reduced pressure to remove most acetone. The residue was diluted in ethyl acetate (15 mL) and 
aqueous hydrochloric acid solution (1 M, 20 mL). The layers were separated, and the aqueous layer 
was extracted with ethyl acetate (3 × 25 mL). The combined organic extracts were washed with 
saturated aqueous sodium chloride solution (50 mL) and dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (5% ethyl acetate in cyclohexane) to give 247 (388 mg, 99%) as a 
white solid.  
TLC (5% ethyl acetate in hexanes): Rf = 0.16 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2950, 1735, 1596, 1452, 1381, 1225, 1107, 1013 cm‒1. 
1H NMR (400 MHz, CDCl3) δ = 7.34 (m, 5H), 7.16 (d, J = 8.6 Hz, 1H), 6.81 (d, J = 8.5 Hz, 1H), 
5.10 (s, 2H) 3.94 (s, 3H), 2.34 (s, 3H). 
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13C NMR (100 MHz, CDCl3) δ = 167.2, 154.2, 136.5, 131.6, 130.9, 128.7, 128.1, 127.3, 127.1, 
121.8, 112.1, 71.0, 52.8, 22.3. 
HRMS (ESI): calcd for (C16H15BrO3Na)+ [M + Na]+: 357.0097; found: 357.0046. 
 
Triene 236 
 
n-Butyllithium (2.51 M in n-hexane, 2.11 mL, 5.29 mmol, 1.20 equiv) was added dropwise to a 
solution of diisopropylamine (0.810 mL, 5.73 mmol, 1.30 equiv) in tetrahydrofuran (40 mL) 
at 78 °C. After 5 min, the cooling bath was removed, and the reaction mixture was allowed to 
warm to 24 °C. After 20 min, the solution was cooled to ‒78 °C and a solution of enone ent-71 
(600 mg, 4.41 mmol, 1 equiv) in tetrahydrofuran (6 mL) was added slowly. After 1 h, 
hexamethylphosphoric triamide (2.35 mL, 13.2 mmol, 3.00 equiv) was added and the solution was 
stirred for another hour at ‒78 °C. Methyl bromoacetate (2.14 mL, 22.0 mmol, 5.00 equiv) was 
added and the reaction mixture was allowed to warm to 24 °C and was stirred for 14 h. The solution 
was diluted with water (40 mL), aqueous hydrochloric acid solution (1 M, 30 mL) and ethyl acetate 
(60 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (3 × 
30 mL). The combined organic layers were washed with water (2 × 20 mL) and saturated aqueous 
sodium chloride solution (2 × 15 mL). The washed solution was dried over sodium sulfate. The 
dried solution was filtered, and the filtrate was concentrated. The residue was purified by flash 
column chromatography on silica gel (10% ethyl acetate in cyclohexane) to yield 235 (688 mg, 
75%) as a yellow oil.  
A solution of enone 235 (120 mg, 0.58 mmol, 1 equiv) in dichloromethane (6 mL) was cooled to 
0 °C. 2,6-Lutidine (0.20 mL, 1.73 mmol, 3.00 equiv) and triisopropylsilyl trifluoromethane-
sulfonate (0.20 mL, 0.86 mmol, 1.50 equiv) were added in sequence. The reaction mixture was 
allowed to warm to 24 °C and was stirred for 22 h. The solution was diluted with water (20 mL). 
The layers were separated, and the aqueous layer was extracted with dichloromethane (3 × 20 mL). 
The combined organic extracts were dried over sodium sulfate. The dried solution was filtered, and 
the filtrate was concentrated. The residue was purified by flash column chromatography on silica 
gel (100% cyclohexane) to yield 236 (183 mg, 99%) as a yellow oil.  
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TLC (5% ethyl acetate in hexanes): Rf = 0.57 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2952, 2929, 2858, 1712, 1687, 1637, 1577, 1435, 1293, 1252, 1205 
1055 cm‒1. 
1H NMR (400 MHz, CDCl3) δ = 5.85 (dd, J = 17.4, 10.5 Hz, 1H), 5.71 (d, J = 9.8 Hz, 1H), 5.52 
(d, J = 9.8 Hz, 1H), 5.06 – 4.86 (m, 2H), 3.66 (s, 3H), 3.28 – 2.99 (m, 2H), 2.23 (q, J = 16.4 Hz, 
2H), 1.11 (s, 3H), 0.94 (s, 9H), 0.11 (d, J = 3.1 Hz, 6H). 
13C NMR (100 MHz, CDCl3) δ = 172.3, 145.1, 143.8, 135.6, 124.6, 111.3, 107.0, 51.7, 39.7, 38.1, 
35.3, 25.9, 25.2, 18.2, ‒4.0. 
HRMS (ESI): calcd for (C18H30O3Si)+: 322.1959; found: 322.1960. 
[𝛂]𝑫
𝟐𝟎
 = +55.0 (c = 1.21, CH2Cl2). 
 
Tricyclo-[3.2.1.0]oct-3-ene 237 
 
A solution of 236 (170 mg, 0.53 mmol, 1 equiv) in toluene (11 mL) was sealed in a pressure tube 
and the solution was heated to 170 °C. After 13 h, the solution was cooled to 24 °C and concentrated 
to yield 237 (170 mg, quant.) as a yellow oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.58 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2947, 2930, 2853, 1741, 1722, 1689, 1637, 1462, 1280, 1217, 1160, 
1050 cm1. 
1H NMR (600 MHz, CDCl3) δ = 4.90 (d, J = 6.4 Hz, 1H), 3.64 (s, 3H), 2.62 – 2.42 (m, 2H), 1.66 
(ddd, J = 11.3, 2.5, 0.8 Hz, 1H), 1.35 (dd, J = 11.2, 1.1 Hz, 1H), 1.30 – 1.23 (m, 4H), 1.19 (d, J = 
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11.3 Hz, 1H), 1.12 (d, J = 11.3 Hz, 1H), 1.07 (dd, J = 7.1, 2.3 Hz, 1H), 0.89 (s, 9H), 0.13 (s, 3H), 
0.14 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ = 172.9, 153.8, 95.0, 51.2, 44.5, 41.1, 37.5, 35.5, 25.9, 23.3, 22.3, 
21.5, 18.5, 18.3, ‒4.4, ‒4.6. 
HRMS (ESI): calcd for (C18H30O3Si)+: 322.1959; found: 322.1957. 
[𝛂]𝑫
𝟐𝟎
 = –8.9 (c = 0.30, CH2Cl2). 
 
Vinyl triflate 243 
 
To a solution of rac-233 (21 mg, 0.10 mmol, 1 equiv) in tetrahydrofuran (2 mL) was added 
dropwise a solution of potassium bis(trimethylsilyl)amide (1 M, 141 μL, 0.14 mmol, 1.40 equiv) at 
‒78°C. After 1 h, N-phenylbis(trifluoromethanesulfonimide) (50.4 mg, 0.14 mmol, 1.40 equiv) was 
added. The reaction mixture was allowed to warm to 24 °C and stirred for 14 h. Water (10 mL) and 
ethyl acetate (10 mL) was added and the layers were separated. The aqueous layer was extracted 
with ethyl acetate (3 × 10 mL). The combined organic layers were washed with water (10 mL) and 
saturated aqueous sodium chloride solution (10 mL), the washed solution was dried over sodium 
sulfate and the dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (10% ethyl acetate in cyclohexane) to yield 243 
(7 mg, 20%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.36 (CAM, UV). 
HRMS (ESI): calcd for (C13H14O5F3S)+ [M‒H]+: 339.0509; found: 339.0504. 
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Triene 242 
 
A solution of enone ent-233 (688 mg, 3.30 mmol, 1 equiv) in dichloromethane (20 mL) was cooled 
to 0 °C. Dimethylpyridine (1.96 mL, 16.5 mmol, 5.00 equiv) and triisopropylsilyl 
trifluoromethane-sulfonate (2.75 mL, 9.91 mmol, 3.00 equiv) were added in sequence. The 
reaction mixture was allowed to warm to 24 °C and was stirred for 18 h. The solution was diluted 
with water (30 mL). The layers were separated, and the aqueous layer was extracted with 
dichloromethane (4 × 20 mL). The combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered, and the filtrate was concentrated. The residue was purified by flash 
column chromatography on silica gel (2% ethyl acetate in cyclohexane) to yield 242 (688 mg, 84%) 
as a yellow oil.  
TLC (5% ethyl acetate in hexanes): Rf = 0.40 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2945, 2866, 1739, 1660, 1463, 1210, 997 cm‒1. 
1H NMR (600 MHz, CDCl3) δ = 5.86 (dd, J = 10.6, 17.5 Hz, 1H), 5.74 (d, J = 9.86 Hz, 1H), 5.52 
(d, J = 9.87 Hz, 1H), 4.96 (m, 2H), 3.65 (s, 3H), 3.20 (m, 2H), 2.24 (m, 2H), 1.14 (m, 3H), 1.10 (s, 
3H), 1.08 (d, J = 7.47 Hz, 18H). 
13C NMR (150 MHz, CDCl3) δ = 172.1, 145.3, 143.9, 135.7, 124.2, 111.2, 105.4, 51.6, 39.8, 38.0, 
35.4, 25.2, 18.2, 13.2. 
HRMS (ESI): calcd for (C21H36O3SiNa)+ [M+Na]+: 387.2136; found: 387.2271. 
[𝛂]𝑫
𝟐𝟎
 = +21.5 (c = 0.55, CH2Cl2). 
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Tricyclo-[3.2.1.0]oct-3-ene 244 
 
A solution of 242 (1.01 g, 2.76 mmol, 1 equiv) in toluene (20 mL) was sealed in a pressure tube 
and the solution was heated to 170 °C. After 15 h, the solution was cooled to 24 °C and concentrated 
to yield 244 (1.01 g, quant.) as a yellow oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.40 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2944, 2866, 1741, 1637, 1462, 1223, 1161 cm1. 
1H NMR (600 MHz, CDCl3) δ = 4.85 (d, J = 6.4 Hz, 1H), 3.63 (s, 3H), 2.59 (q, J = 10.2, 15.8 Hz, 
2H), 1.68 (dd, J = 2.5, 11.3 Hz, 1H), 1.36 (m, 1H), 1.25 (s, 3H), 1.18 (m, 6H), 1.06 (m, 19H). 
13C NMR (150 MHz, CDCl3) δ = 173.0, 153.9, 93.7, 51.2, 44.7, 41.2, 37.5, 35.6, 23.2, 22.4, 21.5, 
18.6, 18.2, 12.9.  
HRMS (ESI): calcd for (C21H36O3SiNa)+ [M+Na]+: 387.2136; found: 387.2270. 
[𝛂]𝑫
𝟐𝟎
 = –6.4 (c = 0.10, CH2Cl2). 
 
Alcohol S9 
 
To a solution of 244 (10.0 g, 27.4 mmol, 1 equiv) in diethyl ether (400 mL) was added lithium 
aluminum hydride (2.60 g, 68.6 mmol, 2.50 equiv) in small portions at 24 °C. After 4 h, the 
reaction mixture was diluted in diethyl ether (250 mL) and cooled to 0 °C. Excess lithium 
aluminum hydride was quenched by addition of water (10 mL), 15% aqueous sodium hydroxide 
solution (10 mL) and again water (30 mL) again. The suspension was allowed to warm to 24 °C. 
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After 30 min, anhydrous sodium sulfate was added. After 15 min, the suspension was filtered 
through a plug of sodium sulfate and the filtrate was concentrated. The remaining colorless oil S9 
was used in the next step without further purification. The product is sensitive to silica and could 
not be purified any further using flash column chromatography.  
TLC (10% ethyl acetate in hexanes): Rf = 0.18 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 3345, 2942, 2865, 1635, 1463, 1218, 1012 cm‒1. 
1H NMR (600 MHz, C6D6) δ = 5.00 (d, J = 6.4 Hz, 1H), 3.75 (ddd, J = 3.7, 6.4, 7.6 Hz, 2H), 1.91 
(m, 2H), 1.51 (dd, J = 2.4, 11.2 Hz, 1H), 1.26 (t, J = 6.8 Hz, 1H), 1.16 (m, 9H), 1.11 (dd, J = 3.4, 
6.8 Hz, 18H), 1.00 (dd, J = 2.4, 7.1 Hz, 1H). 
13C NMR (150 MHz, C6D6) δ = 155.0, 95.0, 61.2, 45.5, 41.8, 36.8, 36.4, 23.3, 22.7, 22.0, 18.6, 
18.4, 13.2. 
HRMS (ESI): calcd for (C20H37O2Si)+ [M+H]+: 337.2558; found: 337.2554. 
[𝛂]𝑫
𝟐𝟎
 = –2.5 (c = 0.74, CH2Cl2). 
 
Iodide 246 
 
To a solution of triphenylphosphine (10.9 g, 41.1 mmol, 1.50 equiv) in a mixture of diethyl ether 
(200 mL) and acetonitrile (100 mL) was added imidazole (5.65 g, 82.2 mmol, 3.00 equiv) and 
iodine (10.5 g, 41.1 mmol, 1.50 equiv) at 24 °C. A solution of S9 (9.22 g, 27.4 mmol, 1 equiv) in 
diethyl ether (50 mL) was added slowly. After 5 h, the reaction mixture was diluted with diethyl 
ether (100 mL). The suspension was washed with aqueous sodium thiosulfate solution (2 × 
150 mL) and water (150 mL). The combined aqueous layer was extracted with diethyl ether (3 × 
150 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
solution (150 mL) and dried over sodium sulfate. The dried solution was filtered, and the filtrate 
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was concentrated. The residue was purified by flash column chromatography on silica gel (2% ethyl 
acetate in cyclohexane) to yield 246 (8.81 g, 72% over two steps) as a yellow oil.  
TLC (5% ethyl acetate in hexanes): Rf = 0.19 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax cm‒1: 2942, 2865, 1634, 1461, 1359, 1249, 1164, 1073 cm‒1. 
1H NMR (600 MHz, CDCl3) δ = 4.85 (d, J = 6.3 Hz, 1H), 3.30 (dddd, J = 18.7, 11.8, 8.8, 5.4 Hz, 
2H), 2.26 (m, 2H), 1.52 (m, 1H), 1.23 (m, 9H), 1.09 (dd, J = 2.8, 7.5 Hz, 18H), 0.97 (dd, J = 11.0, 
6.2 Hz, 2H). 
13C NMR (150 MHz, CDCl3) δ = 154.2, 94.5, 48.6, 41.2, 40.2, 35.6, 23.2, 22.3, 21.7, 18.5, 18.3, 
13.0, 3.7. 
HRMS (ESI): calcd for (C20H36IO3Si)+ [M + H]+: 447.1575; found: 447.2881. 
[𝛂]𝑫
𝟐𝟎
 = –42.2 (c = 0.43, CH2Cl2). 
 
Coupling product 248 
 
To a solution of 246 (153 mg, 0.343 mmol, 1.30 equiv) and B-methoxy-9-BBN (1 M in hexanes, 
0.791 mL, 0.791 mmol, 3.00 equiv) in tetrahydrofuran (1.4 mL) was added t-butyllithium (1.72 M 
in hexanes, 0.598 mL, 1.03 mmol, 3.90 equiv) dropwise at –78 °C. After 5 min the reaction mixture 
was allowed to warm to 24 °C. After 30 min, the solution was transferred to a suspension of 247 
(88.0 mg, 0.264 mmol, 1 equiv), caesium carbonate (174 mg, 0.527 mmol, 2.00 equiv), SPhos 
(5.6 mg, 0.013 mmol, 0.05 equiv) and SPhos Pd G2 (9.5 mg, 0.013 mmol, 0.05 equiv) in a mixture 
of dimethylformamide and water (9:1, 2.6 mL) at 24 °C. After 30 min, the reaction mixture was 
diluted in ethyl acetate (10 mL) and water (10 mL). The layers were separated, and the aqueous 
layer was extracted with ethyl acetate (3 × 15 mL). The combined organic extracts were washed 
with saturated aqueous sodium chloride solution (25 mL) and dried over sodium sulfate. The dried 
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solution was filtered, and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (3% ethyl acetate in cyclohexane) to yield 248 (133 mg, 88%) as a 
colorless oil.  
TLC (5% ethyl acetate in hexanes): Rf = 0.27 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax cm‒1: 2944, 2865, 1732, 1634, 1454, 1242, 1065, 882, 799, 694. 
1H NMR (400 MHz, CDCl3) δ = 7.35 (m, 5H), 7.07 (d, J = 8.4 Hz, 1H), 6.70 (d, , J = 8.4 Hz, 1H), 
5.08 (s, 2H), 4.87 (d, J = 6.4 Hz, 1H), 3.87 (s, 3H), 2.63 (t, J = 8.7 Hz, 2H), 2.27 (s, 3H), 1.86 (m, 
2H1.73 (dd, J = 2.4, 11.1 Hz, 1H), 1.40 (d, J = 11.0 Hz, 1H), 1.27 (s, 3H), 1.22 (m, 4H), 1.06 (dd, 
J = 1.7, 7.4 Hz, 19H), 0.87 (m, 2H). 
13C NMR (100 MHz, CDCl3) δ = 169.5, 155.7, 153.7, 139.9, 137.3, 131,8, 129.2, 128.6, 127.8, 
127.0, 125.0, 110.4, 94.1, 70.6, 52.1, 46.7, 39.9, 34.1, 31.7, 27.4, 23.3, 22.6, 21.6, 18.9, 18.8, 18.3, 
13.1. 
HRMS (ESI): calcd for (C36H50O4SiNa)+ [M + Na]+: 597.3370; found: 597.3309.  
[𝛂]𝑫
𝟐𝟎
 = –3.6 (c = 0.95, CH2Cl2). 
 
Ketone S10 
 
To a solution of TIPS enol ether 248 (388 mg, 0.675 mmol, 1 equiv) in tetrahydrofuran (7 mL) was 
added tetrabutylammonium fluoride (1 M in n-hexanes, 0.810 mL, 0.810 mmol, 1.20 equiv) at 0 °C. 
After 1 h, the reaction mixture was added ethyl acetate (15 mL) and saturated aqueous sodium 
bicarbonate solution (20 mL). The layers were separated, and the aqueous layer was extracted with 
ethyl acetate (3 × 20 mL). The combined organic extracts were washed with water (30 mL) and 
saturated aqueous sodium chloride solution (30 mL) and dried over sodium sulfate. The dried 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
 
 
127 
 
solution was filtered, and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (5% ethyl acetate in cyclohexane) to yield S10 (269 mg, 95%) as a 
colorless oil.  
TLC (20% ethyl acetate in hexanes): Rf = 0.23 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax cm‒1: 3030, 2921, 2862, 1714, 1587, 1479, 1382, 1265, 1064, 733, 
484.  
1H NMR (400 MHz, CDCl3) δ = 7.34 (m, 5H), 7.07 (d, J = 8.4 Hz, 1H), 6.70 (d, J = 8.4 Hz, 1H), 
5.07 (s, 2H), 3.93 (s, 3H), 2.55 (m, 4H), 2.33 (s, 3H), 1.73 (dd, J = 3.4, 12.7 Hz, 1H), 1.78 (m, 3H), 
1.65 (m, 2H), 1.28 (s, 3H), 1.20 (dd, J = 3.3, 7.6 Hz, 1H), 0.92 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ = 212.2, 169.4, 153.6, 139.0, 137.3, 132.0, 129.5, 128.6, 127.8, 
127.0, 124.9, 110.5, 70.6, 55.0, 52.3, 40.0, 34.8, 34.3, 33.5, 27.5, 23.0, 22.4, 19.6, 18.6, 18.1. 
HRMS (ESI): calcd for (C27H30O4K)+ [M+K]+: 457.1776; found: 457.1710. 
[𝛂]𝑫
𝟐𝟎= –3.5 (c = 0.75, CH2Cl2). 
 
Vinyl triflate S10 
 
S10 (150 mg, 0.358 mmol, 1 equiv) and N-(5-chloro-2 pyridyl)-bis(trifluoromethanesulfonimide) 
(176 mg, 0.430 mmol, 1.20 equiv) were dissolved in tetrahydrofuran (0.1 M, 3.6 mL) and cooled 
to 78 °C. A potassium bis(trimethylsilyl)amide solution (1 M in tetrahydrofuran, 0.434 mL, 
0.434 mmol, 1,21 equiv) was added dropwise. After 3 h, the reaction mixture was allowed to warm 
to 24 °C. Saturated aqueous ammonium chloride solution (10 mL) and ethyl acetate (10 mL) were 
added. The layers were separated, and the aqueous layer was extracted with ethyl acetate 
(3 × 15 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
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solution (20 mL) and dried over sodium sulfate. The dried solution was filtered, and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (5% ethyl 
acetate in cyclohexane) to yield S11 (152 mg, 77%) as a colorless oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.23 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax cm‒1: 2947, 2867, 1730, 1588, 1415, 1207, 1139, 1061, 843, 611, 
496.  
1H NMR (600 MHz, CDCl3) δ = 7.37 (m, 4H), 7.30 (m, 1H), 7.07 (d, J = 8.5 Hz, 1H), 6.73 (d, J = 
8.4 Hz, 1H), 6.00 (d, J = 6.8 Hz, 1H), 5.08 (s, 2H), 3.89 (s, 3H), 2.66 (dd, J = 7.5, 10.0 Hz, 2H), 
2.28 (s, 3H), 1.90 (m, 2H), 1.83 (dd, J = 2.3, 11.4 Hz, 1H), 1.52 (m, 2H), 1.38 (m, 1H), 1.33 (s, 
3H), 1.05 (dd, J = 7.6, 11.4 Hz, 2H). 
13C NMR (150 MHz, CDCl3) δ = 169.42, 153.80, 148.97, 138.30, 137.18), 132.15, 129.20, 128.59, 
127.85, 127.02, 124.91, 118.78 (q, J = 321 Hz), 112.4, 110.8, 70.6, 52.3, 46.0, 40.2, 34.7, 31.7, 
27.2, 25.2, 24.0, 22.0, 18.7, 18.0. 
HRMS (ESI): calcd for (C28H29F3O6SNa)+ [M+Na]+: 589.1268; found: 589.1214. 
[𝛂]𝑫
𝟐𝟎= –7.8 (c = 0.12, CH2Cl2). 
 
Phenol 249 
 
To a solution of S11 (61.0 mg, 0.111 mmol, 1 equiv) in dichloromethane (5.55 mL) was added 
dropwise boron tribromide (1 M in dichloromethane, 0.332 mL, 0.332 mmol, 3.00 equiv)  
at 78 °C. After 30 min, excess boron tribromide was quenched with methanol (1.5 mL) at –78 °C. 
Then, the solution was poured into a saturated sodium bicarbonate solution (10 mL) at 0 °C. The 
layers were separated, and the aqueous layer was extracted with dichloromethane (3 × 15 mL). The 
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combined organic extracts were washed with saturated aqueous sodium chloride solution (20 mL) 
and dried over sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. 
The residue was purified by flash column chromatography on silica gel (5% ethyl acetate in 
cyclohexane) to yield 249 (39.3 mg, 77%) as a white solid.  
TLC (10% ethyl acetate in hexanes): Rf = 0.22 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax cm‒1: 2955, 1663, 1596, 1463, 1412, 1201, 1138, 841, 720, 610, 495.  
1H NMR (600 MHz, CDCl3) δ = 10.54 (s, 1H), 7.21 (d, J = 8.5 Hz, 1H), 6.80 (d, J = 8.4 Hz, 1H), 
6.00 (d, J = 6.8 Hz, 1H), 3.96 (s, 3H), 2.96 (m, 2H), 2.27 (s, 3H), 1.97 (dd, J = 2.3, 11.5 Hz, 1H), 
1.87 (m, 2H), 1.64 (d, J = 11.4, 1H), 1.55 (m, 1H), 1.40 (m, 1H), 1.35 (s, 3H), 1.02 (dd, J = 7.7, 
11.4 Hz, 2H). 
13C NMR (150 MHz, CDCl3) δ = 171.8, 160.3, 149.1, 142.0, 137.0, 128.2, 118.8 (q, J = 321 Hz), 
115.7, 113.1, 112.7, 52.4, 46.0, 39.2, 33.7, 30.0, 27.2, 25.2, 23.9, 21.9, 19.7, 18.1. 
HRMS (ESI): calcd for (C21H23F3O6SK)+ [M+K]+: 499.0798; found: 499.0734.  
[𝛂]𝑫
𝟐𝟎= –14.9 (c = 0.12, CH2Cl2). 
 
Dienone 212 
 
Cesium carbonate (9.9 mg, 0.030 mmol, 1.50 equiv), (S)-AntPhos (1.9 mg, 0.005 mmol, 
0.25 equiv) and palladium (π-cinnamyl) chloride dimer (1.6 mg, 0.003 mmol, 0.15 equiv) were 
added to a Schlenk tube and the mixture was pumped and back-filled with argon for three times. A 
solution of 249 (9.2 mg, 0.020 mmol, 1 equiv) in toluene (0.5 mL) was added. The reaction mixture 
was placed in a preheated oil bath at 90 °C. After 13 h, heating was ceased and ethyl acetate (5 mL) 
was added. The suspension was filtered through a plug of celite and the filtrate was concentrated. 
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The residue was purified by flash column chromatography on silica gel (2% ethyl acetate in 
cyclohexane) to yield traces of 212 as a yellow oil. 
Only small amounts of 212 were isolated, which could be analyzed by 1H-NMR spectroscopy and 
mass spectroscopy. Unfortunately, repeating the experiment on a larger scale mainly resulted in 
decomposition. 
1H NMR (300 MHz, CDCl3) δ = 7.21 (d, J = 10.3 Hz, 1H), 6.24 (d, J = 10.2 Hz, 1H), 5.92 (d, J = 
6.1 Hz, 1H), 3.86 (s, 3H), 2.69 (m, 2H), 2.31 (m, 1H), 1.70 (m, 2H), 1.48 (s, 3H), 1.25 (s, 4H), 1.13 
(d, J = 11.2 Hz, 1H), 0.80 (m, 3H). 
HRMS (ESI): calcd for (C20H22O3Na)+ [M + Na]+: 333.1461; found: 333.1416.  
 
Diol 252 
 
To a solution of 249 (70 mg, 0.15 mmol, 1 equiv) in dichloromethane (2 mL) was added di-iso-
butylaluminum hydride solution (1 M in tetrahydrofuran, 334 μL, 0.33 mmol, 2.20 equiv) at 78°C. 
The reaction mixture was allowed to warm to 24 °C. After 3 h, saturated aqueous Rochelle salt 
solution (10 mL) was added and the mixture was stirred for 30 min. Dichloromethane (10 mL) was 
added and the layers were separated. The aqueous layer was extracted with dichloromethane (3 × 
10 mL). The combined organic layers were washed with water (10 mL) and saturated aqueous 
sodium chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10‒20% ethyl acetate in cyclohexane) to yield 252 (21 mg, 32%) as 
a colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.22 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 3296, 2925, 2861, 1718, 1644, 1595, 1464, 14161218, 1246, 1208, 
1140, 1119, 1061 cm‒1 
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1H NMR (600 MHz, CDCl3) δ = 7.34 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H), 6.69 (d, J = 8.2 Hz, 1H), 
6.01 (d, J = 6.8 Hz, 1H), 4.98 (d, J = 5.3 Hz, 2H), 2.70 (ddd, J = 10.6, 6.3, 2.3 Hz, 2H), 2.26 (s, 
3H), 2.18 (t, J = 5.4 Hz, 1H), 1.83 – 1.69 (m, 3H), 1.57 – 1.53 (m, 1H), 1.52 – 1.48 (d, 11.3 Hz, 
1H), 1.40 (dd, J = 7.0, 2.1 Hz, 1H), 1.34 (s, 3H), 1.16 (m, 2H). 
13C NMR (150 MHz, CDCl3) δ = 155.2, 148.9, 138.2, 131.1, 127.7, 123.1, 114.6, 112.7, 112.7, 
60.6, 46.2, 40.9, 35.5, 33.1, 25.9, 25.2, 23.9, 22.1, 19.4, 18.0. 
HRMS (ESI): calcd for (C20H23F3O5SNa)+ [M+Na]+: 455.111; found: 455.111.  
[𝛂]𝑫
𝟐𝟎= –8.5 (c = 0.80, CH2Cl2). 
 
Aldehyde 254 
 
Cesium carbonate (11.4 mg, 0.03 mmol, 1.50 equiv), palladium(π-cinnamyl) chloride dimer 
(1.2 mg, 2.31 μmol, 0.10 equiv) and AntPhos (1.7 mg, 4.62 μmol, 0.2 equiv) were added to a dry 
Schlenk flask and the flask was evacuated and back-filled with argon three times. A solution of 252 
(10 mg, 0.02 mmol, 1 equiv) in degassed toluene (1.5 mL) was added. The yellow suspension was 
heated to 90 °C. After 17 h, heating was ceased and the mixture was allowed to cool to 24 °C. 
Dichloromethane (5 mL) was added and the mixture was filtered through a short pad of celite. The 
filter cake was rinsed with dichloromethane (30 mL) and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (5% ethyl acetate in hexanes) 
to yield 254 (3.5 mg, 54%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.57 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 3035, 2921, 2863, 1642, 1611, 1465, 1285, 1233, 1203, 1157, 1101, 
729 cm‒1. 
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1H NMR (600 MHz, CDCl3) δ = 11.92 (s, 1H), 10.36 (s, 1H), 7.30 (d, J = 8.5 Hz, 1H), 6.74 (d, J 
= 8.5 Hz, 1H), 6.04 (dd, J = 8.3, 5.6 Hz, 1H), 5.84 (dd, J = 8.4, 1.9 Hz, 1H), 3.00 – 2.92 (m, 2H), 
2.28 (s, 3H), 1.75 – 1.68 (m, 2H), 1.56 (dd, J = 10.9, 2.3 Hz, 1H), 1.52 – 1.47 (m, 1H), 1.31 (s, 3H), 
1.26 (m, 2H), 0.81 (m, 2H). 
13C NMR (150 MHz, CDCl3) δ = 195.7, 161.9, 144.9, 140.2, 131.0, 126.9, 124.3, 117.9, 115.6, 
44.0, 40.5, 39.9, 34.7, 24.6, 24.2, 24.1, 23.2, 18.8, 18.7. 
HRMS (ESI): calcd for (C19H23O2)+ [M+H]+: 283.169; found: 283.264.  
 
Silyl ether 255 
 
To a solution of 252 (60 mg, 0.14 mmol, 1 equiv) in dichloromethane (5 mL) was added imidazole 
(21 mg, 0.31 mmol, 2.20 equiv) and tert-butyldimethylchlorosilane (26 mg, 0.17 mmol, 
1.20 equiv) at 0 °C. After 2.5 h, water (10 mL) and dichloromethane (10 mL) was added and the 
layers were separated. The aqueous layer was extracted with dichloromethane (3 × 10 mL). The 
combined organic layers were washed with water (10 mL) and saturated aqueous sodium chloride 
solution (10 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography 
on silica gel (10% ethyl acetate in cyclohexane) to yield 255 (73 mg, 96%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.57 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 3367, 2927, 2857, 1597, 1464, 1418, 1248, 1210, 1142, 1063 cm‒1. 
1H NMR (400 MHz, CDCl3) δ = 8.50 (s, 1H), 6.98 (d, J = 8.2 Hz, 1H), 6.67 (d, J = 8.2 Hz, 1H), 
6.01 (d, J = 6.8 Hz, 1H), 5.03 (s, 2H), 2.65 (m, 2H), 2.25 (s, 3H), 1.83 (dd, J = 11.4, 2.2 Hz, 1H), 
1.72 (m, 2H), 1.59 – 1.47 (m, 2H), 1.41 (m, 1H), 1.35 (s, 3H), 1.14 (m, 2H), 0.94 (s, 9H), 0.16 (s, 
6H). 
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13C NMR (100 MHz, CDCl3) δ = 155.9, 148.8, 137.1, 130.8, 127.1, 122.2, 120.4, 114.8, 112.8, 
62.6, 46.2, 40.6, 35.1, 32.1, 25.9, 25.6, 25.2, 23.9, 22.1, 19.44, 18.2, 18.0, 5.4. 
HRMS (ESI): not found 
[𝛂]𝑫
𝟐𝟎= –7.5 (c = 0.08, CH2Cl2).  
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Dienone 256 
 
Potassium carbonate (7.6 mg, 0.05 mmol, 1.50 equiv), palladium(π-cinnamyl) chloride dimer 
(1.9 mg, 3.66 μmol, 0.10 equiv) and (S)-AntPhos (2.7 mg, 7.32 μmol, 0.20 equiv) were added to a 
dry Schlenk flask and the flask was evacuated and back-filled with argon three times. A solution 
of 255 (20 mg, 0.04 mmol, 1 equiv) in degassed toluene (1.5 mL) was added. The yellow suspension 
was heated to 90 °C. After 13 h, heating was ceased and the mixture was allowed to cool to 24 °C. 
Dichloromethane (5 mL) was added and the mixture was filtered through a short pad of celite. The 
filter cake was rinsed with dichloromethane (30 mL) and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (0‒5% ethyl acetate in hexanes) 
to yield 256 (3.0 mg, 21%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.48 (CAM, UV). 
IR (Diamond-ATR, neat) ṽmax: 2954, 2926, 2855, 1732, 1661, 1628, 1461, 1406, 1253, 1211, 1141, 
1072 cm‒1. 
Peaks of the minor diastereomer are also visible in the NMR spectra, but only chemical shifts of 
the major diastereomer are reported: 
1H NMR (400 MHz, CDCl3) δ = 7.16 (d, 1H), 6.21 (d, 1H), 5.88 (d, 1H), 4.53 (s, 2H), 3.02 (ddd, 
1H), 2.83 (dd, 1H), 2.34 (dd, 1H), 1.76 – 1.63 (m, 2H), 1.43 (s, 3H), 1.37 (m, 1H), 1.29 (s, 2H), 
1.24 (s, 3H), 1.11 (d, 1H), 0.96 – 0.92 (m, 1H), 0.86 (s, 9H), 0.72 (d, 1H), 0.05 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ = 183.9, 164.9, 153.9, 142.6, 132.8, 125.8, 118.0, 55.1, 44.0, 42.5, 
41.9, 36.9, 30.5, 30.0, 29.9, 26.1, 25.8, 24.3, 23.1, 18.4, 1.2, 5.0. 
HRMS (ESI): calcd for (C25H36O2SiNa)+ [M + Na]+: 419.237; found: 419.470.  
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Aldehyde S12 
 
To a suspension of 2-methyl-1,3-cyclohexanedione (261) (27.5 g, 211 mmol, 1 equiv) in water 
(250 mL) was added acrolein 260 (21.2 mL, 317 mmol, 1.50 equiv) and dropwise acetic acid 
(0.60 mL, 10.6 mmol, 0.05 equiv) at 24 °C. The mixture was vigorously stirred under exclusion of 
light.  After 28 h, saturated aqueous sodium chloride soluetion (150 mL) was added the aqueous 
mixture was extracted with ethyl acetate (4 × 150 mL). The combined organic layers were washed 
with saturated sodium chloride solution (120 mL) and dried over sodium sulfate. The dried solution 
was filtered and the filtrated was concentrated. The concentrated oil was filtered over a short plug 
of celite, to remove a white solid that precipitated, to yield S12 (29.4 g, 76%) as a yellow oil, which 
was used without further purification. The analytical data were in full agreement with the 
literature.[80] 
 
α,β-Unsaturated ester 262 
 
A solution of S12 (19.3 g, 106 mmol, 1 equiv), phosphonium ylide S13 (47.9 g, 127 mmol, 
1.20 equiv) and benzoic acid (13 g, 106 mmol, 1.00 equiv) in toluene (300 mL) was heated to 
80 °C. After 21 h, heating was ceased and aqueous saturated sodium bicarbonate solution (400 mL) 
was added and the layers were separated. The aqueous layer was diluted with saturated aqueous 
sodium chloride solution (200 mL) and extracted with ethyl acetate (5 × 200 mL). The combined 
organic layers were washed with saturated sodium chloride solution, dried over sodium sulfate and 
concentrated. The residue was purified by flash column chromatography on silica gel (10% ethyl 
acetate in cyclohexane) to yield 262 (26.0 g, 88%) as a pale-yellow oil. The analytical data were in 
full agreement with the literature.[80] 
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Acid S15 
 
A solution of fluorotris(triphenylphosphine)copper (703 mg, 0.768 mmol, 0.0075 equiv) and 
S,S-Taniaphos (528 mg, 0.768 mmol, 0.0075 equiv) in toluene (1 L) was stirred at 24 °C for 30 
min. Phenylsilane (17.1 mL, 133 mmol, 1.30 equiv) was added dropwise. The mixture was cooled 
to 50 °C and a solution of 262 (28.7 g, 102 mmol, 1 equiv) in toluene (150 mL) was added via a 
dropping funnel over the course of 2 h. The mixture was stirred at –50 °C for 6 h and then allowed 
to slowly warm up to 10 °C over 17 h. Then aqueous hydrogen chloride solution (2 M, 500 mL) 
was added and the biphasic mixture was left stirring for 2 h at 24 °C. The layers were separated 
and the aqueous layer was extracted with diethyl ether (4 × 300 mL). The combined organic layers 
were washed with saturated sodium chloride solution (400 mL) and dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated to yield a mixture of crude products 
S14 and 264 (85% ee as determined by chiral GC analysis).  
To a solution of S14 and 264 in dichloromethane (1 L) was dropwise added trifluoracetic acid 
(76.5 mL, 1020 mmol, 10.0 equiv) at 24 °C. After 4 h, water (600 mL) was added. The layers were 
separated and the aqueous layer was extracted with dichloromethane (4 × 300 mL). The combined 
organic layers were concentrated to a volume of 200 mL and cooled to 0 °C. Aqueous sodium 
hydroxide solution (3 M, 800 mL) was added until pH 9. The layers were separated and the aqueous 
layer was washed with dichloromethane (3 × 400 mL). Concentrated aqueous hydrochloric acid 
was added to acidify the solution to pH 2. The aqueous layer was extracted with dichloromethane 
(5 × 300 mL) and diethyl ether (2 × 300 mL) and the combined organic layers were dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated to yield S15 (18 g, 
78% over 2 steps) as a white solid, which was used without further purification. The analytical data 
were in full agreement with the literature.[80] 
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Methylester 265 
 
To a solution of S15 (18.0 g, 79.6 mmol, 1 equiv) in N,N-dimethyl formamide (450 mL) were 
added potassium carbonate (13.6 g, 239 mmol, 3.00 equiv) and iodomethane (5.25 mL, 83.5 mmol, 
1.05 equiv) successively at 0 °C. The mixture allowed to warm to 24 °C. After 22 h, the mixture 
was cooled to 0 °C and aqueous hydrochloric acid (2 M, 200 mL) was added carefully. The mixture 
was diluted with water (500 mL) and the aqueous layer was extracted with ethyl acetate 
(4 × 250 mL). The combined organic layers were washed with aqueous lithium chloride solution 
(10 wt%, 2 × 300 mL), aqueous hydrochloric acid (2 M, 300 mL)  and saturated aqueous sodium 
chloride solution (300 mL) and dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash column chromatography on silica gel 
(20‒30% ethyl acetate in cyclohexane) to yield 265 (9.0 g, 47%) as a white solid. The analytical 
data were in full agreement with the literature.[80] 
 
Olefin S16 
 
To a solution of 265 (4.58 g, 19.1 mmol, 1 equiv) in pyridine (150 mL) was added dropwise thionyl 
chloride (2.79 mL, 38.1 mmol. 2.00 equiv) over 10 min at 0 °C. After stirring for 5 min at 0 °C the 
mixture was diluted with water (150 mL) and the layers were separated. The aqueous layer was 
extracted with ethyl acetate (3 × 250 mL). The combined organic layers were washed with 
saturated aqueous cupper sulfate solution (6 × 300 mL). The washed solution was dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexan) to yield 
S16 (3.74 g, 88%) as a colorless oil. The analytical data were in full agreement with the literature.[80] 
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Acetal S17 
 
To a solution of S16 (6.82 g, 30.7 mmol, 1 equiv) in dichloromethane (300 mL) was dropwise 
added freshly distilled trimethylsilyl trifluoromethylsulfonate (285 µL, 1.53 mmol, 0.05 equiv) and 
ethylenedioxybis(trimethylsilane) (15.4 mL, 61.4 mmol, 2.00 equiv) at –78 °C. After 1 h, the 
mixture was warmed to 24 °C. After 21 h, pyridine (2 mL) was added dropwise. Aqueous saturated 
sodium bicarbonate solution (200 mL) was added and the layers were separated. The aqueous layer 
was extracted with dichloromethane (3 × 200 mL) and the combined organic layers were dried over 
sodium sulfate. The dried solution was filtered and the filtrated was concentrated. The residue was 
purified by flash column chromatography on silica gel (10% ethyl acetate in cyclohexan) to yield 
S17 (6.6 g, 80%) as a white solid. The analytical data were in full agreement with the literature.[80] 
 
α-Tertiary methyl ester S18 
 
To a solution of diisopropylamine (15.8 mL, 111 mmol, 4.50 equiv) in tetrahydrofuran (300 mL) 
was added n-butyl lithium (2.5 M in hexanes, 39 mL, 4.00 equiv) at –78 °C. The mixture was 
warmed to 0 °C. N,N’-dimethylpropylene urea (29.9 mL, 246 mmol, 10.0 equiv) was added 
dropwise and the solution was stirred for 30 min at 0 °C. A solution of S17 (6.55 g, 24.6 mmol, 
1 equiv) in tetrahydrofuran (20 mL) was added dropwise at 0 °C. The dark red solution returned 
pale yellow. After 3 h, the mixture was cooled to –78 °C and iodomethane (15.5 mL, 246 mmol, 
10.00 equiv) was added dropwise. The reaction mixture was warmed to 24 °C. After 4 h, the excess 
of iodomethane was distilled off from the reaction mixture. Then, aqueous saturated ammonium 
chloride solution (200 mL) was added and the layers were separated. The aqueous layer was 
extracted with diethyl ether (3 × 200 mL). The combined organic layers were washed with 
saturated sodium chloride solution (200 mL) and dried over sodium sulfate. The dried solution was 
filtered and the filtrated was concentrated. The residue was purified by flash column 
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chromatography on silica gel (10% ethyl acetate in cyclohexane) to yield S18 (5.35 g, 78%) as a 
white solid. The analytical data were in full agreement with the literature.[80] 
Ketone 129 
 
To a solution of S18 (5.35 g, 19.1 mmol, 1 equiv) in tetrahydrofuran (100 mL) was added aqueous 
hydrogen chloride solution (2 M, 100 mL) and the solution was stirred at 24 °C. After 7 h, the 
reaction mixture was extracted with diethyl ether (3 × 100 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (100 mL) and dried over sodium sulfate. 
The dried solution was filtered and the filtrate was concentrated to yield 129 (3.97 g, 88%) as a 
white solid, which was used without further purification. The analytical data were in full agreement 
with the literature.[80] 
 
Diol 266 
 
To a solution of 129 (3.97 g, 16.8 mmol, 1 equiv) in a mixture of acetone (160 mL) and water 
(30 mL) in a pressure tube was added N-methylmorpholine oxide in water (50 wt%, 10.4 mL, 
50.4 mmol, 3.00 equiv), hydroquinine 1,4-phthalazinediyldiether (276 mg, 0.34 mmol, 0.02 equiv) 
and osmium tetroxide in water (4 wt%, 10.4 mL, 50.4 mmol, 0.10 equiv). The mixture was heated 
to 90 °C in a pressure tube. After 72 h, heating was ceased and saturated aqueous saturated sodium 
thiosulfate solution (200 mL) and water (100 mL) was added to the reaction mixture and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (6 × 150 mL). The combined 
organic layers were dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (20–70% 
ethyl acetate in cyclohexane) to yield 266 (3.66 g, 81%) as a white solid and recover 129 (0.58 g, 
15%). 
TLC (50% ethyl acetate in n-pentane): Rf = 0.50 (CAM). 
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1H-NMR (400 MHz, CDCl3): δ = 5.03 (dt, J = 10.5, 5.3 Hz, 1H, H-6), 3.76 (s, 3H, H-21), 2.76 (d, 
J = 5.0 Hz, 1H, sec. OH), 2.69 – 2.55 (m, 2H, tert OH, H-8a), 2.33 (ddd, J = 15.5, 6.0, 3.2 Hz, 1H, 
H-8b), 2.09 – 1.97 (m, 2H, H-7), 1.95 – 1.81 (m, 2H, H-3), 1.78 – 1.68 (m, 1H, H-2), 1.62 – 1.48 
(m, 2H, H-2, H-1a), 1.42 (ddd, J = 14.2, 3.1, 1.7 Hz, 1H, H-1b), 1.33 (s, 3H, H-18), 1.03 (s, 3H, 
H-20).  
13C-NMR (101 MHz, CDCl3): δ = 213.0 (C-9), 177.9 (C-19), 79.5 (C-5), 70.1 (C-6), 52.6 (C-10), 
52.4 (C-21), 49.6 (C-4), 34.6 (C-8), 33.9 (C-3), 28.3 (C-7), 28.0 (C-1), 26.8 (C-18), 19.4 (C-20), 
18.3 (C-2). 
IR (Diamond-ATR, neat): ṽmax = 3484, 2948, 2878, 1711, 1459, 1433, 1308, 1211, 1149, 1093, 
1070, 1052, 1038 cm‒1. 
HRMS (ESI): calcd for (C14H23O5)+ [M+H]+: 271.154; found: 271.153. 
[𝛂]𝐃
𝟐𝟎 = –7.95 (c = 0.67 in CH2Cl2). 
 
Enone 267 
 
To a solution of 266 (1.58 g, 5.84 mmol, 1 equiv) in toluene (15 mL) and tetrahydrofuran (25 mL) 
was added sodium hydride suspended in mineral oil (60 wt%, 935 mg, 23.4 mmol, 4.00 equiv) in 
one portion at 0 °C. After 40 min, methyl formate (5 mL, 80.8 mmol, 13.8 equiv) was added 
dropwise to the suspension. The reaction mixture was allowed to warm to 24 °C. After 90 min, 
aqueous saturated ammonium chloride solution (40 mL) was added and the layers were separated. 
The aqueous layer was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were 
washed with saturated sodium chloride solution (50 mL) and dried over magnesium sulfate. The 
dried solution was filtered and the filtrate was concentrated.  
To a solution of the crude product in dichloromethane (10 mL) were dropwise added freshly 
distilled methyl vinyl ketone (2.43 mL, 29.2 mmol, 5.00 equiv) and triethyl amine (3.22 mL, 
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23.4 mmol, 4.00 equiv) at 24 °C. The mixture was left stirring at 24 °C under exclusion of light. 
After 40 h, the solvent was evaporated. 
To a solution of the yellow residue in methanol (20 mL) was added sodium methoxide (995 mg, 
17.5 mmol, 3.00 equiv) in one portion and the mixture was stirred at 24 °C. After 20 h, aqueous 
saturated ammonium chloride solution (20 mL) was added and the aqueous layer was extracted 
with dichloromethane (3 × 50 mL). The combined organic layers were washed with saturated 
sodium chloride solution (50 mL) and dried over magnesium sulfate. The dried solution was filtered 
and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel (9% acetone in dichloromethane) to yield 267 (1.16 g, 62%) as a pale yellow solid. 
TLC (17% ethyl acetate in n-pentane): Rf = 0.50 (CAM, UV). 
1H-NMR (400 MHz, CDCl3): δ = 5.95 (d, J = 2.2 Hz, 1H, H-11), 4.82 (dt, J = 11.9, 5.2 Hz, 1H, H-
6), 3.77 (s, 3H, H-21), 2.77 – 2.66 (m, 1H, H-8), 2.64 (d, J = 5.3 Hz, 1H, sec OH), 2.42 (dt, J = 
16.2, 4.0 Hz, 1H, H-16a), 2.25 (ddd, J = 16.3, 14.1, 5.0 Hz, 1H, H-16b), 2.13 (s, 1H, tert OH), 2.13 
– 2.08 (m, 1H, H-15a), 2.03 – 1.97 (m, 1H, H-7a), 1.94 – 1.85 (m, 3H, H-1, H-2, H-3), 1.74 – 1.58 
(m, 4H, H-2, H-3, H-7b, H-15b), 1.48 – 1.43 (m, 1H, H-1), 1.39 (s, 3H, H-18), 1.03 (s, 3H, H-20).  
13C-NMR (100 MHz, CDCl3): δ = 200.4 (C-12), 178.0 (C-19), 171.8 (C-9), 123.8 (C-11), 79.0 (C-
5), 70.3 (C-6), 52.4 (C-21), 49.7 (C-4), 46.7 (C-10), 37.5 (C-7), 36.4 (C-16), 34.1 (C-3), 32.8 (C-
8), 31.3 (C-1), 29.7 (C-15), 28.0 (C-18), 22.1 (C-20), 18.9 (C-2). 
IR (Diamond-ATR, neat): ṽmax = 3463, 2944, 2877, 1719, 1660, 1606, 1458, 1379, 1353, 1263, 
1210, 1188, 1155, 1108, 1009 cm‒1. 
HRMS (ESI): calcd for (C18H26NaO5)+ [M+Na]+: 345.1672; found: 345.1707. 
[𝛂]𝐃
𝟐𝟎 = +30.4 (c = 0.70 in CH2Cl2). 
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Acetonide S19 
 
To a solution of 267 (967 mg, 3.00 mmol, 1 equiv) in dichloromethane (30 mL) was dropwise 
added 2-methoxypropene (888 µL, 9.00 mmol, 3.00 equiv) and para-toluene sulfonic acid (6.0 mg, 
0.03 mmol, 0.01 equiv) at 0 °C. The mixture was warmed to 24 °C. After 25 min, pyridine (300 µL) 
and aqueous saturated ammonium chloride solution (30 mL) was added to the mixture. The layers 
were separated and the aqueous layer was extracted with dichloromethane (3 × 30 mL). The 
combined organic layers were washed with saturated sodium chloride solution (30 mL) and dried 
over magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
residue was purified by flash column chromatography on silica gel (17–33% ethyl acetate in 
n-pentane) to yield S19 (823 mg, 76%) as an amorphous white solid.  
TLC (50% ethyl acetate in n-pentane): Rf = 0.64 (CAM, UV). 
1H-NMR (400 MHz, CDCl3): δ = 5.80 (dd, J = 2.7, 0.9 Hz, 1H), 4.81 (dd, J = 3.5, 1.8 Hz, 1H), 
3.69 (s, 3H), 2.72 (dddd, J = 11.5, 9.6, 4.1, 2.5 Hz, 1H), 2.60 (ddd, J = 15.3, 9.6, 1.9 Hz, 1H), 2.50 
– 2.44 (m, 1H), 2.40 – 2.23 (m, 2H), 2.22 – 2.12 (m, 1H), 2.10 – 2.04 (m, 1H), 2.02 – 1.95 (m, 1H), 
1.91 – 1.79 (m, 2H), 1.65 – 1.55 (m, 2H), 1.32 – 1.28 (m, 3H), 1.28 (s, 3H), 1.26 (s, 3H), 1.16 – 
1.11 (m, 1H), 1.10 (d, J = 1.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ = 200.5, 176.9, 173.6, 123.5, 106.2, 89.0, 75.9, 51.8, 48.7, 46.2, 
39.0, 33.2, 33.1, 32.4, 30.5, 29.8, 28.2, 27.8, 26.6, 21.5, 18.4. 
IR (Diamond-ATR, neat): ṽmax = 3005, 2936, 2879, 1723, 1666, 1615, 1454, 1377, 1347, 1317, 
1254, 1207, 1178, 1154, 1141, 1118 (m), 1045, 1018 cm1. 
HRMS (ESI): calcd for (C21H30NaO5)+ [M+Na]+: 385.1985; found: 385.2021. 
[𝛂]𝐃
𝟐𝟎 = +22.1 (c = 4.13 in CH2Cl2). 
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α-Methyl enone S20 
 
A solution of S19 (800 mg, 2.21 mmol, 1 equiv) in tetrahydrofuran (11 mL) was dropwise added 
to a sodium bis(trimethylsilyl)amide solution (1 M in tetrahydrofuran, 2.43 mL, 2.43 mmol, 
1.10 equiv) at –78 °C. After stirring for 1 h the mixture was slowly heated to 0 °C. After 1 h, it was 
cooled to –72 °C and a triethylborane solution (1 M in n-hexane, 1.77 mL, 1.77 mmol, 0.800 equiv) 
was added dropwise at this temperature. After 30 min, iodomethane (555 µL, 8.83 mmol, 
4.00 equiv) was added dropwise to the reaction mixture. The reaction mixture was warmed to 
24 °C. After 17 h, the mixture was cooled to 0 °C and water (10 mL) was added. The aqueous layer 
was extracted with ethyl acetate (3 × 25 mL). The combined organic layers were washed with 
saturated sodium chloride solution (25 mL) and dried over magnesium sulfate. The dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (17–33% ethyl acetate in n-pentane) to yield S20 (522 mg, 63%) as 
an amorphous, white solid. 
TLC (50% ethyl acetate in n-pentane): Rf = 0.67 (CAM, UV). 
1H-NMR (400 MHz, CDCl3): δ = 5.71 (d, J = 2.6 Hz, 1H), 4.81 (dd, J = 3.5, 1.9 Hz, 1H), 3.68 (s, 
3H), 2.87 (dddd, J = 12.0, 9.5, 4.5, 2.7 Hz, 1H), 2.59 (ddd, J = 15.3, 9.6, 1.9 Hz, 1H), 2.56 – 2.42 
(m, 2H), 2.16 (td, J = 12.7, 4.2 Hz, 1H), 2.09 – 2.02 (m, 1H), 1.89 – 1.79 (m, 2H), 1.75 (ddd, J = 
12.5, 4.3, 1.5 Hz, 1H), 1.64 – 1.58 (m, 1H), 1.57 (dd, J = 6.7, 4.7 Hz, 1H), 1.33 – 1.27 (m, 3H), 
1.25 (s, 3H), 1.25 (s, 3H), 1.18 – 1.13 (m, 1H), 1.11 (d, J = 7.4 Hz, 3H), 1.10 (d, J = 1.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ = 203.7, 176.8, 172.4, 122.1, 106.2, 89.1, 76.0, 51.7, 48.7, 46.1, 
40.8, 39.2, 32.4, 30.2, 29.6, 28.2, 27.7, 27.3, 26.6, 21.4, 18.4, 15.7. 
IR (Diamond-ATR, neat): ṽmax = 3006, 1724, 1663, 1616, 1456, 1436, 1377, 1315, 1256, 1231, 
1207, 1179, 1149, 1133, 1034, 1017 cm1. 
HRMS (ESI): calcd for (C22H32NaO5)+ [M+Na]+: 399.2145; found: 399.2179. 
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[𝛂]𝐃
𝟐𝟎 = +3.71 (c = 6.96 in CH2Cl2). 
 
Secondary alcohol 268 
 
To a solution of diisopropyl amine (144 µL, 1.01 mmol, 4.00 equiv) in tetrahydrofuran (1.2 mL) 
was added n-butyl lithium (2.45 M in hexanes, 303 µL, 757 µmol, 3.00 equiv) at –78 °C. 
Tetramethyl ethylene diamine (462 µL, 3.03 mmol, 12.0 equiv) was added dropwise to the reaction 
mixture. S20 (95 mg, 252 µmol, 1 equiv) in tetrahydrofuran (1.8 mL) was added dropwise to 
solution at 78 °C. After 1 h, the reaction mixture was heated to –20 °C and stirred for 1 h. The 
mixture was cooled to –78 °C and acetaldehyde (285 µL, 5.05 mmol, 20.0 equiv) was added 
dropwise to the solution. After 80 min, water (3 mL) containing aqueous saturated ammonium 
chloride solution (3 drops) was added and the aqueous layer was extracted with ethyl acetate 
(3×10 mL). The combined organic layers were dried over magnesium sulfate. The dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (33–38% ethyl acetate in n–pentane) to yield 268 (105 mg, quant.) as 
a white solid.  
TLC (25% ethyl acetate in n-pentane): Rf = 0.13 (CAM, UV). 
1H-NMR (400 MHz, CDCl3): δ = 5.79 (d, J = 2.5 Hz, 1H), 4.82 (dd, J = 3.4, 1.8 Hz, 1H), 3.98 (qd, 
J = 6.3, 1.8 Hz, 1H), 3.69 (s, 3H), 2.80 (dddd, J = 12.2, 9.4, 4.4, 2.6 Hz, 1H), 2.58 (ddd, J = 15.3, 
9.6, 1.9 Hz, 1H), 2.38 (dd, J = 13.8, 12.4 Hz, 1H), 2.25 – 2.14 (m, 2H), 2.12 – 2.04 (m, 1H), 1.93 
– 1.79 (m, 3H), 1.66 – 1.57 (m, 2H), 1.33 – 1.29 (m, 3H), 1.28 (s, 3H), 1.27 (s, 3H), 1.19 (d, J = 
6.4 Hz, 3H), 1.17 – 1.12 (m, 1H), 1.11 (d, J = 1.0 Hz, 3H), 1.02 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ = 205.1, 176.8, 173.2, 122.5, 106.2, 89.3, 76.0, 67.7, 51.8, 49.2, 
48.7, 46.1, 43.5, 32.4, 30.4, 29.7, 28.7, 28.2, 27.7, 26.6, 21.3, 18.4, 17.4, 16.4. 
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IR (Diamond-ATR, neat): ṽmax = 3481, 1725, 1651, 1552, 1456, 1312, 1259, 1237, 1209, 1179, 
1103, 1084 cm1. 
HRMS (ESI): calcd for (C24H36NaO6)+ [M+Na]+: 443.2404; found: 443.2442. 
[𝛂]𝐃
𝟐𝟎 = +2.10 (c = 1.48 in CH2Cl2). 
 
α-Vinyl enone S21 
 
To a solution of 268 (65.0 mg, 155 µmol, 1 equiv) in benzene (1 mL) was added dropwise a 
solution of Martin sulfurane (114 mg, 170 µmol, 1.10 equiv) in benzene (2 mL) at 24 °C. After 1 h, 
further Martin sulfurane (60 mg, 89.2 µmol, 0.570 equiv) in benzene (1 mL) was added. After 1 h, 
aqueous saturated sodium bicarbonate solution (5 mL) was added and the layers were separated. 
The aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the combined organic layers 
were dried over magnesium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (17% ethyl 
acetate in n-pentane) to yield S21 (62 mg, quant.) as an amorphous, white solid.  
TLC (25% ethyl acetate in n-pentane): Rf = 0.69 (CAM, UV). 
1H-NMR (400 MHz, CDCl3): δ = 5.81 – 5.71 (m, 2H), 5.02 (dd, J = 10.6, 0.9 Hz, 1H), 4.90 (dd, J 
= 17.6, 0.9 Hz, 1H), 4.83 (dd, J = 3.5, 1.9 Hz, 1H), 3.69 (s, 3H), 2.79 (dddd, J = 12.1, 9.5, 4.3, 2.8 
Hz, 1H), 2.58 (ddd, J = 15.3, 9.7, 1.9 Hz, 1H), 2.38 (dd, J = 13.1, 11.9 Hz, 1H), 2.18 (td, J = 12.8, 
4.4 Hz, 1H), 2.10 – 2.05 (m, 1H), 1.90 – 1.79 (m, 3H, H-2), 1.67 – 1.57 (m, 2H), 1.32 – 1.29 (m, 
3H), 1.29 – 1.28 (m, 3H), 1.27 (s, 3H), 1.16 (s, 3H), 1.15 – 1.09 (m, 1H), 1.06 (d, J = 1.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 202.1, 176.9, 172.2, 140.8, 122.8, 114.5, 106.3, 89.2, 76.0, 51.8, 
49.4, 48.7, 46.2, 46.0, 32.4, 30.2, 29.8, 29.8, 28.3, 27.7, 26.6, 24.2, 21.3, 18.4. 
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IR (Diamond-ATR, neat): ṽmax =3319, 2931, 1726, 1651, 1630, 1454, 1379, 1314, 1264, 1230, 
1210, 1192, 1176, 1079 cm1. 
HRMS (ESI): calcd for (C24H34NaO5)+ [M+Na]+: 425.2298; found: 425.2283. 
[𝛂]𝐃
𝟐𝟎 = +11.1 (c = 1.43 in CH2Cl2). 
 
Allylic alcohol S22 
 
To a solution of S21 (62.0 mg, 154 µmol, 1 equiv) in methanol (3 mL) were added 
cerium(III)chloride heptahydride (63.1 mg, 169 µmol, 1.10 equiv) and sodium borohydride 
(11.9 mg, 308 µmol, 2.00 equiv) successively in one portion at 0 °C. The reaction mixture was 
slowly warmed to 24 °C. After 1 h, further sodium borohydride (11.9 mg, 308 µmol, 2.00 equiv) 
was added. After 1.5 h, the reaction mixture was diluted with water (5 mL) and aqueous saturated 
ammonium chloride solution (5 mL) was added. The aqueous layer was extracted with ethyl acetate 
(3 × 20 mL) and the combined organic layers were dried over magnesium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10% ethyl acetate in n-pentane) to yield S22 (55.8 mg, 90%) as a 
white solid.  
TLC (10% ethyl acetate in n-pentane): Rf = 0.33 (CAM). 
1H-NMR (400 MHz, CDCl3): δ = 6.17 – 5.90 (m, 1H), 5.23 (t, J = 1.3 Hz, 1H), 5.22 – 5.12 (m, 
2H), 4.74 (dd, J = 3.3, 2.0 Hz, 1H), 4.01 (dd, J = 3.8, 2.0 Hz, 1H), 3.67 (s, 3H), 2.63 (ddt, J = 11.4, 
7.7, 4.1 Hz, 1H), 2.39 (ddd, J = 15.3, 10.2, 2.1 Hz, 1H), 2.16 (td, J = 12.8, 4.4 Hz, 1H), 2.09 – 2.03 
(m, 1H), 1.98 – 1.80 (m, 2H), 1.67 (dd, J = 15.3, 3.2 Hz, 1H), 1.64 – 1.46 (m, 4H), 1.42 – 1.35 (m, 
3H), 1.34 – 1.30 (m, 3H), 1.25 (s, 3H), 1.17 (s, 3H), 1.09 – 1.05 (m, 1H), 1.03 (d, J = 1.0 Hz, 3H). 
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13C-NMR (101 MHz, CDCl3): δ = 177.2, 146.4, 140.5, 122.3, 116.4, 105.8, 89.5, 76.3, 76.2, 51.6, 
48.6, 46.2, 44.2, 42.0, 32.7, 30.0, 29.8, 28.5, 28.1, 27.5, 26.7, 24.4, 24.4, 18.6. 
IR (Diamond-ATR, neat): ṽmax = 3498, 3005, 2931, 1727, 1413, 1312, 1234, 1205, 1180, 1122, 
1103, 1056, 1021 cm1. 
HRMS (ESI): calcd for (C24H36NaO5)+ [M+Na]+: 427.2455; found: 427.2472. 
[𝛂]𝐃
𝟐𝟎 = –44.05 (c = 0.70 in CH2Cl2). 
 
Triene 258 
 
To a solution of S22 (20.9 mg, 51.7 µmol, 1 equiv) in benzene (1 mL) was added a solution of 
Martin sulfurane (52.1 mg, 77.5 µmol, 1.50 equiv) in benzene (0.5 mL) and the mixture was stirred 
at 24 °C. After 2 h, aqueous saturated sodium bicarbonate solution (3 mL) was added to the reaction 
mixture. The layers were separated and the aqueous layer was extracted with ethyl acetate (3 × 
10 mL). The combined organic layers were dried over magnesium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography 
on silica gel (1–2% ethyl acetate in n-pentane) to yield 258 (10.0 mg, 50%) as an amorphous white 
solid.  
TLC (5% ethyl acetate in n-pentane): Rf = 0.57 (CAM, UV). 
1H-NMR (600 MHz, CDCl3): δ = 6.01 (d, J = 9.7 Hz, 1H), 5.68 (dd, J = 17.3, 10.5 Hz, 1H), 5.41 
(dd, J = 9.7, 1.4 Hz, 1H), 5.35 (dd, J = 4.8, 1.3 Hz, 1H), 4.87 (dd, J = 17.3, 1.5 Hz, 1H), 4.80 (dd, 
J = 10.5, 1.6 Hz, 1H), 3.66 (s, 3H), 2.69 (dt, J = 17.6, 4.2 Hz, 1H), 2.20 (dd, J = 17.3, 3.3 Hz, 1H), 
2.12 – 1.99 (m, 4H), 1.83 (tdd, J = 13.8, 9.2, 4.6 Hz, 1H), 1.65 (td, J = 13.6, 5.1 Hz, 1H), 1.52 (td, 
J = 4.7, 2.3 Hz, 1H), 1.47 – 1.43 (m, 1H), 1.42 – 1.38 (m, 3H), 1.25 (s, 3H), 1.19 (s, 3H), 1.11 (s, 
3H), 0.84 (s, 3H). 
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13C-NMR (151 MHz, CDCl3): δ = 177.2, 143.7, 137.0, 133.2, 127.8, 122.7, 110.3, 109.2, 91.8, 
78.1, 51.7, 48.5, 42.5, 42.3, 37.3, 36.6, 32.3, 32.0, 29.2, 29.1, 27.3, 26.0, 20.9, 18.6. 
IR (Diamond-ATR, neat): ṽmax = 2923, 2802, 1727, 1456, 1376, 1244, 1222, 1201, 1168, 1040, 
1000 cm1. 
HRMS (ESI): not found 
[𝛂]𝐃
𝟐𝟎 = –135.0 (c = 0.22 in CH2Cl2). 
 
Tricyclo[3.2.1.02,7]octene 257 
 
A solution of 258 (4.00 mg, 10.3 µmol, 1 equiv) in toluene (2 mL) was sealed in a pressure tube 
and the solution was heated to 170 °C. After 3 h, the solution was cooled to 24 °C and concentrated 
to yield 257 (4 mg, quant.) as amorphous, white solid. 
TLC (100% toluene): Rf = 0.17 (CAM, UV). 
1H-NMR (600 MHz, C6D6): δ = 5.79 (d, J = 5.7 Hz, 1H, H-11), 5.12 – 5.01 (m, 1H, H-6), 3.24 (s, 
3H, H-21), 2.52 (d, J = 14.9 Hz, 1H, H-7a), 2.29 (dd, J = 13.5, 5.3 Hz, 1H, H-3a), 2.24 (td, J = 
12.9, 5.1 Hz, 1H, H-1a), 2.10 (d, J = 12.2 Hz, 1H, H-14a), 2.05 (dd, J = 14.9, 3.7 Hz, 1H, H-7b), 
1.98 (dddd, J = 18.9, 13.5, 9.3, 5.2 Hz, 1H, H-2a), 1.81 (td, J = 13.5, 5.9 Hz, 1H, H-3b), 1.61 – 1.55 
(m, 2H, H-2b, H-15a), 1.46 (s, 3H, H-23), 1.43 (d, J = 4.8 Hz, 1H, H-1b), 1.39 (d, J = 6.4 Hz, 1H, 
H-12), 1.30 (s, 3H, H-23), 1.26 (s, 3H, H-17), 1.25 (s, 3H, H-18),1.22 (d, J = 11.7 Hz, 1H, H-14b), 
1.09 (s, 3H, H-20), 1.05 (dd, J = 6.8, 1.8 Hz, 1H, H-13), 0.80 (d, J = 10.8 Hz, 1H, H-15b). 
13C-NMR (151 MHz, C6D6): δ = 175.6 (C-19), 146.1 (C-9), 113.9 (C-11), 105.7 (C-22), 86.9 (C-
5), 75.5 (C-6), 49.7 (C-21), 47.7 (C-4), 44.4 (C-14), 43.3 (C-10), 40.1 (C-8), 36.1 (C-15), 33.0 (C-
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7), 31.7 (C-3), 29.0 (C-12), 28.5 (C-1), 28.2 (C-23), 28.1 (C-23), 26.5 (C-20), 25.5 (C-18), 23.3 (C-
16), 22.1 (C-13), 18.1 (C-17), 17.6 (C-2). 
IR (Diamond-ATR, neat): ṽmax = 3001 (w), 2929 (s), 2850 (w), 1728 (s), 1457 (m), 1376 (m), 1310 
(m), 1260 (w), 1226 (s), 1204 (s), 1179 (m), 1150 (m), 1140 (m), 1055 (m), 1041 (s), 1030 (s), 988 
(w), 872 (w), 776 (w) cm1. 
HRMS (ESI): calcd for (C24H35O4)+ [M+H]+: 387.2530; found: 387.2521. 
[𝛂]𝐃
𝟐𝟎 = +53.60 (c = 0.25 in CH2Cl2). 
 
Benzylidene 271a 
 
 
To a solution of 267 (65 mg, 0.20 mmol, 1 equiv) in dichloromethane (4 mL) was added 
benzaldehyde (31 μL, 0.30 mmol, 1.50 equiv) and para-toluenesulfonic acid (0.4 mg, 2.02 μmol, 
0.01 equiv) at 24 °C. After 2 h, the mixture was concentrated and the crude product was purified 
by flash column chromatography on silica gel (5% ethyl acetate in cyclohexane) to yield 271a 
(52 mg, 63%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexan): Rf = 0.32 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 7.43 – 7.29 (m, 5H), 5.99 (d, J = 2.6 Hz, 1H), 5.80 (s, 1H), 5.33 
(dd, J = 4.3, 2.0 Hz, 1H), 3.72 (s, 3H), 2.89 (m, 1H), 2.77 (ddd, J = 16.0, 10.4, 4.3 Hz, 1H), 2.60 – 
2.51 (m, 1H), 2.44 – 2.26 (m, 2H), 2.18 – 2.08 (m, 1H), 2.07 – 1.98 (m, 1H), 1.89 – 1.78 (m, 1H), 
1.65 – 1.55 (m, 2H), 1.34 – 1.24 (m, 2H), 1.13 (d, J = 0.9 Hz, 3H), 1.10 (s, 3H), 0.92 – 0.81 (m, 
1H). 
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13C-NMR (100 MHz, CDCl3) δ = 199.8, 176.4, 172.9, 138.0, 128.8, 128.2, 126.1, 123.8, 102.1, 
88.8, 75.9, 51.9, 48.6, 45.5, 38.6, 33.0, 33.0, 32.2, 31.6, 31.3, 23.9, 21.5, 18.5. 
IR (Diamond-ATR, neat): ṽmax = 2930, 1724, 1669, 1613, 1515, 1462, 1306, 1031 cm1. 
HRMS (ESI): calcd for (C25H30NaO5)+ [M+Na]+: 433.199; found: 433.197. 
 
Silyl ether 271i 
 
To a solution of 267 (130 mg, 0.40 mmol, 1 equiv) in dichloromethane (4 mL) was added 2,6-
lutidine (480 μL, 4.03 mmol, 10.00 equiv) and tert-butyldimethylsilyl trifluoromethanesulfonate 
(190 μL, 0.81 mmol, 2.00 equiv) at 0 °C. After 4 h, water (20 mL) and dichloromethane (20 mL) 
was added and the layers were separated. The aqueous layer was extracted with dichloromethane 
(3 × 20 mL). The combined organic layers were washed with water (20 mL) and saturated aqueous 
sodium chloride solution (20 mL), the washed solution was dried over sodium sulfate. The dried 
solution was filtered. and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (5‒10% ethyl acetate in cyclohexane) to yield 271i (140 mg, 80%) as 
a colorless oil. 
TLC (30% ethyl acetate in cyclohexane): Rf = 0.33 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 5.93 (d, J = 1.9 Hz, 1H), 5.22 (dd, J = 11.1, 5.4 Hz, 1H), 3.72 (s, 
3H), 2.71 – 2.61 (m, 1H), 2.56 (s, 1H), 2.40 (dt, J = 16.2, 4.6 Hz, 1H), 2.23 (m 1H), 2.10 (m, 1H), 
2.01 – 1.92 (m, 2H), 1.87 – 1.79 (m, 2H), 1.74 – 1.60 (m, 3H), 1.40 (m, 1H), 1.29 (s, 3H), 0.99 (s, 
3H), 0.89 (s, 9H), 0.19 (s, 3H), 0.15 (s, 3H). 
13C-NMR (100 MHz, CDCl3) δ = 200.5, 177.0, 172.3, 122.9, 79.2, 71.3, 51.8, 50.0, 46.5, 40.3, 
36.0, 34.1, 32.2, 31.1, 29.3, 27.0, 26.2, 22.1, 18.9, 18.3, 3.4, 3.6. 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
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IR (Diamond-ATR, neat): ṽmax = 3545, 2928, 2856, 1723, 1670, 1609, 1461, 1257, 1155, 1060 
cm1. 
HRMS (ESI): calcd for (C24H40NaO5Si)+ [M+Na]+: 459.254; found: 459.252. 
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α-Methyl enone 272 
 
A solution of n-butyl lithium (2.16 M in hexanes, 0.292 mL, 0.63 mmol, 2.50 equiv) was added 
dropwise to a solution of diisopropyl amine (0.108 mL, 0.76 mmol, 3.00 equiv) in tetrahydrofuran 
(3 mL) at 78 °C. After 10 min, the solution was allowed to warm to 0 °C. After 20 min at 0 °C, 
the solution was cooled to ‒78 °C and a solution of 271i (110 mg, 0.25 mmol, 1 equiv) in 
tetrahydrofuran (1.5 mL) was added dropwise. After 35 min, iodomethane (0.127 mL, 2.02 mmol, 
8.00 equiv) was added. After 6 h, water (20 mL) and ethyl acetate (20 mL) was added and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (3 × 20 mL). The combined 
organic layers were washed with water (20 mL) and saturated aqueous sodium chloride solution 
(20 mL), the washed solution was dried over sodium sulfate and the dried solution was filtered and 
the filtrate was concentrated. The residue was purified by flash column chromatography on silica 
gel (5‒10% ethyl acetate in cyclohexane) to yield 272 (78 mg, 69%) as white amorphous solid. 
TLC (30% ethyl acetate in cyclohexane): Rf = 0.47 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 5.83 (d, J = 1.5 Hz, 1H), 5.22 (dd, J = 10.9, 5.4 Hz, 1H), 3.71 (s, 
3H), 2.79 – 2.68 (m, 1H), 2.59 (s, 1H), 2.45 (td, J = 7.3, 5.0 Hz, 1H), 2.01 (td, J = 12.9, 4.5 Hz, 
1H), 1.94 – 1.62 (m, 6H), 1.59 – 1.50 (m, 1H), 1.37 – 1.30 (m, 1H), 1.27 (s, 3H), 1.08 (d, J = 7.0 
Hz, 3H), 1.01 – 0.99 (s, 3H), 0.89 (s, 9H), 0.19 (s, 3H), 0.15 (s, 3H). 
13C-NMR (100 MHz, CDCl3) δ 203.4, 177.1, 170.4, 121.3, 79.5, 71.8, 51.8, 50.0, 46.1, 39.8, 38.1, 
35.9, 34.1, 30.9, 29.5, 27.1, 26.3, 21.3, 18.9, 18.3, 15.8, 3.3, 3.4. 
IR (Diamond-ATR, neat): ṽmax = 2954, 2926, 2855, 1725, 1673, 1461, 1378, 1257, 1154, 1081, 
1058 cm1. 
HRMS (ESI): calcd for (C25H43O5Si)+ [M+H]+: 451.287; found: 451.285. 
  
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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PMP acetal 271b 
 
To a solution of 267 (445 mg, 1.38 mmol, 1 equiv) in dichloromethane (15 mL) was added para-
anisaldehyde (428 μL, 3.45 mmol, 2.50 equiv) and para-toluenesulfonic acid (13 mg, 0.07 mmol, 
0.05 equiv) at 0 °C. After 10 min, the reaction mixture was warmed to 24 °C and stirred for 15 h. 
Water (20 mL) and dichloromethane (20 mL) was added and the layers were separated. The 
aqueous layer was extracted with dichloromethane (3 × 30 mL). The combined organic layers were 
washed with water (20 mL) and saturated aqueous sodium chloride solution (20 mL), the washed 
solution was dried over sodium sulfate and the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (10‒20% 
ethyl acetate in cyclohexane) to yield 271b (340 mg, 56%) as a white foam. 
TLC (30% ethyl acetate in cyclohexane): Rf = 0.21 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 7.32 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.99 (d, J = 2.6 
Hz, 1H), 5.78 (s, 1H), 5.35 – 5.30 (m, 1H), 3.80 (s, 3H), 3.74 (s, 3H), 2.91 (m, 1H), 2.78 (ddd, J = 
15.2, 10.4, 4.3 Hz, 1H), 2.57 (dt, J = 17.1, 3.3 Hz, 1H), 2.36 (m, 2H), 2.19 – 2.08 (m, 2H), 2.08 – 
2.00 (m, 2H), 1.95 – 1.78 (m, 1H), 1.68 – 1.54 (m, 2H), 1.34 – 1.28 (m, 1H), 1.15 (s, 3H), 1.14 (s, 
3H). 
13C-NMR (100 MHz, CDCl3) δ = 199.9, 176.4, 173.1, 160.1, 130.2, 127.2, 123.8, 113.6, 102.1, 
88.7, 75.8, 55.3, 51.9, 48.6, 45.6, 38.7, 33.1, 32.3, 31.6, 31.3, 27.0, 24.0, 21.5, 18.5. 
IR (Diamond-ATR, neat): ṽmax = 2930, 1724, 1669, 1613, 1515, 1462, 1306, 1031 cm1. 
HRMS (ESI): calcd for (C26H33O6)+ [M+H]+: 441.227; found: 441.225. 
[𝛂]𝐃
𝟐𝟎 = –95.5 (c = 0.07 in CH2Cl2). 
  
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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α-Methyl enone 274 
 
A solution of n-butyl lithium (2.3 M in hexanes, 395 μL, 0.91 mmol, 2.00 equiv) was added 
dropwise to a solution of diisopropyl amine (149 μL, 1.04 mmol, 2.30 equiv) in tetrahydrofuran 
(4.5 mL) at 78 °C. After 10 min, the solution was allowed to warm to 0 °C. After 20 min at 0 °C, 
the solution was cooled to ‒78 °C and a solution of 271b (200 mg, 0.45 mmol, 1 equiv) in 
tetrahydrofuran (4.5 mL) was added dropwise. After 10 min, hexamethylphosphoric triamide 
(403 μL, 2.27 mmol, 5.00 equiv) was added. After 30 min, iodomethane (228 μL, 3.63 mmol, 
8.00 equiv) was added. After 4 h, the reaction mixture was allowed to warm to 24 °C. After 14 h, 
aqueous hydrochloric acid (1 M, 20 mL) and ethyl acetate (20 mL) was added and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 × 20 mL). The combined organic 
layers were washed with water (20 mL) and saturated aqueous sodium chloride solution (20 mL), 
the washed solution was dried over sodium sulfate and the dried solution was filtered and the filtrate 
was concentrated. The residue was purified by flash column chromatography on silica gel (5‒10% 
ethyl acetate in cyclohexane) to yield 274 (185 mg, 90%) as a yellow oil. 
TLC (40% ethyl acetate in cyclohexane): Rf = 0.42 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 7.29 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 5.92 (d, J = 2.7 
Hz, 1H), 5.73 (s, 1H), 5.33 (dd, J = 4.5, 1.9 Hz, 1H), 3.79 (s, 3H), 3.72 (s, 3H), 3.04 (t, J = 11.7 
Hz, 1H), 2.78 (ddd, J = 15.5, 10.5, 4.4 Hz, 1H), 2.62 – 2.52 (m, 1H), 2.29 (m, 2H), 2.07 – 1.80 (m, 
4H), 1.65 – 1.52 (m, 2H), 1.31 – 1.24 (m, 1H), 1.19 (d, J = 7.5 Hz, 3H), 1.13 (s, 3H), 1.12 (s, 3H). 
13C-NMR (101 MHz, CDCl3) δ 203.3, 176.6, 172.1, 160.2, 130.3, 127.7, 122.7, 113.7, 102.3, 88.9, 
76.0, 55.4, 52.0, 48.7, 45.6, 40.6, 39.2, 33.1, 31.7, 31.3, 26.7, 24.1, 21.6, 18.7, 15.7. 
IR (Diamond-ATR, neat): ṽmax = 2927, 1725, 1667, 1516, 1462, 1376, 1315, 12511172, 1077, 1045 
cm1. 
HRMS (ESI): calcd for (C27H35O6)+ [M+H]+: 455.243; found: 455.241. 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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[𝛂]𝐃
𝟐𝟎 = –9.5 (c = 0.05 in CH2Cl2). 
 
Carbonate 271h 
 
To a solution of 276 (500 mg, 1.55 mmol, 1 equiv) in dichloromethane (15 mL) was added pyridine 
(0.63 mL, 7.75 mmol, 5.00 equiv) at 0 °C. A solution of triphosgene (388 mg, 2.33 mmol, 
1.50 equiv) in dichloromethane (4 mL) was added dropwise. The reaction mixture was allowed to 
warm to 24 °C. After 14 h, saturated aqueous sodium bicarbonate (20 mL) and dichloromethane 
(20 mL) was added and the layers were separated. The aqueous layer was extracted with 
dichloromethane (3 × 30 mL). The combined organic layers were washed with water (20 mL) and 
saturated aqueous sodium chloride solution (20 mL), the washed solution was dried over sodium 
sulfate and the dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (1% methanol in dichloromethane) to yield 271h 
(501 mg, 93%) as a yellow oil. 
TLC (60% ethyl acetate in cyclohexane): Rf = 0.23 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 5.94 (d, J = 2.7 Hz, 1H), 5.57 (dd, J = 3.6, 2.2 Hz, 1H), 3.76 (s, 
3H), 2.89 – 2.80 (m, 1H), 2.71 (ddd, J = 16.4, 9.8, 3.6 Hz, 1H), 2.60 – 2.50 (m, 1H), 2.37 – 2.24 
(m, 1H), 2.22 – 2.17 (m, 1H), 2.07 (m, 4H), 1.89 – 1.62 (m, 3H), 1.38 – 1.31 (m, 1H), 1.28 (s, 3H), 
1.16 (s, 3H). 
13C-NMR (100 MHz, CDCl3) δ = 199.1, 174.9, 167.1, 152.6, 125.9, 89.1, 76.7, 52.6, 48.3, 44.6, 
38.8, 33.2, 31.6, 31.1, 30.9, 30.5, 22.7, 21.4, 18.4. 
IR (Diamond-ATR, neat): ṽmax = 2950, 1799, 1722, 1672, 1464, 1356, 1268, 1221, 1186, 1159, 
1091, 1040 cm1. 
HRMS (ESI): calcd for (C19H24O6Na)+ [M+Na]+: 371.146; found: 371.144. 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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[𝛂]𝐃
𝟐𝟎 = –12.0 (c = 0.13 in CH2Cl2). 
 
α-Methyl enone 276 
 
A solution of n-butyl lithium (2.5 M in hexanes, 1.10 mL, 2.76 mmol, 2.00 equiv) was added 
dropwise to a solution of diisopropyl amine (0.45 mL, 3.17 mmol, 2.30 equiv) in tetrahydrofuran 
(50 mL) at 78 °C. After 10 min, the solution was allowed to warm to 0 °C. After 20 min at 0 °C, 
the solution was cooled to ‒78 °C and a solution of 271h (480 mg, 1.38 mmol, 1 equiv) in 
tetrahydrofuran (5 mL) was added dropwise. After 10 min, hexamethylphosphoric triamide 
(1.47 mL, 8.27 mmol, 6.00 equiv) was added and the yellow solution turned dark orange. After 
30 min, iodomethane (0.69 mL, 11.0 mmol, 8.00 equiv) was added and the solution turned yellow 
again. The reaction mixture was allowed to warm to ‒10 °C. After 7 h, aqueous phosphate buffer 
solution (pH = 7) (50 mL) and ethyl acetate (50 mL) was added and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 × 30 mL). The combined organic layers were 
washed with water (50 mL) and saturated aqueous sodium chloride solution (50 mL), the washed 
solution was dried over sodium sulfate and the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (20‒50% 
ethyl acetate in cyclohexane) to yield 276 (253 mg, 51%) as amorphous white solid. 
TLC (60% ethyl acetate in cyclohexane): Rf = 0.23 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 5.88 (d, J = 2.7 Hz, 1H), 5.57 (dd, J = 3.7, 2.3 Hz, 1H), 3.76 (s, 
3H), 3.00 (ddt, J = 13.0, 9.8, 3.7 Hz, 1H), 2.72 (ddd, J = 16.5, 9.9, 3.7 Hz, 1H), 2.55 (ddd, J = 7.5, 
5.4, 2.0 Hz, 1H), 2.29 – 2.06 (m, 3H), 2.00 (dd, J = 16.5, 2.2 Hz, 1H), 1.89 – 1.61 (m, 4H), 1.37 – 
1.30 (m, 1H), 1.27 (s, 3H), 1.16 – 1.14 (m, 6H). 
13C-NMR (100 MHz, CDCl3) δ = 202.3, 174.9, 166.1, 152.6, 124.9, 89.2, 77.4, 52.6, 48.2, 44.6, 
40.2, 39.3, 31.1, 30.7, 30.4, 26.0, 22.8, 21.4, 18.3, 15.2. 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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IR (Diamond-ATR, neat): ṽmax = 2932, 1797, 1734, 1670, 1616, 1464, 1358, 1317, 1268, 1221, 
1185, 1160, 1049 cm1. 
HRMS (ESI): calcd for (C20H27O6)+ [M+H]+: 363.180; found: 363.178. 
[𝛂]𝐃
𝟐𝟎 = +27.0 (c = 0.07 in CH2Cl2). 
 
Secondary alcohol 277 
 
A solution of n-butyl lithium (2.4 M in hexanes, 0.20 mL, 0.47 mmol, 2.00 equiv) was added 
dropwise to a solution of diisopropyl amine (77.0 μL, 0.54 mmol, 2.30 equiv) in tetrahydrofuran 
(20 mL) at 78 °C. After 10 min, the solution was allowed to warm to 0 °C. After 20 min at 0 °C, 
the solution was cooled to ‒78 °C and a solution of 276 (85 mg, 0.23 mmol, 1 equiv) in 
tetrahydrofuran (2 mL) was added dropwise. After 10 min, N,N,N',N'-tetramethylethylenediamine 
(0.29 mL, 1.88 mmol, 8.00 equiv) was added. After 30 min, acetaldehyde (0.66 mL, 11.7 mmol, 
50.00 equiv) was added. The reaction mixture was allowed to warm to 10 °C. After 2 h, aqueous 
phosphate buffer solution (pH = 7, 30 mL) and ethyl acetate (30 mL) was added and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 × 30 mL). The combined organic 
layers were washed with water (30 mL) and saturated aqueous sodium chloride solution (30 mL), 
the washed solution was dried over sodium sulfate and the dried solution was filtered and the filtrate 
was concentrated. The residue was purified by flash column chromatography on silica gel (20‒50% 
ethyl acetate in cyclohexane) to yield 277 (75 mg, 79%) as amorphous white solid. 
TLC (70% ethyl acetate in cyclohexane): Rf = 0.22 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 5.92 (d, J = 2.7 Hz, 1H), 5.54 (dd, J = 3.6, 2.2 Hz, 1H), 3.98 (q, 
J = 6.4 Hz, 1H), 3.76 (s, 3H), 3.03 – 2.94 (m, 1H), 2.68 (ddd, J = 16.5, 10.0, 3.6 Hz, 1H), 2.24 – 
2.07 (m, 2H), 2.05 – 1.94 (m, 3H), 1.88 – 1.65 (m, 3H), 1.38 – 1.31 (m, 1H), 1.27 (s, 3H), 1.21 (d, 
J = 6.4 Hz, 3H), 1.16 (s, 3H), 1.06 (s, 3H). 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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13C-NMR (100 MHz, CDCl3) δ = 204.1, 174.8, 166.9, 152.44, 125.0, 89.3, 67.6, 53.6, 52.6, 49.1, 
48.2, 44.6, 43.6, 31.1, 30.6, 30.6, 27.5, 22.8, 21.2, 18.3, 17.6, 16.9. 
IR (Diamond-ATR, neat): ṽmax = 3501, 2938, 1794, 1724, 1658, 1459, 1361, 1313, 1268, 1222, 
1161, 1049, 1032 cm1. 
HRMS (ESI): calcd for (C22H31O7)+ [M+H]+: 407.206; found: 407.204. 
[𝛂]𝐃
𝟐𝟎 = +17.6 (c = 0.11 in CH2Cl2). 
 
α-Vinyl enone S23 
 
To a solution of 277 (70 mg, 0.17 mmol, 1 equiv) in benzene (10 mL) was added bis[α,α-
bis(trifluoromethyl)benzyloxy]diphenylsulfur (232 mg, 0.34 mmol, 2.00 equiv) at 24 °C. After 
7.5 h, water (10 mL) and ethyl acetate (20 mL) was added and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were 
washed with water (20 mL) and saturated aqueous sodium chloride solution (20 mL), the washed 
solution was dried over sodium sulfate and the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (5‒20% ethyl 
acetate in cyclohexane) to yield S23 (43 mg, 67%) as amorphous white solid. 
TLC (40% ethyl acetate in cyclohexane): Rf = 0.30 (CAM, UV). 
1H-NMR (400 MHz, CDCl3) δ = 5.88 (d, J = 2.8 Hz, 1H), 5.70 (dd, J = 17.6, 10.7 Hz, 1H), 5.53 
(t, J = 2.8 Hz, 1H), 5.05 (d, J = 10.6 Hz, 1H), 4.87 (d, J = 17.6 Hz, 1H), 3.73 (s, 3H), 2.90 (ddt, J = 
12.3, 9.8, 3.6 Hz, 1H), 2.66 (ddd, J = 16.5, 10.0, 3.6 Hz, 1H), 2.21 – 2.14 (m, 1H), 2.06 (dd, J = 
13.3, 4.5 Hz, 1H), 2.01 – 1.53 (m, 6H), 1.34 – 1.28 (m, 1H), 1.25 (s, 3H), 1.16 (s, 3H), 1.09 (s, 3H). 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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13C-NMR (100 MHz, CDCl3) δ = 200.9, 174.7, 166.0, 152.5, 139.8, 124.9, 115.3, 89.3, 52.5, 49.6, 
48.1, 45.9, 44.4, 31.0, 30.6, 30.3, 28.3, 24.1, 22.7, 21.1, 18.2. 
IR (Diamond-ATR, neat): ṽmax = 2923, 2852, 1802, 1731, 1671, 1462, 1355, 1266, 1221, 1184, 
1160, 1050 cm1. 
HRMS (ESI): calcd for (C22H28O6Na)+ [M+Na]+: 411.178; found: 411.177. 
[𝛂]𝐃
𝟐𝟎 = +42.0 (c = 0.07 in CH2Cl2). 
 
Triene 278 
To a solution of S23 (45 mg, 0.12 mmol, 1 equiv) in methanol (2 mL) was added cerium(III) 
chloride (43 mg, 0.17 mmol, 1.50 equiv) and sodium borohydride (8.9 mg, 0.23 mmol, 2.00 equiv) 
at 0 °C. The reaction mixture was warmed to 24 °C and stirred for 3.5 h. Water (0.5 mL) and sodium 
sulfate was added. The mixture was filtered through a short plug of celite covered with silica gel 
and the filter cake was rinsed with dichloromethane (10 mL). The filtrate was concentrated and the 
crude product S24 was used in the next step without further purification. 
To a solution of S24 (45 mg, 0.12 mmol, 1 equiv) in benzene (1 mL) was added bis[α,α-
bis(trifluoromethyl)benzyloxy]diphenylsulfur (194 mg, 0.29 mmol, 2.50 equiv) at 24 °C. After 9 h, 
water (10 mL) and ethyl acetate (10 mL) was added and the layers were separated. The aqueous 
layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with 
water (10 mL) and saturated aqueous sodium chloride solution (10 mL), the washed solution was 
dried over sodium sulfate and the dried solution was filtered and the filtrate was concentrated. The 
residue was purified by flash column chromatography on silica gel (5‒20% ethyl acetate in 
cyclohexane) to yield 278 (25 mg, 58% over 2 steps) as amorphous white solid. 
TLC (40% ethyl acetate in cyclohexane): Rf = 0.55 (CAM, UV). 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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1H-NMR (400 MHz, CDCl3) δ = 5.94 (d, J = 9.8 Hz, 1H), 5.80 (dd, J = 4.6, 1.3 Hz, 1H), 5.73 (dd, 
J = 17.4, 10.5 Hz, 1H), 5.51 (dd, J = 9.8, 1.3 Hz, 1H), 4.95 – 4.85 (m, 2H), 3.73 (s, 3H), 2.78 (dq, 
J = 17.6, 1.9 Hz, 1H), 2.37 – 2.29 (m, 1H), 2.22 (m, 3H), 1.98 (td, J = 13.1, 12.5, 4.3 Hz, 1H), 1.89 
– 1.73 (m, 1H), 1.71 – 1.58 (m, 3H), 1.28 (s, 3H), 1.09 (s, 3H), 0.91 (s, 3H). 
13C-NMR (100 MHz, CDCl3) δ = 175.0, 154.4, 144.8, 135.1, 134.9, 124.6, 120.9, 111.0, 90.7, 77.9, 
52.4, 48.1, 42.1, 41.1, 37.4, 34.0, 31.8, 31.0, 25.4, 23.2, 19.6, 18.4. 
IR (Diamond-ATR, neat): ṽmax = 2926, 1790, 1732, 1457, 1355, 1269, 1217, 1155, 1055 cm1. 
HRMS (ESI): calcd for (C22H28O5Na)+ [M+Na]+: 395.183; found: 395.183. 
 
Tricyclo[3.2.1.02,7]octene 279 
 
A solution of 278 (8.0 mg, 0.02 mmol) in toluene (0.5 mL) was sealed in a pressure tube and the 
solution was heated to 170 °C. After 13 h, the solution was cooled to 24 °C and concentrated to 
yield 279 (8 mg, 100%) as a colorless oil. 
TLC (50% ethyl acetate in cyclohexane): Rf = 0.64 (CAM). 
1H-NMR (400 MHz, CDCl3) δ = 5.81 (dd, J = 4.2, 1.8 Hz, 1H), 5.72 (d, J = 6.0 Hz, 1H), 3.71 (s, 
3H), 2.43 (dd, J = 16.1, 4.2 Hz, 1H), 2.14 – 2.07 (m, 1H), 1.94 (dd, J = 16.1, 1.8 Hz, 1H), 1.87 – 
1.71 (m, 2H), 1.68 – 1.55 (m, 5H), 1.44 (t, J = 6.5 Hz, 1H), 1.25 (s, 6H), 1.14 (dd, J = 7.0, 2.1 Hz, 
1H), 0.98 (s, 3H), 0.88 (d, J = 11.3 Hz, 1H), 0.68 (d, J = 11.0 Hz, 1H). 
13C-NMR (100 MHz, CDCl3) δ = 175.1, 154.4, 144.53, 116.4, 89.2, 77.4, 52.3, 48.3, 42.9, 41.4, 
38.8, 37.9, 33.6, 31.9, 31.2, 25.3, 25.2, 24.0, 22.7, 21.8, 18.5, 18.4. 
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
 
 
161 
 
IR (Diamond-ATR, neat): ṽmax = 2924, 1799, 1722, 1458, 1352, 1311, 1268, 1219, 1179, 1153, 
1091, 1043, 1026 cm1. 
HRMS (ESI): calcd for (C22H28O5Na)+ [M+Na]+: 395.183; found: 395.183.  
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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Alcohol 280 
 
To a solution of 279 (3.0 mg, 8.05 μmol, 1 equiv) in toluene (0.3 mL) was added sodium bis(2-
methoxyethoxy)aluminum hydride solution (60 wt% in toluene, 26 μL, 0.08 mmol, 10.0 equiv) 
at 20 °C. The reaction mixture was allowed to warm to 24 °C. After 8 h, water (10 mL) and ethyl 
acetate (10 mL) was added and the layers were separated. The aqueous layer was extracted with 
ethyl acetate (3 × 10 mL). The combined organic layers were washed with water (10 mL) and 
saturated aqueous sodium chloride solution (10 mL), the washed solution was dried over sodium 
sulfate and the dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (10‒50% ethyl acetate in cyclohexane) to yield 280 
(2.5 mg, 58%) as amorphous white solid. 
TLC (50% ethyl acetate in cyclohexane): Rf = 0.29 (CAM). 
1H-NMR (400 MHz, CDCl3) δ = 5.68 (d, J = 6.0 Hz, 1H), 5.50 (dd, J = 4.2, 1.7 Hz, 1H), 4.17 (d, 
J = 11.3 Hz, 1H), 3.55 (d, J = 11.1 Hz, 1H), 2.38 (dd, J = 16.0, 4.2 Hz, 1H), 1.88 – 1.82 (m, 1H), 
1.71 – 1.63 (m, 2H), 1.44 – 1.40 (m, 1H), 1.31 (s, 3H), 1.25 (s, 3H), 1.28 – 1.25 (m, 6H), 1.14 (s, 
3H), 0.91 – 0.85 (m, 2H), 0.72 (d, J = 10.9 Hz, 1H). 
13C-NMR (100 MHz, CDCl3) δ = 146.7, 114.7, 68.7, 45.5, 43.0, 42.8, 40.5, 38.3, 33.8, 32.1, 31.9, 
29.9, 27.8, 25.4, 25.1, 23.8, 22.0, 21.7, 18.6, 17.7 (quaternary C of the Carbonate is not visible). 
IR (Diamond-ATR, neat): ṽmax = 3466, 2949, 2922, 2868, 1789, 1765, 1459, 1377, 1360, 1250, 
1218, 1168, 1080, 1043, 1022 cm1. 
HRMS (ESI): calcd for (C21H29O4)+ [M+H]+: 345.206; found: 345.206. 
 
  
FEHLER! VERWENDEN SIE DIE REGISTERKARTE 'START', UM HEADING 1 DEM TEXT ZUZUWEISEN, DER 
HIER ANGEZEIGT WERDEN SOLL. 
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Triol 281 
 
To a solution of 279 (10.0 mg, 0.03 mmol, 1 equiv) in toluene (1 mL) was added sodium bis(2-
methoxyethoxy)aluminum hydride solution (60 wt% in toluene, 105 μL, 0.53 mmol, 20.0 equiv) 
at 20 °C. The reaction mixture was allowed to warm to 24 °C. After 3 h, the reaction mixture was 
heated to 70 °C. After 3.5 h, heating was ceased and water (10 mL) and ethyl acetate (10 mL) was 
added and the layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 
10 mL). The combined organic layers were washed with water (10 mL) and saturated aqueous 
sodium chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10‒50% ethyl acetate in cyclohexane) to yield 281 (7 mg, 82%) as 
amorphous white solid. 
TLC (60% ethyl acetate in cyclohexane): Rf = 0.28 (CAM). 
1H-NMR (400 MHz, CDCl3) δ = 5.82 (d, J = 6.0 Hz, 1H), 4.28 (t, J = 6.5 Hz, 1H), 3.80 (t, J = 7.9 
Hz, 2H), 3.25 (d, J = 7.3 Hz, 1H), 2.40 (dd, J = 15.5, 6.6 Hz, 1H), 1.97 (s, 1H), 1.61 (m, 2H), 1.41 
(m, 2H), 1.30 (s, 1H), 1.28 – 1.22 (m, 6H)  1.19 (s, 3H), 1.14 (dd, J = 7.1, 2.3 Hz, 1H), 1.07 (s, 3H), 
0.96 (d, J = 11.5 Hz, 1H), 0.90 – 0.83 (m, 2H), 0.65 (d, J = 11.1 Hz, 1H). 
13C-NMR (150 MHz, CDCl3) δ = 148.6, 144.2, 117.4, 66.5, 66.2, 43.9, 42.6, 40.1, 38.9, 38.1, 32.8, 
31.1, 29.7, 25.6, 24.9, 23.7, 22.6, 21.1, 18.5, 17.8. 
IR (Diamond-ATR, neat): ṽmax = 3418, 2923, 2855, 1731, 1458, 1377, 1261, 1012 cm1. 
HRMS (ESI): calcd for (C20H30O3Na)+ [M+Na]+: 341.209; found: 341.208. 
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5.3 1H and 13C NMR Spectra 
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5.4 Single Crystal X-ray Analysis 
Alkyne ent-134. 
Table 22 Crystallographic data for alkyne ent-134. 
net formula C11H12O 
Mr/g mol−1 160.21 
crystal size/mm 0.100 × 0.090 × 0.050 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21 1' 
a/Å 6.4826(2) 
b/Å 21.1847(7) 
c/Å 6.8691(2) 
α/° 90 
β/° 108.6300(10) 
γ/° 90 
V/Å3 893.92(5) 
Z 4 
calc. density/g cm−3 1.190 
μ/mm−1 0.074 
absorption correction Multi-Scan 
transmission factor range 0.8924–0.9705 
refls. measured 7806 
Rint 0.0314 
mean σ(I)/I 0.0456 
θ range 3.274–26.372 
observed refls. 3276 
x, y (weighting scheme) 0.0477, 0.3148 
hydrogen refinement constr 
refls in refinement −0.3(7) 
parameters 3466 
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restraints 219 
R(Fobs) 1 
Rw(F2) 0.0415 
S 0.1090 
shift/errormax 1.081 
max electron density/e Å−3 0.001 
min electron density/e Å−3 0.246 
 
 
Figure 12 Molecular structure of alkyne ent-134. Ellipsoids are drawn at 50% probability level. 
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Diol 266. 
Table 23 Crystallographic data for diol 266. 
Empirical formula  C14H22O5 
Formula weight  270.31 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c (no. 14) 
Unit cell dimensions a = 12.8786(5) Å 
 
b = 6.9825(3) Å 
 
c = 15.1052(6) Å 
Volume 1316.55(9) Å3 
Z 4 
Density (calculated) 1.364 Mg/m3 
Absorption coefficient 0.102 mm-1 
F(000) 584 
Crystal size 0.180 x 0.160 x 0.080 mm3 
Theta range for data 
collection 
2.783 to 25.250°. 
Index ranges 15<=h<=14, -8<=k<=8, -18<=l<=18 
Reflections collected 17524 
Independent reflections 2388 [R(int) = 0.0282] 
Completeness to theta = 
25.242° 
100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.971 and 0.957 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2388 / 2 / 182 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0356, wR2 = 0.0923 
R indices (all data) R1 = 0.0405, wR2 = 0.0957 
Extinction coefficient 0.022(2) 
Largest diff. peak and hole 0.335 and -0.275 e.Å-3 
Empirical formula  C14 H22 O5 
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Formula weight  270.31 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c (no. 14) 
Unit cell dimensions a = 12.8786(5) Å 
 
 
Figure 13 Molecular structure of diol 266. Ellipsoids are drawn at 50% probability level. 
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